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ABSTRACT 
 Disclosed herein are comprehensive details of a study on the total chemical 
synthesis of daphnane diterpene orthoesters (DDOs), a large group of secondary 
metabolites isolated from the plant families Eurphorbiacaea and Thymelaeaceae which 
are known to possess a broad spectrum of powerful biological activities. 
 Characterized by a tricyclo[9.3.0.0]tetradecane core ring system with two trans-
fused ring junctures, an average of nine oxygen appendages, and an unusual orthoester 
functionality, DDOs are amongst the most complex and structurally varied diterpene 
natural products and present a significant challenge towards de novo chemical synthesis. 
 These studies culminated in short (10-12 steps from known starting materials, 
16-18 total operations), stereocontrolled syntheses of tricyclic DDO cores containing 
seven contiguous stereocenters, of which six directly correspond to all known DDOs. 
Key to their assembly was the development of a concise p-quinol functionalization 
choreography that enabled rapid access to C-ring stereopolyads from simple precursors. 
Efforts to apply this strategy to the total synthesis of (±)-resiniferatoxin (RTX) are 
described in addition to a discussion for future work from this laboratory. 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CHAPTER ONE 
Daphnane Diterpene Orthoesters: A Comprehensive Introduction 
1.1 — Introduction to the daphnane diterpene orthoesters (DDOs) 
 Terpene secondary metabolites represent the largest class of natural products, with 
over 35,000 known members.  Their diverse structures, vast biological activities, and 1
peculiar modes of biosynthesis have fascinated chemists for decades, providing impetus 
for the development of new synthetic methods and strategies.  2
 The daphnane diterpene orthoesters (DDOs) are a large group of complex 
phytochemicals with a broad array of potent biological activities (vide infra). A 
representative sampling of common DDOs are shown in Figure 1.1. The extraordinary 
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structural intricacies and variety of DDOs, coupled with their often impressive medicinal 
properties, stands them amongst the great marvels of nature. 
 Characterized by a tricyclo[9.3.0.0]tetradecane core ring system (Figure 1.2, 1.7) 
with two trans-fused ring junctures, the all-carbon 5-7-6 architecture is routinely found 
heavily adorned with oxidative decoration (usually at least nine O-appendages, 1.8). 
Their incredible diversity is largely attributed to the boundless permutations of ester 
linkages on available hydroxyl-substituents as well as complex macrocylic appendages of 
polyketide origin found in higher-order DDOs. 
 As implied by their name, most daphnane diterpenoids possess an unusual 
orthoester motif derived from a complex triol system embedded within the six-membered 
C-ring of the natural product. This exotic structural emblem is exclusive in nature to 
secondary metabolites of plant origin3 and appears limited to DDOs; phragmalin-type 
liminoids (1.9); bufadienolide, ergostanoid, and preganoid steroids (1.11-1.13); and 
coumarinoids (1.10) (Figure 1.3).  
 The purpose of the orthoester functionality has been proposed to embody two 
possible roles as either an essential pharmacophore or as a structural lock that enforces a 
tricyclo[9.3.0.0]tetradecane
ring system
typical sites containing
O-appendages
1.7 1.8
Figure 1.2. All carbon framework of daphnane diterpene orthoesters & DDO numbering system
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specific conformation of the natural product which may be key to its biological function. 
As shown in Figure 1.4, an isolated cyclohexane ring 1.14 with the 9,13,14-orthoester 
linkage typical of DDOs forces the six-membered ring into a typically disfavored boat 
conformation. 
 The plants of the Euphorbiaceae and Thymelaeaceae families from which 
daphnane diterpene orthoesters are exclusively found have been employed as medicines 
in folk remedies by native cultures for over 2000 years.  The curative effects of these 3
plant constituents are also marked by the known lethal toxicity and often detrimental 
outcomes of their consumption. Indeed, the broad-spectrum of their activity runs a full 
spectrum from beneficial anti-cancer, anti-nociceptive, neuroprotective,  pesticidal, 4
cholesterol-lowering, and anti-hyperglycemic properties to negative inflammation, anti-
fertility, irritant, and potent tumor-promotion activities.  This remarkable range of 5
biological reactivity has inspired the scientific community to identify the cause of such 
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non-obvious, dichotomous outcomes in order to exploit these small molecules for the 
advancement of human longevity. 
 Geographically, DDOs from Euphorbiacaea (~900 species) and Thymelaeaceae (> 
7000 species) are abundant in Indomalaysia in addition to the tropical Americas and 
Africa. The plant species are generally shrubs, trees, and herbs and extracts are primarily 
derived from roots, stems, flowers, and sticky saps of the plants. A comprehensive review 
of over one-hundred new daphnane diterpenes isolated between 2009-Jan. 2018 is 
provided in the following section in order to provide a more thorough picture of their 
current known complexities and activities. 
 Biosynthetically, it is presumed that DDOs are a member of a larger ‘super-group’ 
of diterpene natural products which canonically include the lathyrane, tigliane, and 
ingenane families, all derived from the simple macrocyclic diterpene casbene.1 Current 
biosynthetic logic posits two discrete biogenetic phases termed ‘cyclase’ and ‘oxidase’ in 
which an initial building mode is followed by a oxidative, decorative mode. As will be 
discussed in Section 1.3, based on the available data a new combined ‘cyclase-oxidase’ 
paradigm has been hypothesized for the casbene super-family in which constructive 
building modes are predicated on ‘interruptive’ oxidative pathways. This stands in 
O O
R5
R3
R4
R2
O
R1
O
R4
R3
H H
R5 O
R2
O
R1
1.14
Figure 1.4. 9,13,14-orthoesters lock cyclohexane rings in strained boat conformation
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contrast to the currently accepted ‘cyclase-then-oxidase’ paradigm and provides a 
complementary mode of their in-vivo and de novo construction. 
 Historically, the laboratory preparation of these natural products has been arduous 
and the incredible difficulty in their efficient assembly is evident. A comprehensive 
overview of approaches towards the total chemical synthesis of daphnane, tigliane, and 
ingenane diterpenes is provided in the last section of this chapter. To date, DDOs have 
succumbed to synthesis on only three occasions via successful, albeit lengthy, routes from 
two academic groups. Considering the structural similaries of the targets, inclusion of 
successful syntheses of related tigliane and ingenane diterpenes provides a well-rounded 
discussion and is instructive in highlighting the often perilous task of generating fully 
synthetic material of such complexity. 
1.2 — Review of daphnane diterpene isolation literature since 2009 
 The isolation and known biological activities of daphnane diterpenes have been 
comprehensively reviewed up to late 2008.4, , , , ,  Presented herein is a short review of 6 7 8 9 10
one hundred fifty-three new daphnane diterpenes isolated and characterized from 2009 to 
January 2018. 
 For historical and organizational clarity, all chemical structures (Figures 1.6-1.11) 
and their discussion are presented in chronological order by year of isolation while the 
given names of the natural products, their known biological activities, and the plant 
source from which the phytochemicals were obtained are tabulated based on their 
defining structural motifs (Tables 1.1-1.11). Likewise, it should be noted that the 
!  6
following section is limited to the discovery of novel daphnane diterpenes from 
2009-2018; a considerable amount of biological research has been conducted on 
previously isolated DDOs and these new insights are beyond the scope of this review. 
 A total of eleven classifications (Figure 1.5) are used to discriminate amongst the 
incredible diversity of this new collection. Six of the sub-types are canonical in the DDO 
literature [(1) daphnetoxins (1.15); (2) 12-hydroxydaphnetoxins (1.16); (3) 6,7-
hydroxydaphnetoxins (1.19); (4) resiniferanoids (1.18); (5) 1α-alkyldaphnanes (1.17); 
and (6) 16-alkyldaphnanes (1.20)] while an additional five new sub-classes [(7) ketal-
lactone daphnanes (1.21); (8) 19-chlorinated daphnanes (1.22); (9) 4,6-oxetanedaphnanes 
(1.23); (10) 4,7-oxalanedaphnanes (1.24); and (11) 6-hydroxy-7-hydrodaphnanes (1.25)] 
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were coined in consideration of several newly discovered daphnane diterpene motifs 
which have yet to be compehensively reviewed. 
 In 2009 the structures of seven new daphnanes were disclosed. Hirseins A and B 
(1.26-1.27), isolated by Shigemori and co-workers from the aerial parts of T. hirsuta, are 
12-hydroxydaphnetoxins with cinnamyl esters at C12 and were found to inhibit 
melanogenesis in B16 murine melanoma cells.  Two new 16-alkyldaphnanes, 11
trigochilides A and B (1.28-1.29), possessing complex twelve carbon-length polyketide 
appendages were isolated by Yue and co-workers from the twigs and leaves of T. 
chinensis and were found to exhibit only moderate cytotoxicity against two tumor cell 
lines.  A novel 3-hydro-12-hydroxydaphnetoxin (3-hydrogenkwadaphnin 1.30) was 12
isolated from the leaves of D. Lessertii by Yazdanparast and Meshkini and possesses 
differentiation and apoptotic potency among several leukemic cells with no adverse 
effects on normal cells.  Fletcher and co-workers  reported two new daphnanes with, at 13 14
the time, unprecedented structural rearrangements of the A-ring; pimelotides A and B 
(1.31-1.32), minor phytochemical components of P. elongata foilage, are 1α-
alkyldaphnanes wherein the A-ring has undergone oxidative rearrangement to a ketal-
lactone-type moiety. Since their seminal report, five additional examples of ketal-lactone-
type daphnanes have been communicated (vide infra). 
 In 2010 twenty-nine new daphnanes were isolated and their structures and 
biological activities reported. Genkwanine I 1.33 was isolated from the flower bud of 
Daphne genkwa  and exhibited inhibitory activity against human promyelocytic Hl-60 15
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cells (IC50 11.7 µM). Two unnamed 1,2-dihydrodaphnetoxins 1.34 and 1.35 were 
identified as constituents of root barks of D. tangutica and notably were isolated as open-
form esters.  Trigoxyphins A-F (1.36-1.41) were isolated from twigs of T. 16
xyphophylloides by Yue and co-workers  and gave cytotoxic activity against HL60 and 17
A549 tumor cell lines. Structurally, 1.39 and 1.40 possess an unusual 9,12,14-orthoester 
and, along with 1.41, are noteworthy in their complexity with up to five ester appendages 
throughout the carbon skeleton. Liu and co-workers were the first to report a new 
structural-type of daphnane  possessing a bridged 4,6-oxetane ring and an orthoester 18
linkage derived from a 12,13,14-triol: trigonothyrins A-C (1.42-1.44) were isolated from 
the stems of T. thyrsoideum and trigonothyrin C demonstrated anti-HIV activity (EC50 
2.19 µg/mL). The originally proposed α-stereochemistry at C6 by Liu was soon after 
corrected to β by Yue and co-workers in their isolation of trigochinins A-C (1.49-1.51), 
related 4,6-oxetanedaphnanes from T. chinensis.  The relative configuration at C6 was 19
confirmed by X-ray crystallographic analysis  and 1.51 was also shown to significantly 20
inhibit MET tyrosine kinase. Interestingly, 1.49 and 1.50 were isolated as open-form 
esters while 1.51 differs from the trigonothyrins with an equally unusual 9,12,14-
orthoester. The same group to isolate 1.42-1.44 later disclosed additional members 
trigonothyrins D-G (1.45-1.48) which possessed anti-HIV activity  while Yue’s group 21
likewise disclosed the isolation of trigochinins D-I (1.52-1.57), of which some members 
possess potent anti-tumor activities.  Yuanhuahine 1.58 and yuanhualine 1.59 were 22
obtained from the flowers of D. genkwa and exhibited noteworthy cytotoxicity (IC50 
!  10
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Figure 1.7. Structures of new daphnane diterpenes 1.52-1.82
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12-53 nM) against A549 cells.  Continuing along their previous work, Fletcher’s group 23
reported two additional ketal-lactone-type daphnanes, pimelotides C and D (1.60-1.61), 
again from Pimealea elongata.  Two unnamed 1α-alkyldaphnanes, 1.62 and 1.63, were 24
also obtained from the same plant extract. 
 In 2011 the structures and activities of twenty-three new daphnane diterpenes 
were reported. Trigonosins A-F (1.64-1.69) were isolated from T. thyrsoideum by Hao 
and co-workers;  despite their fantastic diversity and complexity none were found to be 25
active against multiple tumor cell lines. Trigohownins A-I (1.70-1.78) are heavily 
oxidized daphnane diterpenes isolated by Yue and co-workers from T. howii.  1.70 and 26
1.73 displayed moderate cytotoxic activity however structurally trigohownins F-I 
(1.75-1.78) are remarkble for their complexity as open-form esters, showcased by thirteen 
contiguous stereocenters—nine of which contain oxygen—and up to six ester 
appendages. The same group soon after reported the isolation of trigoheterins A-E 
(1.79-1.83) from T. hetereophyllus.  1.53 and 1.54 are open-form esters of the 4,6-27
oxetanedaphnane sub-type while 1.82-1.83 contain the archetypal 9,13,14-orthoester 
linkage but differ in overall oxidation states and ester adornment. 1.83 exhibited 
cytotoxic activity (IC50 1.8 µM and 10.0 µM against HL-60 and A549, respectively). 
Stelleralides A-C, complex 1α-alkyldaphnanes 1.84-1.85, and a new ketal-lactone 
daphanane 1.86 with potent anti-HIV activity were isolated from the roots of S. 
chamaejasme L. by Lee, et al.  28
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Figure 1.8. Structures of new daphnane diterpenes 1.83-1.110
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 The structures of nineteen novel daphnane diterpenes were reported in 2012, 
including the disclosure of a new DDO sub-type: 19-chlorinated daphnanes. 
Trigocherrins A-E (1.87-1.92) and trigocherriolides A-D (1.93-1.96) are a series of 
halogenated daphnane diterpene orthoesters isolated from the bark and wood of 
Trigonostemon cherrieri, a rare endemic plant of New Caledonia, and many possessed 
notable anti-viral activity against various pathogens. ,  The novel vinyl chloride moiety 29 30
at C19 in addition to unsaturation at C1-C10 and a 9,12-14-orthoester linkage are 
defining features of this new class of DDOs. B-ring oxidation patterns exist as either 
traditional epoxyalcohol stereopolyads or of the 6,7-dihydroxy-type. Compounds 
1.93-1.96 also possess the 16-alkyldaphnane motif with a saturated eleven-carbon 
macrocyclic ester appendage. The 12-hydroxydaphnetoxin trigoxyphin H 1.97 and a 
related 6,7-dihydroxydaphnetoxin trigoxyphin I 1.98 were obtained from T. 
xyphophylloides and displayed modest cytotoxic activities.  Five new 12-31
hydroxydaphnetoxins, acutilobins A-E (1.99-1.103), and two 1,2,3-trihydrodaphnetoxins 
(acutilobins F-G, 1.104-1.105), isolated from D. acutiloba Rehd. by Zhao and co-
workers  displayed cytotoxicity against several tumor cell lines in addition to potent 32
anti-HIV activity (EC50 <1.5 nM, SI >10,000). 
 Thirty-two new daphnane diterpenes were uncovered in 2013. Trigoxyphins J-K 
(1.106-1.107), obtained from T. xyphophylloides, bear structural similaries to 
trigoxyphins H-I (1.97-1.98) reported the year prior23 but were found inactive against all 
tumor cell lines evaluated.  Trigothysoids A-P (1.108-1.123) were obtained from 33
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methanol extracts of twigs and leaves of T. thyrsoideum with 1.121, a complex 16-
alkyldaphnane, possessing remarkably potent anti-HIV activity (EC50 0.001 nM, TI 
17,619). The authors suggest the free alcohol at C20 could be a contributing factor to the 
anti-HIV activity of the active phytochemicals tested.  Trigolins A-G (1.124-1.130) were 34
isolated from the stems of Trigonostemon lii and displayed modest anti-HIV activities.  35
Bioassay-guided studies on D. genkwa led to the isolation of genkwanine VIII 1.131 with 
a novel 4,7-oxalane bridging motif and open-form ester.  Compound 1.131 displayed 36
anti-cancer activity and notably is the first example of a 4,7-oxalanedaphnane. Two new 
resiniferanoid esters 1.132-1.133 were isolated from the flower buds of D. genkwa by 
Hwang and co-workers  with 1.132 displaying inhibitory activity for melaogenesis. It is 37
worth mentioning that these 12-hydroxyresiniferanoids are a rare example of new 
members of this sub-class, which prior to their discovery posessed no more than five 
members,  including the flagship DDO resiniferatoxin (RTX, 1.4). Genkwadanes A-D 38
(1.134-1.137), cytotoxic constituents from flower buds of D. genkwa, were isolated by 
Song and co-workers.  1.134 is noteworthy for possessing a rare point of unsaturation at 39
C1-C10. 
 Six new daphnane diterpenes were reported in 2014. Trigocherrierin A 1.138 and 
the 19-chlorinated daphnane trigocherriolide E 1.139 were obtained from T. cherrieri and 
possess anti-viral activities.  The EtOAc extracts of E. acertiflia Didr afforded 40
excoecafolins D-E (1.140-1.145).  Notably 1.140 is the first example of a daphnetoxin 41
completely lacking an orthoester appendage and all six alcohol groups are without 
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additional functionalization.  The unnamed open-form ester daphnetoxin 1.142 was 42
isolated from S. chamaejasma L. and was shown to inhibit topoisomerase II.  43
Daphnegiradldigin 1.143 was isolated from D. giraldii as an open-form ester daphnetoxin 
with a benzoate group at C14.  The authors did not report any biological activity. 44
 Twenty-three unique daphnane diterpenes were reported in 2015. Trigoxyphins U-
W (1.144-1.146) were obtained from T. xyphophylloides with 1.146 showing modest 
levels of cytotoxicity.  Bioassay-guided fractionation of petroleum ether extracts of roots 45
of S. chamaejasme led to the identification of stelleralides D-J (1.147-1.152).  46
1.147-1.148 are additional examples of ketal-lactone daphnanes and notably 1α-
alkyldaphnanes 1.149-1.151 are extremely potent in their anti-HIV activity (EC50 < 0.001 
µM, SI >13,000) and low cytotoxicity (> 10 µM). Neogenkwanines A-H (1.154-1.161), a 
series of eight open-form ester 4,6-oxetane- and 4,7-oxalanedaphnanes, were isolated 
from the flower buds of D. genkwa and were tested for cytotoxic activities.  Hamburger 47
and co-workers employed a two-microelectrode voltage clamp assay to uncover the 16-
hydroxydaphnetoxins yuanhuacines A-B (1.162-1.163) which were capable of inhibiting 
the hERG channel, an important antitarget in pharmacology.  1α-alkyldaphnanes 48
wikstroelides R-T (1.164-1.166) were isolated from the flower buds of W. chamaedaphne 
and exhibited moderate cytotoxicity against several cancer cell lines.  49
 To the best of my knowledge, there were no reports of new daphnane diterpenes 
isolated in 2016, however, five new daphnane diterpenes were published in 2017. 
Trigonostempenes A-D (1.167-1.170) from T. thyrsoideus were used for phytochemical 
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investigations of nitric oxide (NO) inhibition for new anti-neuroinflammatory agents. The 
authors posit based on their results that the plant T. thyrsoideus may hold potential 
medicinal value for the treatment of neuroinflammation.  Using ‘massive multi-50
informational molecular networks’ as a prioritization system for natural product 
discovery Litaudon and co-workers disclosed the structure of neoguillauminia 1.171, a 
novel 6,7-dihydroxydaphnetoxin with an unusual unsaturated fatty ester linked at C-20.  51
1.171 displayed inhibition of the Wnt signaling pathway in addition to anti-viral activity 
against CHIKV. 
 As of late January 2018 a single report exists disclosing the structures of five 
unique daphnane diterpenes, thyrsoidpenes A-G (1.172-1.178) from the leaves of T. 
thyrsoideus  by the same group to discover trigonostempenes A-D.43 Like the previous 52
study, NO inhibition activity was studied and the corresponding activities reported. 
Interestingly, the reported structure of 1.177 is the first example of a 6-hydroxy-7-
hydrodaphnane and currently is the only known DDO of this sub-type. 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Table 1.1. Daphnetoxin-type daphnanes
Table 1.2. 12-hydroxydaphnetoxin-type daphnanes
Name No. Activity Source Ref.
Genkwanin I 1.33 anti-tumor D. genkwa 15
Unnamed daphnane 1.34 — D. tangutica M. 16
Unnamed daphnane 1.35 — D. tangutica M. 16
Acutilobin F 1.104 cytotoxic; 
anti-HIV
D. acutiloba R. 32
Acutilobin G 1.105 cytotoxic; 
anti-HIV
D. acutiloba R. 32
Excoecafolin D 1.140 anti-HIV E. acertiflia D. 41
Unnamed daphnane 1.142 topoisomerase II 
inhibition
S. chamaejasme L. 43
Daphnegiraldigin 1.143 — D. giraldii N. 44
Name No. Activity Source Ref.
Hirsein A 1.26 anti-cancer Thymelaea hirsuta 11
Hirsein B 1.27 anti-cancer Thymelaea hirsuta 11
3-Hydrogenkwadaphnin 1.30 anti-leukemia D. lessertii 13
Trigoxyphin A 1.36 cytotoxic T. xyphophylloides 17
Trigoxyphin B 1.37 cytotoxic T. xyphophylloides 17
Trigoxyphin C 1.38 — T. xyphophylloides 17
Trigochinin G 1.55 — T. chinensis 22
Trigochinin H 1.56 — T. chinensis 22
Trigochinin I 1.57 — T. chinensis 22
Yuanhuahine 1.58 anti-cancer D. genkwa 23
Yuanhualine 1.59 anti-cancer D. genkwa 23
Trigonosin A 1.64 — T. thyrsoideum 25
Trigonosin B 1.65 — T. thyrsoideum 25
Trigonosin C 1.66 — T. thyrsoideum 25
Trigoheterin E 1.83 cytotoxic T. heterophyllus M. 27
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Trigoxyphin H 1.97 — T. xyphophylloides 31
Trigoxyphin J 1.106 — T. xyphophylloides 33
Trigoxyphin K 1.107 — T. xyphophylloides 33
Acutilobin A 1.99 cytotoxic; 
anti-HIV
D. acutiloba R. 32
Acutilobin B 1.100 cytotoxic; 
anti-HIV
D. acutiloba R. 32
Acutilobin C 1.101 cytotoxic; 
anti-HIV
D. acutiloba R. 32
Acutilobin D 1.102 cytotoxic; 
anti-HIV
D. acutiloba R. 32
Acutilobin E 1.103 cytotoxic; 
anti-HIV
D. acutiloba R. 32
Trigothysoid M 1.120 anti-HIV T. thyrsoideum 34
Genkwadane D 1.137 — D. genkwa 39
Trigocherrierin A 1.138 anti-viral T. cherrieri 40
Excoecafolin E 1.141 anti-HIV E. acertiflia D. 41
Trigoxyphin V 1.145 — T. xyphophylloides 45
Stelleralide I 1.152 anti-HIV S. chamaejasme 46
Yuanhuacine A 1.162 — D. genkwa 48
Yuanhuacine B 1.163 hERG inhibition D. genkwa 48
Trigonostempene C 1.169 nitric oxide 
inihibition
T. thyrsoideum 50
Thyrsoidpene B 1.173 nitric oxide 
inihibition
T. thyrsoideum 52
Thyrsoidpene C 1.174 nitric oxide 
inihibition
T. thyrsoideum 52
Thyrsoidpene D 1.175 nitric oxide 
inihibition
T. thyrsoideum 52
Thyrsoidpene E 1.176 nitric oxide 
inihibition
T. thyrsoideum 52
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Table 1.3. 6,7-Dihydroxydaphnetoxin-type daphnanes
Name No. Activity Source Ref.
Trigoxyphin D 1.39 — T. xyphophylloides 17
Trigoxyphin E 1.40 — T. xyphophylloides 17
Trigoxyphin F 1.41 — T. xyphophylloides 17
Trigoxyphin I 1.98 cytotoxic T. xyphophylloides 31
Trigoxyphin U 1.144 — T. xyphophylloides 45
Trigoxyphin W 1.144 cytotoxic T. xyphophylloides 45
Trigonothyrin F 1.47 anti-HIV T. thyrsoideum 21
Trigonothyrin G 1.48 — T. thyrsoideum 21
Trigohownin A 1.70 cytotoxic T. howii 26
Trigohownin B 1.71 — T. howii 26
Trigohownin C 1.72 — T. howii 26
Trigohownin D 1.73 cytotoxic T. howii 26
Trigohownin E 1.74 — T. howii 26
Trigohownin F 1.75 — T. howii 26
Trigohownin G 1.76 — T. howii 26
Trigohownin H 1.77 — T. howii 26
Trigohownin I 1.78 — T. howii 26
Trigoheterin C 1.81 — T. heterophyllus M. 27
Trigoheterin D 1.82 — T. heterophyllus M. 27
Trigothysoid A 1.108 — T. thyrsoideum 34
Trigothysoid B 1.109 — T. thyrsoideum 34
Trigothysoid C 1.110 — T. thyrsoideum 34
Trigothysoid D 1.111 — T. thyrsoideum 34
Trigothysoid E 1.112 — T. thyrsoideum 34
Trigothysoid F 1.113 — T. thyrsoideum 34
Trigothysoid G 1.114 — T. thyrsoideum 34
Genkwadane A 1.134 — D. genkwa 39
Stelleralide J 1.153 anti-HIV S. chamaejasme 46
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Table 1.4. Resiniferanoid-type daphnanes
Table 1.5. 1α-Alkyldaphnanes
Table 1.6. 16-Alkyldaphnanes
Neoguillauminia 1.171 Wnt inihibition; 
anti-viral
N. cleopatra 51
Thyrsoidpene G 1.178 nitric oxide 
inihibition
T. thyrsoideum 52
Name No. Activity Source Ref.
Daphneresiniferin A 1.132 melanogenesis 
inhibition
D. genkwa 37
Daphneresiniferin B 1.133 cytotoxic D. genkwa 37
Name No. Activity Source Ref.
Unnamed daphnane 1.62 — Pimelela elongata 24
Unnamed daphnane 1.63 — Pimelela elongata 24
Stelleralide A 1.84 anti-HIV S. chamaejasme L. 28
Stelleralide B 1.85 anti-HIV S. chamaejasme L. 28
Genkwadane B 1.135 — D. genkwa 39
Genkwadane C 1.136 — D. genkwa 39
Stelleralide F 1.149 anti-HIV S. chamaejasme 46
Stelleralide G 1.149 anti-HIV S. chamaejasme 46
Stelleralide H 1.149 anti-HIV S. chamaejasme 46
Wikstroelide R 1.164 cytotoxic W. chamaedaphne 49
Wikstroelide S 1.165 cytotoxic W. chamaedaphne 49
Wikstroelide T 1.166 cytotoxic W. chamaedaphne 49
Name No. Activity Source Ref.
Trigochilide A 1.28 cytotoxic T. chinensis 12
Trigochilide B 1.29 — T. chinensis 12
Trigonosin E 1.68 — T. thyrsoideum 25
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Table 1.7. Ketal-lactone daphnanes 
Table 1.8. 19-Chlorinated daphnanes 
Trigonosin F 1.69 — T. thyrsoideum 25
Trigothysoid N 1.121 — T. thyrsoideum 34
Trigothysoid O 1.122 anti-HIV T. thyrsoideum 34
Trigothysoid P 1.123 — T. thyrsoideum 34
Trigonostempene D 1.170 nitric oxide 
inihibition
T. thyrsoideum 50
Name No. Activity Source Ref.
Pimelotide A 1.31 — Pimelela elongata 14
Pimelotide B 1.32 — Pimelela elongata 14
Pimelotide C 1.60 — Pimelela elongata 24
Pimelotide D 1.61 — Pimelela elongata 24
Stelleralide C 1.86 anti-HIV S. chamaejasme L. 28
Stelleralide D 1.147 anti-HIV S. chamaejasme 46
Stelleralide E 1.148 — S. chamaejasme 46
Name No. Activity Source Ref.
Trigocherrin A 1.87 anti-viral T. cherrieri 29
Trigocherrin B 1.88 anti-viral T. cherrieri 30
Trigocherrin C 1.91 anti-viral T. cherrieri 30
Trigocherrin D 1.89 anti-viral T. cherrieri 30
Trigocherrin E 1.92 anti-viral T. cherrieri 30
Trigocherrin F 1.90 anti-viral T. cherrieri 30
Trigocherrolide A 1.93 anti-viral T. cherrieri 30
Trigocherrolide B 1.95 anti-viral T. cherrieri 30
Trigocherrolide C 1.94 anti-viral T. cherrieri 30
Trigocherrolide D 1.96 anti-viral T. cherrieri 30
Trigocherrolide E 1.139 anti-viral T. cherrieri 40
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Table 1.9. 4,6-Oxetanedaphnanes 
Name No. Activity Source Ref.
Trigonothyrin A 1.42 — T. thyrsoideum 18
Trigonothyrin B 1.43 — T. thyrsoideum 18
Trigonothyrin C 1.44 anti-HIV T. thyrsoideum 18
Trigonothyrin D 1.45 — T. thyrsoideum 21
Trigonothyrin E 1.46 — T. thyrsoideum 21
Trigochinin A 1.49 — T. chinensis 19
Trigochinin B 1.50 — T. chinensis 19
Trigochinin C 1.51 MET tyrosine 
kinase inhibition
T. chinensis 19
Trigochinin D 1.52 — T. chinensis 22
Trigochinin E 1.53 anti-tumor T. chinensis 22
Trigochinin F 1.54 anti-tumor T. chinensis 22
Trigonosin D 1.67 — T. thyrsoideum 25
Trigoheterin A 1.79 — T. heterophyllus M. 27
Trigoheterin B 1.80 — T. heterophyllus M. 27
Trigothysoid H 1.115 — T. thyrsoideum 34
Trigothysoid I 1.116 — T. thyrsoideum 34
Trigothysoid J 1.117 anti-HIV T. thyrsoideum 34
Trigothysoid K 1.118 — T. thyrsoideum 34
 Trigothysoid L 1.119 anti-HIV T. thyrsoideum 34
Trigolin A 1.124 — Trigonostemon lii 35
 Trigolin B 1.125 — Trigonostemon lii 35
Trigolin C 1.126 anti-HIV Trigonostemon lii 35
Trigolin D 1.127 — Trigonostemon lii 35
Trigolin E 1.128 — Trigonostemon lii 35
Trigolin F 1.129 — Trigonostemon lii 35
Trigolin G 1.130 anti-HIV Trigonostemon lii 35
Neogenkwanine H 1.161 — D. genkwa 47
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Table 1.10. 4,7-Oxalanedaphnanes 
Table 1.11. 6-Hydroxy-7-hydrodaphnanes 
 
Trigonostempene A 1.167 nitric oxide 
inihibition
T. thyrsoideum 50
Trigonostempene B 1.168 nitric oxide 
inihibition
T. thyrsoideum 50
Thyrsoidpene A 1.172 nitric oxide 
inihibition
T. thyrsoideum 52
Name No. Activity Source Ref.
Genkwanine VIII 1.131 anti-cancer D. genkwa 36
Neogenkwanine A 1.154 — D. genkwa 47
Neogenkwanine B 1.155 — D. genkwa 47
Neogenkwanine C 1.156 Hep3B inhibition D. genkwa 47
Neogenkwanine D 1.157 Hep3B inhibition D. genkwa 47
Neogenkwanine E 1.158 Hep3B inhibition D. genkwa 47
Neogenkwanine F 1.159 — D. genkwa 47
Neogenkwanine G 1.160 — D. genkwa 47
Name No. Activity Source Ref.
Thyrsoidpene F 1.177 nitric oxide 
inihibition
T. thyrsoideum 52
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1.3 — Neurotrophic daphnane diterpene orthoesters 
 Neurodegenerative diseases affect approximately fifty million people worldwide 
and there is currently no definitive cure to any of these debilitating illnesses. One 
potential mode of therapy involves the use of neutrotrophic factors (NTFs)—endogenous 
peptides known to regulate the development, maintenance, and survival of neurons—to 
rescue certain neuronal cell populations. However, since NTFs are peptides they 
generally possess poor pharmacokinetic properties and cannot readily pass through the 
blood-brain-barrier. Small molecules readily pass through the blood-brain-barrier and 
offer one potential solution to the problems associated with the delivery of NTFs. Thus, 
identification of a small molecule capable of promoting neuronal survival along with the 
development of synthetic methods to generate sufficient quantities for in-depth medicinal 
chemistry and biological studies would greatly aid the search for new therapies in the 
continual advancement of human longevity.  53
 Our group first became interested in daphnane synthesis in 2013 when we became 
aware of kirkinine 1.181, a 12-hydroxydaphnetoxin from the dichloromethane extracts of 
Synaptolepis kirkii first disclosed by De Kimpe and co-workers in 2000 (Figure 1.12).  54
Kirkinine displayed remarkable neurotrophic properties, promoting neuronal survival in a 
dose-dependent fashion comparable to the endogenous protein nerve-growth factor 
(NGF) (IC50 ~70 nM). Bio-assay guided fractionation of S. kirkii led to the discovery of 
additional DDOs, including kirkinine B 1.180, a 1α-alkyldaphnetoxin, and the 
daphnetoxin synaptolepis factor K7 1.179, in 2002.  Kirkinine B and synaptolepis factor 55
!  28
K7 were nearly unprecedented in their neurotrophic activities (IC50 45 and 8.8 nM, 
respectively). Interestingly, the sole structural difference between 1.179 and 1.181 is the 
presence or lack of an acetyl ester at C12 yet 1.179 is roughly an order of magnitude 
more effective in promoting neuronal survival than 1.181. To the best of my knowledge, 
1.179 remains the most potent neurotrophic small molecule discovered to date but the 
low isolation yields and likely nonexistent availability of the phytochemical has greatly 
impeded validation studies in its role as a non-peptidic NTF. 
 However, one recent study published in 2013 by Van Kolen and co-workers  56
reporting investigations in the signaling cascades of synaptoplepis factor K7 led to the 
authors’ conclusion that 1.179 induces neuronal differentiation of SH-SY5Y cells 
concomitant with a transient increase in ERK phosphorylation that is mediated by action 
of protein kinase C-epsilon (PKC-ϵ). Given the known modulation of PKC by DDOs  57
further studies along these lines may in the future provide better understanding of the 
molecular mode of action of neurotrophic DDOs. 
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1.4 — Familial analysis points towards complex biosynthetic origins 
 The incredible diversity in chemical structures of all terpenes can be traced back 
to a single C5 isoprene unit via the mevalonate and methylerythritol pathways.1 The 
chemical skeletons derived from these C5 units provide their classification: hemiterpenes 
(C5), monoterpenes (C10), sequiterpenes (C15), diterpenes (C20), sesterterpenes (C25), 
triterpenes (C30), and tetraterpenes (C40). The actual biochemical isoprene units have been 
identified to be either dimethylallyl diphosphate (DMAPP, 1.182) and isopentenyl 
diphosphate (IPP, 1.183) which generally undergo head-to-tail union to form the 
corresponding linear oligomer (Scheme 1.1). 
 This oligomerization process continues until the specified (C5)n product is 
obtained (i.e. 1.184-1.186). At this point more complex structures can be obtained 
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through cyclization pathways initiated via ionization of the pendant pyrophosphate 
leaving group or protonation of a specific prenyl olefin. The isoprene subunits of the 
resulting cyclized product can sometimes be easily identified although the linear origins 
of the isoprene chain are often lost during these cyclization events in which cationic 
intermediates trigger C- and H-migration, rendering the overall biosynthetic process 
appreciably complex. 
 Within the context of DDOs (and all diterpenes) four isoprene subunits are initally 
joined in a head-to-tail fashion to afford the twenty-carbon linear chain geranylgeranyl 
pyrophosphate (GGPP 1.186, Scheme 1.1). The following series of events depicted—
colloquially termed the Adolf-Hecker hypothesis—is the currently accepted pathway for 
DDO biosynthesis.1 
 Thus, ionization of the -OPP group in GGPP affords a transient allylic cation 
1.187 which undergoes macrocyclization with the terminal ‘tail-end’ prenyl group. The 
intermediate cation 1.188 loses a proton with concomitant formation of a gem-
dimethylcyclopropane moiety to afford the 14-membered macrocycle casbene 1.189, a 
known secondary metabolite (Scheme 1.1). From 1.189 two sequential transannular ring 
closures (Scheme 1.2) afford the tigliane carbon skeleton 1.191; the first ring-closure 
affords the carbon skeleton 1.190 of the related lathyrane diterpenes. Eliminative 
cyclopropane ring-opening thus affords the daphnane carbon skeleton 1.193 with the 
requisite isopropenyl moiety at C13. Alternatively, a ring-expansion of the C-ring affords 
the ingenane skeleton 1.192 with its characteristic ‘inside-outside’ bridgehead 
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configuration. From these polycyclic, all-carbon architectures it has been proposed that 
these saturated systems are then funneled by nature through oxidative enzymatic 
pathways and thus adorned with numerous oxygen appendages to afford the complex, 
bioactive natural products of interest. 
 It is important to stress the pathway shown above is still to date speculative and, 
rather than providing a definitive understanding of the biogenesis on the casbene super-
family, raises more questions as to exactly how these transformations occur. Specifically, 
three major issues have yet to be fully elucidated: (1) the exact sequence of events that 
promote the proposed transannular ring closures; (2) how the gem-dimethylcyclopropane 
ring opening occurs; and (3) the mechanism of the tigliane to ingenane ring-expansion. 
What follows is a discussion of each of these critical problems and what knowledge is 
currently known to corroborate or to reject popular biosynthetic postulates. 
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 Based on the finding that lathyrane, tigliane, and daphnane natural products have 
been co-isolated from the same plant sources, Adolf and Hecker were the first to propose 
a possible biosynthetic unity from casbene.  However, Schmidt was apt in pointing out 58
an alarming problem: assuming an all E-configuration in both the starting GGPP 
precursor 1.186 and casbene 1.189, the ensuing transannular ring closures must formally 
occur with concomitant E → Z isomerization of the intact double-bond (Scheme 1.3).   59
 While a solution to this intractable problem is still debated amongst chemists and 
enzymologists, some recent reports have provided the first evidence which suggests these 
ring closures may occur as a result of oxidation of casbene rather than as a result of a 
cyclase enzyme. Graham and co-workers showed that in-vivo exposure of 1.189 to two 
cytochrome P450 (CYP450) isoforms results in the biosynthesis of jolkinol C 1.196 and 
its epimer (Scheme 1.4).  The authors report that the combination of either CYP726A35 60
or CYP726A20 along with CYP71D495 mediates oxidation of 1.189 to 1.194 which is 
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proposed to undergo an extended keto-enol isomerization (1.194 → 1.196) followed by a 
non-ezymatic transannular aldol cyclization to directly afford 1.197. 
 A report from Hamberger and co-workers the same year corroborates this 
remarkable finding (Scheme 1.5).  The authors demonstrate that an alcohol 61
dehydrogenase enzyme is capable of mediating a similar cyclization step to 1.197 from 
1.189 via two CYP450s (CYP71D445 and CYP726A27) coupled to E. lathyris ADH1.   
 The recent findings from these two seminal studies provide the first concrete 
information in the elementary steps of biogenesis in the casbene super-family. Contrary to 
the long-held Adolf-Hecker hypothesis, C-C bond formation (at least in the case of 
lathyranes) is predicated on oxidative bifurcation  and not mediated by specific cyclase 62
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enzymes. Most compelling is that the oxidation of 1.189 to 1.196 is followed by 
spontaneous, non-enzymatic cyclization. The pathways shown in Schemes 1.5-1.6 also 
provide a sound mechanistic proposal for olefin reorganization and address the issue of E 
→ Z isomerization under hypothetical, non-oxidative pathways. 
 Although no further studies have been published since 2016, it is anticipated that 
the discovery of additional oxidases that mediate the oxidation of lathyrane natural 
products may finally lead to satisfying conclusions regarding the biogenesis of the 
remaining members of the casbene super-family and the mechanisms for the remaining 
C-C bond forming/breaking events. 
 While a few proposals have been posited for the possible conversion of the 
tigliane cyclopropane moiety to the daphnane isopropenyl appendage, none have 
provided definitive proof and are supported at best by circumstantial evidence. The 
known isolation of esters 1.200 and 1.201 from the same plant point to similar biogenetic 
origins but the direct mechanism of conversion was not posited by the authors (Figure 
1.13).  63
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 Ostensibly, C14 oxidation of 1.201 would allow for cleavage of the cyclopropane 
group but a subsequent selective reduction is necessitated, rendering the overall redox-
economy of the sequence poor and unlikely under enzymatic conditions. Although this 
oxidative fragmentation is supported by the known transformation of 1.202 to 1.203—
first shown by Hecker and Gschwendte in 1968 —no tigliane with C14 oxidation has 64
been isolated to date (Scheme 1.6). 
 Fuchs and co-workers proposed an elegant solution  to the cyclopropane ring-65
opening in which a pendant C9 ester could trap a C14 carbocation (1.205) resulting from 
ring-opening of the cyclopropane via ionization of the tigliane C16 1.204 (Scheme 1.7). 
Their model studies, however, were not fruitful and since no C9 tigliane esters have been 
isolated to date is unlikely to proceed in nature. Furthermore, the known conversion of 
tigliane ester 1.207 to 1.208 under acidic conditions  provides some evidence 66
invalidating the Fuchs hypothesis (Scheme 1.8). 
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 The origins of the ingenane class of diterpenes has been proposed to proceed 
directly from tiglianes via C-ring expansion to afford the ‘inside-outside’ bridgehead 
configuration. To date this biosynthetic proposal possesses the most support, interestingly 
not through isolative or ezymatic means but rather via total synthesis. Epstein and Cha 
first demonstrated the feasibility of a biomimetic semipinacol-type reaction of epoxide 
1.209 to the tigliane core 1.210 en route to ingenol (Scheme 1.9).  67
 A similar transform was also employed by Baran and co-workers in their elegant 
fourteen step synthesis of (+)-ingenol (Scheme 1.10, 1.211 → 1.212). While not yet 
supported by biosynthetic proof, this high-yielding rearrangement was shown by the 
authors to be a product of kinetic control.  68
 A transformation of a natural tigliane diterpene to the corresponding ingenane 
would lend definitive support to the proposal occurring in nature but has yet to be proven 
in bulk solvent. Likewise, the complexity of this conversion appears to require the 
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tigliane core already possess some significant level of oxidative decoration, suggesting as 
in the enzymatic lathyrane studies discussed above that ‘cyclase’ productivity is a 
consequence of ‘oxidase’ activities. An additional piece of evidence for the biomimetic 
plausibility of this conversion can be found in the structures of the 19-chlorinated DDOs 
(1.87-1.96, 1.139) along with 1.134 (Figures 1.8-1.9) which all possess a point of 
unsaturation at C1,10 as in 1.211. 
 Although still largely conjectural, the biogenesis of members of the tigliane, 
daphnane, and ingenane classes of diterpenes has provided the motivation for numerous 
chemical and biosynthetic endeavors. The presumed relationship between the three 
related metabolite families suggests the possibility of the future development of a 
general, unified understanding (and perhaps chemical synthesis) of these natural products 
from a single precursor (i.e. 1.189). Future studies of enzymatic pathways should bring to 
light the identification of the key transformations and chemical structures required to 
unify the three families by chemical means, thus expanding the potential to access these 
scarce but potentially beneficial small molecules. 
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1.5 — Prior art in the chemical synthesis of daphnane, tigliane, and ingenane 
diterpenes 
“Overall brevity of a sequence need not compromise the element of art. The technology need not 
be complex, yet it can adequately fulfill a purpose. The effect of an elegant synthetic scheme on 
the observer is comparable to that of a beautiful painting, a photograph, or a musical 
composition. […] In the future more credit should be given to those researchers who focus on 
clever connections in the design of synthetic sequences. Focus on clever design does not in any 
way diminish the need to discover new reactions and to study their mechanistic intricacies for 
eventual optimization. It simply charts the most efficient way to a target. This is, and will 
certainly remain, the purpose of our guild.”—Tomas Hudlicky 
 What follows in this last section of Chapter 1 is a discussion of all known 
completed total syntheses of any daphnane, tigliane, or ingenane diterpenes (a total of 
twelve routes). The inclusion of prior art in tigliane and ingenane synthesis apropos to 
daphnane synthesis is fitting given their presumed biogenesis and demonstrable structural 
parallels. It is hoped the following compilation and analysis, in whole, will be instructive 
in establishing a clear baseline for the current state of the art in synthetic strategy in 
addition to highlighting the Herculean accomplishments of those chemists involved. 
 The chemical synthesis of daphnane, tigliane, and ingenane diterpenes has 
matured into a considerable field of study over the last four decades. Since 1978 over 
seventy publications pertaining to partial studies of either daphnane, tigliane, or ingenane 
diterpenes have materialized. In particular, multiple reports have appeared from the 
groups of Wender,  Paquette,  Harwood,  Funk,  Rigby,  Winkler,  Page,  69 70 71 72 73 74 75
Shibasaki,  Singh,  Carreira,  and Inoue  along with a multitude of studies from other 76 77 78 79
groups.   80
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 However, despite the considerable attention these terpenes have enjoyed from the 
synthetic organic community, rarely have they actually succumbed to synthesis. The low 
levels of success in this arena is a testament to the high level of complexity these 
compounds possess and the still-poor strategies synthetic chemists possess pertaining to 
their efficient assembly. 
1.5.1 — Total synthesis of daphnane diterpene orthoesters 
 Up until the end of 2017, only a single academic group had reported the 
successful preparation of any fully synthetic daphnane diterpene orthoester. In 1997, 
Wender and co-workers disclosed a 44-step (LLS) enantioselective synthesis of (+)-
resiniferatoxin (RTX), a flagship DDO from the latex of Euphorbia resinifera with potent 
irritant properties and PKC activation (Scheme 1.11).  81
 Beginning from the enantiopure benzyl-epoxyalcohol 1.214 (prepared in two 
steps from divinyl alcohol 1.213), epoxide opening with an alkynyllithium reagent, 
lactonization, and α-methylation afforded 1.215 (66%, 3 steps). Addition of 
furanyllithium 1.232, acetylation, reduction, and Achmatowicz rearrangement triggered 
by m-CPBA afforded the enone 1.217 which was acetylated and underwent an 
oxidopyrylium [5+2] cycloaddition upon heated exposure to DBU affording tricycle 
1.218 in 81% yield from 1.217. 
 A five-step sequence (hydrogenation, Wittig olefination, acetylation, allylic 
oxidation, and allylic alcohol oxidation) smoothly converted 1.218 to the exocyclic enone 
!  40
1.219 (81% yield, 5 steps). Conjugate addition of vinyllithium in the presence of a 
copper(I) salt, 1,2-addition of lithium phenylacetylene, and TMS-protection afforded an 
intermedate enyne (not shown) which upon treatment with stoichiometric Cp2ZrBu2 
underwent efficient cyclization to give the 5-7-6 tricycle 1.222 following acidic quench 
and Ley oxidation (21% yield from 1.219). Addition of isopropenylmagnesium bromide 
occurred with complete diastereoselectivity to give the tertiary alcohol 1.223 which was 
exposed to ozone, hydrogen/Pd, and triphogene to afford the carbonate 1.224 in 62% 
yield over three steps. 
 The TBS-protected primary alcohol of 1.224 was cleaved (aq. HF) and converted 
to the corresponding primary alkyl iodide by a triflation/displacement sequence. Reaction 
with Rieke zinc induced elimination of the primary iodide with concomitant opening of 
the bridged furan ring to afford alkene 1.225 (79% yield from 1.224) with the requisite 
tertiary alcohol at C9 (DDO numbering). Allylic oxidation (SeO2, TBHP), chlorinative 
rearrangement (SOCl2) and SN2-displacement with a benzoate salt afforded 1.227. The 
carbonate was removed under basic conditions (aq. NaOH) and the phenylacetyl 
orthoester was secured by the following two-step sequence: esterification of the least 
hindered secondary alcohol with the activated mixed anhydride 1.233 and exposure to 
dilute acid under conditions originally reported by Hecker  delivered the orthoester 82
1.229 in 25% yield from carbonate 1.227. The C13 ketone was converted to the requisite 
isopropenyl group by a Peterson olefination sequence with concomitant cleavage of the 
benzoyl ester which was regenerated in a secondary step. 
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 Functionalization of the A-ring was completed by an efficient three-step sequence 
(silyl enol ether formation, α-bromination, and elimination) to give rise to 1.231. The 
completion of (+)-RTX was realized by silyl ether cleavage (TBAF), mild hydrolysis of 
the C20 benzoyl ester, C20 esterification employing the activated mixed anhydride 1.234, 
and removal of the vanillyl acetate with pyrrolidine (64% yield from 1.231). 
 Overall, the first total synthesis of a DDO required forty-four steps and proceeded 
in 0.038% overall yield. Salient features of the synthesis include a stereocontrolled 
intramolecular [5+2]-cycloaddition of an oxidopyrylium ylide, a Zr-mediated enyne 
cyclization, and the critical orthoester formation under mild conditions. Although lengthy, 
this synthesis stood as the only successful laboratory preparation of (+)-RTX for nearly 
twenty years and underscores several key challenges in DDO synthesis: the 
stereocontrolled establishment of the 5-7-6 tricyclic core; the introduction and 
management of increasing oxidation state; and the selective functionalization of remote 
sectors of the tricyclic scaffold in the presence of equally complex, neighboring systems. 
 A second synthesis of (+)-RTX was recently accomplished by Inoue and co-
workers in late 2017.  Using a conceptually different approach from that of Wender’s 83
seminal work, Inoue’s group employed a radical-based multi-component coupling 
technology previously disclosed from their laboratory in various contexts (Scheme 1.12).
78a,b,  84
 The radical precursor phenylsellenide 1.244 was prepared via a twenty-step linear 
sequence from D-ribose derivative 1.235. Thus, vinylation of 1.235 and ring-closing 
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metathesis afforded 1.237 which underwent an unusual redox-isomerization reaction 
under standard hydrogenation conditions (H2, Pd/C) to give ketone 1.238 (36% yield 
from 1.235). A stereoselective, five-step elaboration to hydroxy-ketone 1.240 was 
followed by orthoester protection, Rubottom oxidation, oxidative cleavage, Barton ester 
formation, and radical selenation to afford phenylselenide 1.242 (31% yield from 1.241). 
The selenide was further functionalized by Luche reduction and silylation to give the 
radical coupling component 1.244. 
 The planned radical multi-component coupling was accomplished by exposure of 
1.244, cyclopentenone 1.254, and allylstannane 1.255 to the azo radical initiator V-40 to 
deliver 1.245 in 52% yield. An eight-step sequence was required to convert 1.245 to the 
5-7-6 tricycle 1.249. Notably, a second radical-based reaction was employed via the bis-
xanthate 1.248 to establish the seven-membered B-ring system of 1.249 (71% yield). The 
acetyl orthoester was cleaved and formation of the phenylacetyl orthoester of (+)-RTX 
was accomplished following oxidation of the C3 secondary allylic alcohol. TMS 
protection, conjugate reduction, and α-methylation afforded 1.250 (14% yield, 6 steps 
from 1.249).  
 The end-game employed a similar sequence originally used in Wender’s synthesis 
of (+)-RTX.80 Thus, 1.250 was converted to allylic chloride 1.253 in five-steps (22% 
yield); SN2-displacement with the homovanillyl cesium salt 1.256 followed by global 
deprotection with TBAF secured a successful synthesis of (+)-RTX in forty-two linear 
steps (0.0057% overall yield). 
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Scheme 1.12. Total synthesis of (+)-resiniferatoxin by Inoue and co-workers
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 Remarkably, since the twenty years following Wender’s (+)-RTX synthesis, the 
second-ever successful laboratory preparation of the diterpene required nearly the same 
number of linear steps and provided the natural product with an overall yield nearly an 
order of magnitude lower than its predecessor. 
 Although Inoue’s route features a novel convergent multi-component radical 
coupling reaction, the C-ring precursor 1.244 required twenty linear steps to prepare and 
the radical coupling adduct 1.245 required a further twenty-one steps to reach the final 
target. Overall, despite the tremendous accomplishment, Inoue’s route does not appear to 
mark a significant improvement in general DDO synthesis.  A bottle-neck in efficiency 85
emerges in the preparation of a fully functionalized C-ring which itself boasts five-
contiguous stereocenters and a challenging syn-triol system required for orthoester 
formation. 
 Furthermore, the similar end-game to Wender’s intimates an innate sophistication 
in the 1997 strategy. Indeed, three years prior to this second (+)-RTX synthesis, Wender 
and co-workers were able to adapt their first-generation DDO strategy to access higher-
order daphnanes. The chemical literature was devoid of further successes in DDO 
synthesis for over a decade following the first completion of (+)-RTX until 2011 when 
the same laboratory published what they termed a ‘gateway synthesis’ of daphnane 
congeners (Scheme 1.13). 
 Building upon fourteen years of additional development, a 41-linear step 
synthesis of 6,7-epi-yuanhuapin, an unnatural 12-hydroxydaphnetoxin analog, along with 
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its 6,7-des-epoxide was reported.  The team devised a route which utilized similar rules 86
and successes from the inaugural synthesis of (+)-RTX, namely the deployment of 
intramolcular cyclization reactions ([5+2]-oxidopyrlium cycloaddition and enyne 
cyclization, respectively) to rapidly access the DDO 5-7-6 tricyclic core. 
 Some considerable advancement in the overall synthetic strategy was made, 
however, since the intended targets, 12-hydroxydaphnetoxins, possess an overall 
oxidation state three levels higher than the resiniferanoids. Judicious choice in starting 
materials were key in enabling facile introduction of the necessary oxidative 
functionalities.  
 Beginning from tartrate ester 1.257, a three-step sequence (vinylation, 
benzylation, Appel bromination) afforded fragment 1.258 which was joined with the 
kojic acid potassium salt 1.276 to give 1.259. Upon heating 1.259 underwent a Claisen 
rearrangement and was silylated (TBSCl) to give pyrone 1.260 (34% yield from 1.257). 
Microwave heating of 1.257 (250°C) triggered silyl-migration and formation of the 
corresponding oxido-pyrylium species which underwent intramolecular cycloaddition to 
give the [5+2]-adduct 1.261 in 91% yield. Allylation, dehydration (SOBr2), TBAF 
deprotection, and 1,2-addition of lithium phenylacetylide gave enyne intermediate 1.263 
which was cyclized under reductive Pd-catalysis. Notably, the resulting 5-7-6 tricycle 
(not shown) was accessed in eleven linear steps; its counterpart in the original (+)-RTX 
route required twenty steps to prepare. 
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Scheme 1.13. Gateway synthesis of DDO congeners by Wender and co-workers
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 The tricycle 1.264 was prepared in three additional steps (ozonolysis, Luche 
reduction, reductive ether ring-opening, 50% yield from 1.263). Directed epoxidation 
reestablished the C6,9 furan motif (1.265) and a series of protecting group manipulations 
led to highly functionalized tricycle 1.267. Dess-Martin oxidation was followed by 
addition of isopropenyllithium which gave similarly remarkable levels of stereocontrol to 
that reported on the simpler (+)-RTX system. 
 Protecting group reorganization (5 steps, 50% yield) gave primary alcohol 1.270 
which was converted to alkene 1.271 using an identical sequence to that reported 
previously. Diol masking, radical bromination, SN2-displacement (KOAc), LiAlH4 
reduction, and benzoylation afforded tricycle 1.272 in 30% yield (5 steps). The desired 
phenyl orthoester moiety was forged by microwave heating 1.272 under acidic conditions 
(TsOH) and the C12-hydroxyl was acetylated to give 1.273 (44% yield, 2 steps). 
 The endgame of the synthesis involved fluoride-mediated deprotection to give a 
secondary alcohol which was oxidized (IBX) to the corresponding A-ring ketone and 
removal of the remaining hydroxyl masks afforded des-epoxyyuanhuapin after forty 
linear steps. Attempted directed epoxidation of 1.274 with the chiral reagent generated in-
situ from VO(Oi-Pr)3, ligand 1.277, and TBHP afforded 6,7-epi-yuanhuapin (81% yield), 
an unnatural 12-hydroxydaphnetoxin, in forty-one linear steps (0.029% overall yield). 
 The stereochemical outcome of the directed epoxidation deserves some 
discussion. The inherent β-selectivity of the C6,7-olefin in tiglianes towards oxidation is 
known  and Wender and co-workers have shown using phorbol-based model systems 87
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that this inherent facial bias can be overcome using a reagent-controlled approach.68g,  In 88
practice, however, this inevitably afforded the undesired β-epoxide. Consideration of 
material supply and the availability of natural yuanhuapin for comparative studies in 
assays dissuaded the authors from pursuing further optimization of this process. 
 Biological activity studies were performed in which 1.274 and 1.275 were 
assayed alongside a natural sample of yuanhuapin. Interestingly, in cell-free PKC binding 
assays the des-epoxide 1.274 and natural yuanhuapin exhibited potent PKC binding 
affinities (Ki 1.6 and 0.48 nM, respectively) while 6,7-epi-yuanhuapin 1.275 gave inferior 
results (Ki 343 nM). Against two cancer cell lines (A549 and K562, respectively) 1.274 
and natural yuanhuapin presented good cell growth inhibition (EC50 for 1.274 1500 nM 
and 87 nM; EC50 for natural yuanhuapin 150 nM and 7 nM) whereas 1.275 was 
essentially inactive (EC50 >10,000 nM for both cell lines). The authors concluded the 
stereochemical identity of the epoxide moiety significantly alters the spatial location of 
the C20 hydroxyl group required for biological activity. Replacement of the epoxide with 
an alkene (as in 1.274) appears to retain the required spatial arrangement of oxygens in 
the molecule and thus preserves activity. 
 While still over forty steps in length, the Wender group’s general strategy towards 
DDOs remains the current state of the art given its proven ability to generate both 
resiniferanoids and 12-hydroxydaphnetoxins. Furthermore, the ability to generate 
unnatural congeners led to preliminary insight in structural requirements for DDO 
biological activity in PKC activation and cancer cell growth inhibition. 
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1.5.2 — Total synthesis of tigliane diterpenes 
 The total synthesis of tigliane diterpenes has historically been limited to efforts 
exclusively towards phorbol 1.297. In total five routes (two racemic; two formal 
asymmetric; one enantiospecific) from three academic laboratories will be discussed in 
the following section. 
 Historically, phorbol 1.297 actually yielded to synthesis almost a decade before 
any DDO. In 1989 Wender and co-workers published the first racemic synthesis of 1.297 
via a fifty-two step linear sequence from furfuryl alcohol 1.278 (Scheme 1.14).  89
Accordingly, the powerful DDO synthetic strategy outlined above is actually an 
adaptation of their original efforts in tigliane synthesis. 
 Employing a similar oxidopyrylium cycloaddition, B-C tricycle 1.280 was 
accessed in eight steps from 1.276. An additional eight-step sequence afforded the 5-7-6 
tricycle 1.284 with the A-ring being formed via an intramolecular 1,3-dipolar 
cycloaddition. Reduction/elimination afforded α,β-unsaturated ketone 1.285 which was 
further advanced to ketone 1.287 in six additional steps (62% from 1.285, ~11% over 26 
steps from 1.278).  
 A six-step protocol was employed to access the gem-dimethylcyclopropane 1.291 
which was formed via a Corey-Chaykovsky type cyclopropanation (1.290 → 1.291, 85% 
yield). Protecting group reorganization and functional group interconversions (10 steps) 
followed by allylic oxidation gave 1.293 which was advanced to the final target 1.297 by 
a final nine-step sequence. Notably, the 6,7-olefin of the B-ring and final A-ring 
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Scheme 1.14. Total synthesis of (±)-phorbol by Wender and co-workers
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elaboration utilized chemistry which would service later successes in DDO synthesis 
(vide supra). 
 A second-generation, formal racemic route to 1.297 was disclosed shortly after by 
Wender and McDonald (Scheme 1.15).  The ketone 1.287 was targeted as a relay point 90
to 1.297 and was synthesized in sixteen linear steps from ethylacetoactate 1.298. Notably, 
this formal racemic synthesis shortened the original route by ten steps and provides 
blueprints to the later strategies employed for the synthesis of (+)-RTX and 6,7-epi-
yuanhuapin. Indeed, comparison of the two routes (Scheme 1.14, 1.259 → 1.264) shows 
near identical reaction sequences, including Claisen rearrangement/oxido-pyrylium 
cycloaddition of kojic acid derivatives (compare 1.259 with 1.300) and enyne 
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Scheme 1.15. Formal synthesis of (±)-phorbol by Wender and co-workers
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cyclizations to form the A-ring (compare 1.263 with 1.305). The overall strategy used 
here is thereby quite flexible in regards to targets with C12 oxygenation. 
 The first formal asymmetric synthesis of 1.297 was reported by Wender and co-
workers in 1997 shortly before their completion of (+)-RTX (Scheme 1.16).  Beginning 91
from furfuryl alcohol 1.278, absolute stereochemistry was secured via an Evans 
asymmetric aldol of aldehyde 1.307 and chiral oxazolidinone 1.325. Furan 1.308 was 
advanced to the [5+2]-precursor 1.312 in seven steps (44% overall) which upon exposure 
to DBU underwent cyclization to afford B-C tricycle 1.313 (79% yield). 
 Following their well-established general procedure, 1.313 was advanced to enyne 
1.316 (42%, 6 steps) which underwent Zr-mediated cyclization to 5-7-6 tricycle 1.317. 
The C-ring gem-dimethylcyclopropane moiety was installed employing an identical six-
step sequence (57% overall from 1.318) and intermediate 1.319 was elaborated to 1.321 
by familiar methods. After B-ring completion, the A-ring was finalized to give protected 
phorbol 1.324 (12% yield from 1.321). Two-step global deprotection yielded phorbol 
1.297 in forty linear steps and 0.001% yield. It important to note this synthesis ultimately 
yielded (±)-1.297; the enantiopure intermediate 1.318 was relayed with (±)-1.318 for the 
completion of the synthesis, thus securing a formal asymmetric synthesis of 1.297. 
 An additional formal asymmetric synthesis was later completed by Lee and Cha 
in 2001 (Scheme 1.17).  Targeting the same relay point used by Wender’s group (1.318), 92
a novel strategy was employed to access an enantiopure B-ring system via asymmetric 
desymmetrization of the [4+3] cycloadduct 1.327 (prepared in two steps from 1.326, 
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80-93% yield). 
 Desymmetrization was performed using chemoenzymatic methods (Candida 
rugosa, 90% yield, 80% ee) and the seven-membered ketone 1.329 was elaborated to the 
Scheme 1.17. Formal asymmetric synthesis of (+)-phorbol by Cha and co-workers
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enyne intermediate 1.333 in eight steps (38% overall). Notably, use of the chiral Li-amide 
base 1.340 enabled a regioselective deprotonation of 1.330 en route to 1.333. 
 The six-membered C-ring was first established via an intramolecular reductive 
Heck transform of vinyl iodide 1.337 which was prepared in six steps from 1.333, 
featuring a diastereoselective conjugate addition of methyl Grignard controlled by a 
chiral auxiliary (1.335 → 1.336). Enyne cyclization was accomplished employing a low-
valent Ti-reagent generated in-situ from titanium tetraisopropoxide and 
isopropylmagnesium bromide. Allylic oxidation and conjugate reduction finalized a 
twenty-four step (LLS) asymmetric synthesis of Wender’s ketone 1.318. 
 Although employing a conceptually distinct approach—featuring stereoselective 
events controlled by enzymatic resolution, chiral auxiliary, and chiral reagents—Lee and 
Cha’s route is five-steps longer than Wender’s reported pathway and retains similar 
tactical motifs (enyne cycloadduct 1.339 and bridged B-C furan) of its predecessor. 
 The latest successful synthesis of 1.297 was reported in 2016 by Baran and co-
workers  based on a divergent approach from the tigliane tricycle 1.343 first prepared en 93
route to (+)-ingenol (vide infra). Baran’s group first completed a synthesis of (+)-ingenol 
in 2014 but for organizational purposes their synthesis of (+)-phorbol is discussed here 
first (Scheme 1.18). 
 Beginning from the previously reported tricycle 1.343, a Mukaiyama hydration-
TMS protection sequence afforded intermediate 1.344 in 70% yield. C-H oxidation at 
C12 was accomplished with TFDO and the gem-dimethylcyclopropane was ruptured by 
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treatment with ZnI2 and MgI2. A second Mukaiyama hydration afforded the tertiary 
alcohol 1.345 (34% yield from 1.344). A six-electron oxidation of the C12,13 olefin in 
1.345 employing catalytic RuCl3 afforded the dione 1.346 in near quantitative yield. 
 A remarkable ring closure to reform the gem-dimethylcyclopropane group was 
realized by treatment of 1.346 with first TFAA, then zinc, and finally Ac2O and 
triethylamine, via the intermediacy of an ene-diol (not shown). This five-step sequence 
Scheme 1.18. Total synthesis of (+)-phorbol by Baran and co-workers
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enables the necessary formal four electron oxidation of 1.343 to the phorbol C-ring 
oxidation state and forms the basis of a short synthesis of 1.297. 
 The A-ring was completed by a Cr-mediated allylic oxidation and enone α-
iodination/Stille coupling sequence (29% yield, 3 steps). The B-ring was completed in 
three steps (silyl cleavage, dehydration/allylic oxidation, reduction/aceylation) to afford 
1.352 in 47% overall yield from 1.350. Reduction and global deprotection afforded 1.297 
in 72% yield and nineteen steps from commercial materials (0.053% overall yield). 
 It is worth mentioning that the authors specifically define a reaction step as “one 
in which a substrate is converted to a product in a single reaction flask (irrespective of the 
number of transformations) without intermediate workup in a separate flask or 
purification. If the substrate leaves the flask, this must constitute the end of a step.” Thus, 
their ‘nineteen step’ preparation of 1.297 is based primarily on ‘one-pot’ operations rather 
than discrete chemical transformations. Regardless of the nomenclature and designations 
used, Baran’s synthesis of phorbol is the shortest and most concise synthesis of any 
tigliane to date and makes use of a powerfully versatile intermediate 1.343 which has 
proven pivotal in the short synthesis of ingenane diterpenes (vide infra). 
1.5.3 — Total synthesis of ingenane diterpenes 
 The total synthesis of ingenane diterpenes has enjoyed considerably more success 
than daphnane and tigliane diterpenes with the successful syntheses of ingenol 1.374 via 
four distinct chemical pathways disclosed between 2002 and 2014. 
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 The first synthesis of 1.374 was reported by Winkler and co-workers and made 
use of an interesting intramolecular [2+2] dioxenone photoaddition of 1.357, prepared in 
eleven steps from enone 1.353 (Scheme 1.19).  Following fragmentation (K2CO3, 94
MeOH), two inconsequential regioisomers (1.358-1.359) were obtained which could be 
funneled through a four-step sequence to tricycle 1.362 (21% from 1.357) possessing the 
characteristic ‘inside-outside’ bridgehead configuration of 1.374. 
 The gem-dimethylcyclopropane moiety of the ingenane C-ring was installed in 
three steps to afford 1.363 in 71% overall yield. The necessary oxidation state of the A-
ring was obtained remotely from functionality on the B-ring by an allylic oxidation-
eliminative conjugation sequence (1.363 → 1.365, 33% overall). An oxidation-protecting 
group sequence gave afforded 1.368 in 30% yield over six steps. The cyclic sulfate 1.369 
was prepared in two steps and advanced to 1.370 in two additional steps (27% overall) 
with the desired B-ring oxidation state. 
 Protecting group reorganization and Dess-Martin oxidation afforded ketone 1.372 
(48% yield from 1.370) from which A-ring functionalization was completed via a three-
step sequence employing a Tsuji-type dehydrogenation catalyzed by Pd(0) (20% over 3 
steps). Luche reduction and global deprotection yielded (±)-ingenol in 45 linear steps 
from 1.353 in 0.002% overall yield. 
 Although lengthy in nature, this inaugural success in ingenane synthesis is 
hallmarked by a unique solution to the challenging  ‘inside-outside’ bridgehead system of 
1.374 via an intramolecular [2+2] dioxenone photoaddition. The remaining functionality 
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Scheme 1.19. Total synthesis of (±)-ingenol by Winkler and co-workers
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of the target, primarily consisting of a considerable leap in oxidation state from the 
simple tricycle 1.362, was secured by a translocative, remote functionalization from a 
simple handle installed early in the B-ring, although extensive protecting group 
manipulations and functional group interconversions necessitated an additional twenty-
nine steps to reach the intended target. 
 The second total synthesis of ingenol was accomplished by Kuwajima and co-
workers in 2003 (Scheme 1.20).  The cyclic hydroxy ketal 1.375 was advanced to the 95
vinyl dichloride 1.381 in twelve steps and 7% overall yield. A Fritsch-Buttenburg-
Wiechell-type reaction was employed to access a propargylic acetate (not shown) which 
upon exposure to Co2(CO)8 afforded the dicobalt-acetylene complex 1.382 in 86% yield 
over three steps. Exposure of 1.382 to the Lewis acid 1.394 triggered a Nicholas-type 
cyclization which after Birch reduction, dibromocyclopropanation, methylation, and 
directed epoxidation yielded gem-dimethylcyclopropane 1.384. 
 The epoxy alcohol 1.384 was treated with trimethylaluminum to induce a semi-
Pinacol-type rearrangement and established the ‘inside-outside’ bridgehead 1.385 (23% 
from 1.383). An eight-step sequence advanced 1.385 to dione 1.387 (69% overall) which 
after elimination with the cyclicguanidine base 1.395 underwent stereoselective 
tetrahydroxylation after treatment with osmium tetroxide (45% over 4 steps) to give 
mono-protected pentaol 1.388. 
 Protecting group manipulations (13% over 6 steps) followed by an additional 
five-step elaboration (protection, silyl enol ether formation, α-bromination, deprotection, 
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Scheme 1.20. Total synthesis of (±)-ingenol by Kuwajima and co-workers
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and Corey-Chaykovsky epoxidation) afforded the bromo-epoxide 1.391 in 39% yield 
from 1.390. Reductive epoxide opening and hydrolysis completed a total synthesis of (±)-
ingenol in 46 linear steps (0.012% overall yield). 
 The efforts of Kuwajima and co-workers provided a slightly longer but overall 
higher yielding route when compared to the route from Winkler and co-workers. The 
semi-Pinacol rearrangement of 1.384 holds biogenetic significance and provided good 
precedence for the later success of Baran’s group (vide infra). Similar to the difficulties 
encountered by Winkler, a substantial amount of protecting group manipulations and 
functional group interconversions were necessary to selectively functionalize the A-B 
stereotriad, firmly establishing a time-consuming problem to be addressed in later 
ingenane syntheses. 
 In 2004 Wood and co-workers disclosed their completed work towards a 
successful total synthesis of (+)-ingenol.  Cycloheptenone 1.396 (prepared in four steps 96
from (+)-3-carene) was advanced in twelve steps (12% overall yield) following a 
previous report.79l Salient features of this opening sequence include a diastereoselective 
Diels-Alder cycloaddition between enone 1.398 and cyclopentadiene followed by a high-
yielding ring-opening metathesis catalyzed by Grubbs’ second-generation catalyst under 
an ethylene atmosphere. 1.400 was transformed to diene 1.401 by a straight-forward four 
step sequence (Scheme 1.21). 
 Ring-closing metathesis of 1.401 employing 25 mol% of the Hoveyda-Grubbs 
2nd-generation catalyst afforded the ingenane core structure 1.402 (76% yield). Ketal 
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Scheme 1.21. Total synthesis of (+)-ingenol by Wood and co-workers
!  65
hydrolysis followed by reduction-iodination-elimination gave the 1,1-disubstituted alkene 
1.403 (74% yield from 1.402) which was oxidized (Dess-Martin) and isomerized (RhCl3, 
EtOH) to enone 1.405 in 27% overall yield. 
 Enolate autooxidation (O2, KOt-Bu, P(OMe)3) afforded the α-hydroxyenone 
1.406 in near quantitative yield. The B-ring was finalized in eleven additional steps (9% 
overall yield) to 20-deoxy-ingenol 1.413 which underwent selective allylic oxidation 
(SeO2, SiO2) to afford (+)-ingenol in thirty-seven linear steps from commercial material 
and 0.063% overall yield from 1.396. 
 The efforts of Wood’s group led to a significant improvement in step-economy in 
addition to providing the first non-racemic route to 1.374. Showcasing a conceptually 
novel mode to access the ‘inside-outside’ bridgehead system via two olefin-metathesis 
transforms, the overall brevity of the route was, like its predecessors, hampered by an 
ultimately lengthy process to install the remaining oxygenation of the southern A-B ring 
systems. Notwithstanding, this work stood as the most concise preparation of any 
ingenane for nearly a decade after its disclosure. 
 In 2014, Baran and co-workers reported a game-changing fourteen-step synthesis 
of (+)-ingenol from (+)-3-carene (Scheme 1.21). The authors’ retrosynthetic analysis 
banked on a proposed ‘cyclase’/‘oxidase’ strategy previously applied on other terpene 
classes.  97
 Beginning from the commercially available chiral pool starting material (+)-3-
carene 1.415, a regio- and stereoselective allylic chlorination was accomplished with 
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NCS in the presence of catalytic DMAP. Ozonolytic cleavage of the exocyclic alkene 
1.416 afforded ketone 1.417 (48% yield over 2 steps) which was reductively alkylated to 
give an intermediate methyl ketone (not shown). In-situ distillation of excess methyl 
iodide and exposure to LiHMDS followed by treatment with the chiral allenyl aldehyde 
1.425 led to ketone 1.418 in 44% yield. This one-pot reductive alkylation-distillation-
aldol procedure was reportedly critical in successfully obtaining workable yields of 
1.419. 
 1,2-Addition of ethynyl magnesium bromide and bis-silyl protection generated the 
alleneyne intermediate 1.420. An intramolecular Pauson-Khand cyclization catalyzed by 
[RhCl(CO)2]2 under at atmosphere of CO afforded the tigliane core 1.343 (41% from 
1.413). This key intermediate has reportedly been prepared in quantities in excess of 100 
g with an industrial collaborator and later enabled a concise, divergent synthesis of (+)-
phorbol (vide supra). 
 1,2-Addition of methyl Grignard gave a tertiary alcohol 1.421 that was exposed to 
stoichiometric osmium tetraoxide to afford the mono-protected tetraol 1.422. Carbonate 
formation afforded the tricycle 1.211 in 51% yield over three steps. 
 Following the precedents established by Kuwajima94 and Cha66 a semi-pinacol 
rearrangement was performed upon treatment of 1.211 with boron trifluoride etherate and 
quenching with methanol-triethylamine at low temperatures to afford the ingenane core 
1.212 in 80% yield. Later studies showed this exact quenching protocol was necessary to 
obtain 1.212 as it is presumably a product of kinetic trapping.96b 
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 With 1.212 in hand, a four-step ‘oxidase’-sequence secured an incredibly short 
synthesis of (+)-ingenol 1.374. Thus, allylic oxidation/in-situ acetylation of 1.212 gave 
1.423; silyl-cleavage (aq. HF), dehydration with Martin’s sulfurane, and basic aqueous 
work-up afforded 20-deoxy-ingenol 1.413 in 43% yield over three steps. A final allylic 
Scheme 1.22. Total synthesis of (+)-ingenol by Baran and co-workers
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oxidation with selenium dioxide in the presence of formic acid and basic aqueous workup 
(NaOH) to cleave in-situ generated formate esters afforded (+)-ingenol 1.374 (76% yield) 
via a longest linear sequence of fourteen steps and 1.17% overall yield. 
 This landmark synthesis by Baran and co-workers marks a turning-point in 
diterpene synthesis. The brevity and scalability of the route has enabled the preparation 
and biological evaluation of unnatural ingenane congeners96c and provides ingenius 
solutions to longstanding problems in ingenane synthesis. 
 The deft choice of (+)-3-carene 1.415 as starting material and its short, 
stereoselective conversion to the tigliane core 1.343 enabled the execution of a greatly 
simplifying biomimetic rearrangement to the ingenane core 1.212 in addition to providing 
a starting point for the concise preparation of tigliane diterpenes. Judicious application of 
allenyl aldehyde 1.425 served a three-fold purpose in (1) providing a handle for the 
intramolecular Pauson-Khand cyclization; (2) directly providing the correct oxidation 
needed for selective elaboration of the A-B triol; and (3) providing properly masked 
functionality for the C6,7 B-ring olefin which could be unveiled following installation of 
the southern stereotriad. 
 These key features of the synthesis solve the long-standing problems identified in 
the earlier work of Winkler, Kuwajima, and Wood (vide supra) and elevates the state of 
the art in diterpene synthetic strategy. Although Baran and co-workers were able to apply 
these early blueprints to a later synthesis of (+)-phorbol, successful conversion to any 
daphnane diterpene orthoester has yet to be reported. 
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1.6 — Concluding remarks 
 In conclusion, I hope this introductory review chapter has adequately served the 
following purposes: 
 (1) Introduction of the reader to the daphnane diterpene orthoesters (DDOs), a 
complex family of diterpene natural products with remarkable biological activities and 
equally impressive chemical constitution; 
 (2) Deliver an up-to-date account of all new daphnanes and their biological 
activities reported since the last comprehensive review up to the time of this writing; 
 (3) Provide an in-depth discussion of the biosynthesis of DDOs apropos to their 
intricate relations to other complex classes of diterpenoids derived from casbene. In 
particular, highlighting an emerging hypothesis for the biogenesis of the casbene family 
of natural products which, in juxtaposition to the longheld postulate of Adolf and Hecker, 
suggests a complementary mode of construction predicated on oxidative bifurcations in 
their biosynthetic pathways; 
 (4) Lay out an in-depth presentation, discussion, and analysis of all successful 
total syntheses of daphnane, tigliane, and ingenane diterpenes in an effort to provide a 
definitive bench-mark on synthetic efficiency and the state of the art in the development 
of synthetic strategy in this sub-discipline of chemical synthesis. 
 Daphnane diterpenes represent an exciting and challenging problem for organic 
chemists, not only in their concise and practical preparation but also in the exploration of 
their potential as therapuetic applicationss in human disease. Likewise, their complex 
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origins leave considerable room for the continual investigation of their biosynthesis. 
These problems remain, for the most part, unsolved and the discovery of solutions, as this 
chapter intimates, should provide the impetus for synergistic explorations from all 
branches of the chemical sciences. 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CHAPTER TWO 
A first-generation synthesis of the daphnane diterpene all-carbon architecture 
2.1 — Retrosynthetic analysis of the daphnane diterpene orthoesters 
 Given the information detailed in the previous chapter, my initial attempts to 
unravel the complex stereopolyad embedded within the 5-7-6 all-carbon DDO 
architecture eventually relied on a blend of biosynthetic logic and basic pattern 
recognition (Figures 2.1-2.2). It seemed reasonable to propose the C5,6,7 stereotriad of 
the daphnetoxins (i.e. synaptolepis factor K7, 2.6) arises from the corresponding allylic 
alcohol B-ring system found in the resiniferanoids (i.e. RTX, 2.1)—the simplest DDO 
members—via a step-wise increase in oxidation state, i.e. allylic oxidation at C5 and 
epoxidation at C6,7. Thus it was reasoned first targeting the RTX oxidation state could 
lead to higher-order DDO oxidation patterns via a late-stage oxidation platform.  1
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Figure 2.1. Early retrosynthetic analysis of daphnane diterpene orthoesters
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 I reasoned that the orthoester moiety should arise from the corresponding triol-
system by first selective acylation followed by known acid-mediated condensation.  This 2
disconnects back to a highly functionalized unnatural daphnane diterpene dubbed ‘pre-
DDO’ (2.2). This hypothetical target structure was appealing from the outset since it (a) is 
a true—albeit unnatural—diterpene with a total carbon count of twenty; (b) possesses an 
A-ring found in the majority of DDOs; (c) contains a complex stereoheptad common to 
all DDOs; and (d) is capable of forging the namesake orthoester appendage within two 
precedented chemical steps. 
 The stereopolyad contained within 2.2—although a considerable simplification 
from any of the natural products—was regarded as nontrivial. Most alarming was the 
combined tasks of establishing the 5-7-6 tricyclic framework and correctly generating a 
key stereopentad contained within the 6-membered C-ring which itself contains half of 
the oxygen atoms in the hypothetical target. From the stand-point of practicality and the 
projected levels of effort required to transform 2.2 to any real DDO via the proposed late-
stage oxidation sequence, a short synthesis plan (ideally ten to fifteen steps) was 
necessitated. 
 From a basic pattern-recognition exercise three early ideas surfaced that remained 
large focal points of interest during the course of my studies (Figure 2.2). Firstly, it was 
reasoned that the 7-membered B-ring could be accessed rapidly by a ring-closing 
metathesis (RCM). Second, the complete C-ring could arise from the corresponding arene 
through a dearomatization event followed by selective transformations to install the 
!  80
desired functionality within the ring system with high precision. While the RCM holds 
precedent, the employment of an achiral benzene nucleus as a synthon for a cyclohexane 
ring with at least five contiguous stereocenters was not exactly something I was aware 
had been performed in this context.  3
 Stepwise disconnection of the C-ring stereopolyad, however, revealed that a 
quinol precursor (2.7) might be ideal for introducing the angular C18 methyl group as 
well as providing an electrophilic carbonyl for introduction of the C13 isopropenyl group 
by 1,2-addition. A formal, trans anti-Markovnikov hydration of a trisubstituted olefin 
would allow installation of the remaining functionality required although from the outset 
how this would be accomplished was not fully realized until later in the project (see 
Chapter 3). And thirdly, it was reasoned the target RCM precursor that would lead to 
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2.2
Me
H
OHO
Me OH
O
2.7
RCM
vicinal 
difunctionalzation
Me
H
HO
Me
OH
Me
O
OR
[O] 2.8
1,4-
addition
1,2-addition
reductive
hydration
Me
H
HO
OR
2.9
2.10
2.11
2.12
decorate
quinol
oxidative
dearomatization
decorate
A-ring
Figure 2.2. First-generation DDO retrosynthetic analysis
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tricycle 2.9 might be assembled in a single operation via vicinal difunctionaliztion of 
cyclopentenone 2.10 with a styrenyl nucleophile (2.11) and an allylic electrophile (2.12). 
 The complete A-ring could be established by an α-methylation/dehydrogenation 
sequence followed by an enolate oxidation  to install the C4 tertiary alcohol and it was 4
thus proposed that 2.2 could be assembled in perhaps eleven to twelve steps. Unsure of 
the exact sequence of events that would be required to efficiently functionalize the arene 
nucleus of tricycles 2.8 or 2.9, initial investigations began with evaluating the feasibility 
of a rapid vicinal difunctionalization of cyclopentenone 2.10. 
2.2 — Attempts at a vicinal difunctionalization transform 
 The vicinal difunctionalization of α,β-unsaturated enones is well-established and 
often employed as a tactic in chemical synthesis for rapid assembly of molecular 
complexity.  1,4-Addition of a carbon-based nucleophile to an enone followed by 5
trapping of the resulting transient enolate with a carbon-based electrophile generates two 
vicinal stereocenters, often with good relative stereocontrol, and the nature of the enone, 
the nucleophile, and the electrophile can be considerably varied. My initial attempts 
commenced with the synthesis of styrene 2.14 which was readily prepared by TIPS 
protection, nuclear bromination, and Wittig olefination of commercially available 3-
hydroxybenzaldehyde 2.13 (Scheme 2.1). 
 Disappointingly, addition of this styrene derivative to cyclopentenone, under a 
large variety of conditions, failed to produce either the desired 1,4-adduct or the vicinal 
difunctionalization product 2.18 upon quenching with an electrophile (Scheme 2.1). First, 
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metallation of bromostyrene 2.14 could be affected with either magnesium or n-BuLi; 
transmetallation with catalytic or stoichiometric quantities of a copper(I) salt failed to 
produce a nucleophile competent in 1,4-addition to cyclopentenone. Extensive 
exploration into solvents, temperature regimes, additives (e.g. TMSCl, BF3·OEt2, HMPA) 
failed to produce any desired product. Similar attempts were made employing the 
corresponding aryltitanate  and arylboronic acid  but to no avail. 6 7
 Although disheartening, these results highlight a unique limitation of certain 
vicinal difunctionalization transforms, namely the addition of a ortho-substituted aryl 
nucleophile to a 5-membered enone. A quick SciFinder search reveals similar 1,4-
additions have been shown to succeed, albeit in generally low yield.  In general, the 8
failure of this reaction sequence can be attributed to sterics—addition of a bulky ortho-
substituted aryl nucleophile—and the generally higher reactivity of cyclopentenone to 
that of cyclohexenone in which undesired reaction pathways are dominant.  9
 A reductive allylation protocol designed to overcome such problems developed by 
Jansen and Shenvi  in their elegant synthesis of (-)-neothiobinupharidine was next 10
explored (Scheme 2.2); however conjugate reduction of β-styrenyl cyclopentenone 2.19 
was never observed after considerable experimentation.  11
O
OH
TIPSCl, imidazole
MeCN, rt
NBS, HCl
acetone, 0°C
MePPh3Br, n-BuLi
THF, 0°C → rt
(80-90% yield)
OTIPS
Br
1.
2.
3.
n-BuLi
or
Mg0
OTIPS
X
2.13 2.14 2.15: X = Li
2.16: X = Mg
O
Me
X
2.10
2.17: X = Cl, Br, or I
O
H
H
Me
2.18
Scheme 2.1. Attempted vicinal difunctionalization of cyclopentenone
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2.3 — Synthesis of 5-7-6 tricycle containing a key stereotriad 
 It was ultimately decided that a direct vicinal difunctionalization of 
cyclopentenone, at least in this case, was not feasible after evaluating all available 
methods at hand. A stepwise approach was devised, as shown in Scheme 2.3, which 
eventually led to more productive results.  
 Beginning from commercially available cyclopentane-1,3-dione (2.21), a C2-
selective allylation reaction was developed employing catalytic Cu(MeCN)4BF4 (5 
mol%) and sodium dodecyl sulfate (SDS) under basic aqueous conditions.  The resulting 12
methallylated cyclic dione 2.22 (65% yield from 2.21) was exposed to CBr4 and PPh3 to 
afford the corresponding β-bromocyclopentenone 2.23 (87% yield). A Negishi cross-
coupling of 2.23 and the arylzinc reagent 2.24 employing Organ’s Pd-PEPPSI catalyst  13
(1 mol%) smoothly afforded the cyclopentenone 2.25 in 91% yield. 
O
OTIPS
2.19
CuCl, NaOtBu
(p-tolyl)2BINAP
Ph2SiH2
O
OTIPS
H
O
OTIPS
H
Si
Ph Ph
MeLi; then
Me
Cl
Pd2(dba)3
O
H
H
Me
2.182.20
OTIPS
Scheme 2.2. Attempted reductive vicinal difunctionalization of cyclopentenone 2.19
OHO
O
TIPSO
Me
Cu(MeCN)4BF4 (5 mol%)
SDS (20 mol%)
1N NaOH, rt
(65% yield)
Me
Cl OHO CBr4, PPh3
CH2Cl2, rt
(87% yield)
BrO
Me
IPr-PEPPSI
(1 mol%)
THF-NMP, 60°C
(91% yield)
1. 2. 3.
ZnCl
TIPSO
2.24
2.21 2.22 2.23 2.25
Me
Scheme 2.3. Preparation of β-styrenyl-α-methallyl cyclopentenone 2.25
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 Attempted conjugate reduction of 2.25 under a variety of conditions likewise 
failed to afford the desired trans adduct, a product of formal vicinal difunctionalization of 
cyclopentenone (Scheme 2.4). 
 A highly conjugated tricycle 2.26 could be obtained by heating a solution of 2.25 
in PhMe with Grubbs’ 2nd-generation catalyst (10 mol%) in a sealed tube but only in 
moderate yields even after extensive reaction times (>100 h). Larger catalyst loadings (up 
to 100 mol%) still afforded only moderate conversion (< 50%). 
 It is known that ruthenium carbenes formed upon engagement with an alkene can 
strongly coordinate to Lewis basic moieties in close proximity. Hypothesizing that a 
strong 6-membered chelate (2.28) was forming upon metathesis with the methallyl 
portion of 2.25 and effectively shutting down all catalysis,  I evaluated the use of Ti(Oi-14
Pr)4 as a Lewis acid additive  that would chelate the Lewis basic carbonyl (2.25), 15
Grubbs II (10 mol%)
PhMe, 110°C, 5 days
(~50% conversion)
O Me
OTIPS
O
TIPSO
Me
LRuO
TIPSO
LRu
Me
2.25 via:
2.282.26 2.27
Scheme 2.5. Initial observation in the ring-closing metathesis of 2.25 reveals carbonyl group as a bad actor
O
TIPSO
Me
conjugate reduction
see Table 2.1
O
H
H
Me
2.18
OTIPS
2.25
Scheme 2.4. β-styrenyl-α-methallyl cyclopentenone 2.25 fails to undergo conjugate reduction
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blocking coordination with the pendant Ru-carbene, and thus allow for productive 
metathesis. 
 Encouragingly, a 76% isolated yield of tricycle 2.26 was obtained upon treatment 
with 2 mol% Grubbs II catalyst and 20 mol% Ti(Oi-Pr)4 in toluene at 70°C for 3 h 
(Scheme 2.6). Addition of 200 mol% of the Lewis acid and increasing the reaction 
temperature to 110°C with continuous nitrogen sparging afforded a 96% isolated yield of 
2.26 on gram scale (1 mol% Ru-catalyst). 
 With a scalable route to conjugated tricycle 2.26, I next evaluated reduction of the 
tetrasubstituted enone in hope that a thermodynamic preference for the trans adduct could 
be obtained. After considerable experimentation a conjugate reduction capable of such an 
outcome was discovered employing Mg in MeOH  to afford the desired trans-adduct 16
2.30 (70% yield from 2.25, ~4:1 dr). 
 Some discussion of this unusual reduction is warranted. A sampling of attempted 
reaction conditions is shown in Table 2.1. Of the myriad of reductants screened Mg in 
MeOH was the sole condition capable of delivering 2.30. The exquisite selectivity may in 
part be due to the redox potential of elemental Mg (-2.7 V) which is remarkably powerful 
in protic media. Notably, the pKa of the alcohol employed as solvent appears to have a 
O
TIPSO
LRu
Me Ti(OiPr)n
Grubbs II (1 mol%)
Ti(OiPr)4, PhMe, 110°C
2.25 2.26
5. Mg0, MeOH, 0°C
sonication
(70% yield,
2 steps
4:1 dr) O Me
OTIPS
H
H
2.30
4.
2.29
Scheme 2.6. Successful RCM and conjugate reduction
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critical effect on the efficiency of this reaction as use of EtOH or i-PrOH gave no 
reaction. 
 With tricycle 2.30 in hand it was decided to evaluate the ease with which A-ring 
elaboration could be achieved (Scheme 2.7). Literature methods for the conversion of 
cyclic ketones to the corresponding α-methylcycloalkenones generally require at least 
three steps. It was reasoned that a direct α-methylenation followed by olefin 
isomerization would be more direct. To this end, an initial success (~20% yield) was 
found employing conditions developed by Connell.  The resulting enone 2.31 is unstable 17
following chromatography and was immediately exposed to catalytic RhCl3 in EtOH4 to 
no reaction
no reaction
no reaction
no reaction
no reaction
1,2-reduction
1,2-reduction
complex mixture
no reaction
no reaction
no reaction
no reaction
no reaction
no reaction
no reaction
no reaction
no reaction
no reaction
no reaction
no reaction
72% isolated, 4:1 dr
no reaction
no reaction
complex mixture
CuCl / BINAP / NaOtBu / silane
Cu(OAc)2 / BINAP / NaOtBu / silane
[(PPh3)CuH]6
(DTBM-SEGPHOS)CuH
IPrCuCl / NaOtBu / silane
CuI / LiAlH4
L-selectride
HMPA / SiCl3
In(OTf)3 / silane
Zn / NiCl2
Hantsch ester
Na2S2O4 / nBu4NHSO4
TiCl3
SmI2 / HMPA
Co(acac)2 / DIBAL-H
NaBH4 / pyridine
Ir(ppy)3 / Et3N / HCO2H / 26W CFL
Mn(dpm)3 / TBHP / PhSiH3 / iPrOH
Zn / protic solvents
Al / protic solvents
Mg / MeOH
Mg / EtOH, i-PrOH, or t-BuOH
Na / protic solvents
Li-naphthalenide
Zn (-0.76 V)
Al (-1.66 V)
Mg (-2.37 V)
Mg (-2.37 V)
Na (-2.71 V)
Li (-3.04 V)
conditions result
O Me
OTIPS
H
HO Me
OTIPS
conjugate reduction
2.26 2.30
Table 2.1. Selected attempted conditions in the conjugate reduction of 2.26
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smoothly provide 2.32 (93% yield). The silyl protecting group could be removed with 
48% aqueous HF to afford phenol 2.33 in 91% yield. Eventually it was found treatment 
of 2.33 with PIDA in MeCN/H2O could afford quinol 2.34 as a 5:1 mixture of 
diastereomers  in 30-40% yield after flash chromatography on silica gel. 18
 Optimization and scale up efforts led to the ten step sequence depicted in Scheme 
2.8. On larger scale, the Mg0/MeOH conjugate reduction gave varying quantities of over 
reduced material arising from 1,4-reduction followed by 1,2-reduction; a more practical 
procedure was developed in which following aqueous workup the crude reaction material 
was immediately treated to Dess-Martin periodinane which served to re-oxidize any 
saturated alcohols produced back to the corresponding carbonyl, affording 2.30 in 
comparable yields to small scale runs on a gram scale. 
 The efficiency of the direct α-methylenation transform initially employed in the 
exploratory phase was found to be inadequate upon scaleup. A survey of reactions 
O Me
OTIPS
H
H
2.30
i-Pr2NH·TFA, (CH2O)n
THF, reflux
(~20% yield) O Me
OTIPS
H
H
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H
H
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OH
H
H
Me
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MeCN-H2O, 0°C
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O
H
H
Me OH
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Scheme 2.7. Successful route to DDO tricyclic core 2.34 from 2.30
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conditions revealed that a recent method developed by Colby employing Danheiser’s 
trifluoroacetylation protocol followed by exposure to paraformaldehyde in the presence 
of K2CO3 cleanly afforded 2.37.  Rh-catalyzed olefin isomerization occurred without 19
incident and subsequent treatment with TBAF buffered with HOAc cleanly afforded the 
corresponding free phenol. Finally, oxidative dearomatization reliably afforded quinol 
2.34 in 34% yield over four steps. Notably all ten steps in this sequence were successfully 
executed on ≥ 1 g scale (11% overall yield) to afford preparative quantites of quinol 2.34. 
O
TIPSO
Me
Cu(MeCN)4BF4 (5 mol%)
SDS (20 mol%)
1N NaOH, rt
(65% yield)
Me
Cl OHO
Me
CBr4, PPh3
CH2Cl2, rt
(87% yield)
BrO
Me
IPr-PEPPSI (1 mol%)
THF, rt
(91% yield)
1. 2. 3.
ZnCl
TIPSO
2.24
2.21
2.22 2.23 2.25
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OTIPS
H
H
Mg0, MeOH
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CH2Cl2, rt
(70% yield, 2 steps
4:1 dr)
LiHMDS, THF, -78°C
then CF3CO2CH2CF3
O Me
OTIPS
H
H
HO
F3C
Grubbs II (1 mol%)
Ti(OiPr)4, PhMe, 110°C
5.
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O
H
H
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O
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H
H
RhCl3 (10 mol%)
EtOH-H2O, 100°C
TBAF, HOAc
THF, rt
PhI(OAc)2
MeCN-H2O, 0°C
(34% yield, 5 steps)
8.
9.
10.
11.
2.34
12% overall yield
all steps ≥ 1 g scale
2.26
not isolated
2.35
not isolated
2.31
not isolated
2.30
2.36
Scheme 2.8. 11-step synthesis of the DDO tricycle core
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2.4 — Alkoxide-directed conjugate addition thwarts a short synthesis of the complete 
DDO skeleton 
 With an efficient synthetic pathway to 2.34 in hand, I was on the verge of 
completing the assembly of the DDO full-carbon skeleton. However, as the title of this 
section suggests, the proposed quinol functionalization proved to be intractable. 
 Completion of the C-ring would first require two stereocontrolled C-C bond 
forming events: (1) tertiary alkoxide directed 1,4-addition of a methyl nucleophile; and 
(2) diastereoselective 1,2-addition of an isopropenyl nucleophile. The first of these 
transformations has been well-documented, including in strategically similar model 
studies performed by Li and co-workers.  Following the general literature procedure, 20
quinol 2.34 was first exposed to a strong lithium base (e.g. LDA, LiHMDS). Exposure of 
O Me
O
H
H
Me OH
O Me
O
H
H
Me OH
Rbase, then MeMgX
or CH3-[M]
or nucleophile
bases:
LiHMDS
KHMDS
NaHMDS
LDA
KH
NaH
[CH3]n-M:
MeMgCl
MeMgBr
MeMgI
Me3Al
Me2Zn
Me3ZnLi
Me3ZnMgX
MeLi
Me2CuLi
Me2Cu(CN)Li2
Me(2-thienyl)Cu(CN)Li2
additives:
HMPA
DMPU
TMEDA
LiCl
LiBr
ZnCl2
18-crown-6
15-crown-5
BF3·OEt2
alternative nucleophiles:
NaCN
n-Bu4NCN
MeNO2
NaI
MeOH/hv
MeBF3K
B2Pin2
malonates
silyl ketene acetals
CH2I2/Zn
TMS-CH2N2
→ NR
→ NR
→ NR
→ decomposition
→ rearomatization
→ NR
→ NR
→ NR
→ NR
→ rearomatization
→ complex mixture
NR or unselective 1,2-addition for all cases
2.34 2.38: R = Me
2.39: R = alt. nucleophile
                (see table)
Table 2.2. An alkoxide-directed conjugate addition thwarts successful elaboration of quinol 2.34
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the resulting lithium alkoxide to methyl Grignard in the presence of a polar, aprotic 
cosolvent (e.g. HMPA, DMPU) would, based on precedent, direct addition of the methyl 
nucleophile from the same face as the alkoxide. Unfortunately, all attempts to accomplish 
such a sequence on 2.34 (≥ 50 conditions, Table 2.2) did not afford the desired 1,4-
adduct. Either recovered starting material, nonspecific 1,2-addition products, or 
rearomatized phenol 2.33 were generally isolated.  21
 Table 2.3 summarizes potential work-arounds that were explored. Intramolecular 
cases such as the venerable Stork-Ueno radical cyclization (2.42 → 2.43),  Barbier-type 22
O Me
O
H
HMe
O
SiMe
Me
Br
O Me
O
H
HMe
O
O
Br
O Me
O
H
HMe
O
O
O OR
Bu3SnH, AIBN, PhH, reflux
Et3B, air
Ir(ppy)3, Et3N, HCO2H, hv
Zn, THF, reflux
Mg, THF, reflux
tBuLi, Et2O-pentane
K2CO3
Cs2CO3
NaH
Et3N
iPr2NEt
DBU
→ rearomatization
→ rearomatization
→ rearomatization
→ rearomatization
→ NR
→ tert-butylation
→ NR
→ NR
→ NR
→ NR
→ NR
→ NRO Me
O
H
HMe
O
O
H
O
OR
O Me
O
H
HMe
O
O
O Me
O
H
HMe
O
SiMe
Me
Bu3SnH, AIBN, PhH, reflux
Et3B, air
Ir(ppy)3, Et3N, HCO2H, hv
Zn, THF, reflux
→ rearomatization
→ rearomatization
→ rearomatization
→ rearomatization
O Me
O
H
HMe
O
MeO
O Me
O
H
HMe
O
TMSO
O Me
O
H
HMe
O
O
N2
2.40 2.41
2.42 2.43
2.44 2.45
2.46 2.47 2.48
Table 2.3. Select attempts at an intramolecular strategy to append the angular C12 methyl group
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cyclizations (2.40 → 2.41), and malonate Michael additions (2.44 → 2.45)  all failed; it 23
was quickly realized that the propensity of quinols 2.40-2.46 to undergo facile and rapid 
rearomatization under both radical and basic conditions severely limited the scope of 
available methods that could be brought to arms. Alternative nucleophiles that could 
serve as methyl surrogates (e.g. cyanide, nitromethane, boronic esters, halides; see Table 
2.2) were unsuccessful.  24
2.5 — A ‘pre-installed’ methyl group yields an unexpected stereochemical outcome 
 Still eager to claim to a short synthesis of the complete DDO carbon skeleton, a 
final plan was devised to evaluate the feasibility of at least securing all 20 carbons of this 
diterpene architecture. It was reasoned that incorporation of a styrene with a methyl 
already appended onto the benzene nucleus would, following the identical sequence 
previously developed and nucleophilic addition of an isopropenyl nucleophile could 
afford a molecule with all twenty carbons of the DDO skeleton. The stereochemistry of 
angular methyl would need to be introduced later by an as-yet unrealized sequence. 
 The required styrene 2.51 was at the time unknown. Accordingly, an efficient 
five-step synthesis was developed from commercially available 3,5-dimethylphenol 2.49 
(Scheme 2.9). TBS-protection,  benzylic monobromination, nuclear para-bromination,  25 26
Hass-Bender oxidation,  and Wittig olefination afforded >50 g of styrene 2.51 in a single 27
batch (43% overall yield) which, using the previously described sequence outlined in 
Scheme 2.8, was advanced in seven additional steps to the quinol 2.58. 
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 Single crystals suitable for X-ray diffraction were grown and the relative 
stereochemistry of the stereotriad was revealed to be all-cis, confirming initial 
assignments based on J-coupling constants of the vicinal methine protons generated from 
conjugate reduction. 
 The stereochemical outcome from this system was unexpected and deserves some 
discussion. Employing Mg0/MeOH, conjugate reduction of 2.53 is stereoselective (>20:1) 
for the cis isomer but also overall low-yielding (20%, 3 steps). This is in contrast to the 
modest diastereoselectivity (4:1) for the trans isomer in the des-methyl system that was 
overall high-yielding (70%, 3 steps). Yields of the oxidative dearomatization for either 
Mg, THF, 22°C
then add ZnCl2
then add 2.23
IPr-PEPPSI (1 mol%)
(57% yield) O
TBSO
Me
8. Mg
MeOH
HO Me
OTBS
H
O Me
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H
Me OH
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Me
O Me
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H
H
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H
X-ray
Me Me
OH TBSCl, imidazole
DMA, rt
NBS, AIBN
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NBS, MeCN, rt
Me
OTBS
Br
1.
2.
3.
6.
RhCl3 (10 mol%)
EtOH-H2O, 100°C
PhI(OAc)2
MeCN-H2O, 22°C
(30% yield, 4 steps
10:1 dr)
13.
O Me
OH
H
H
Me
Me
H
HH
H
2.49 2.51 2.52
O Me
OTBS
Me
Grubbs II (2 mol%)
Ti(OiPr)4, PhMe, reflux
7.
2.532.542.55
O Me
OTBS
H
H
Me LiHMDS, THF, 78°C;
CF3CO2CH2CF3
K2CO3, (CH2O)n
THF, 60°C
10.
11.
12.
2.56
2.57 2.58
2-nitropropane
KOt-Bu, i-PrOH, rt
MePPh3Br, NaH
THF, rt
4.
5.
(43% yield,
5 steps)
Me
BrBr
OTBS
2.50
Scheme 2.9. A pre-installed methyl route to the DDO tricycle core
9. Dess-
Martin
(20% yield
3 steps
>20:1 dr)
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system are comparable but the stereoselectivity is higher for the preparation of 2.58 (10:1 
dr). 
 A working model to explain the stereochemical outcome of the conjugate 
reduction of 2.53 (Scheme 2.9) is largely based on a non-obvious steric effect imparted 
by the benzylic methyl of the arene. Following 2e-/2H+ reduction of 2.53 the 
stereodefining event occurs following tautomerization of enol 2.54. Steric clashing and 
torsional effects are minimized by generating the cis-adduct 2.58. 
 Extensive efforts to correct the stereochemistry at C4 via epimerization (2.58 → 
2.60) or enolate autooxidation (2.58 → 2.61) were unsuccessful (Scheme 2.10). 
Similarly, attempts to secure the stereochemistry of the angular C18 methyl through 
reduction (2.58 → 2.59) could not be acheived. Lastly, exposing 2.58 to 
isopropenylmagnesium bromide to 2.62 failed to give a clean reaction profile.  Given 28
O Me
O
H
H
Me OH
Me
epimerizationconjugate reduction
O Me
O
R
H
Me OH
Me
O Me
O
H
H
Me OH
Me
enolate
oxidation
2.582.59 2.60: R = H
2.61: R = OH
Me MgBr
O Me
OH
H
H
Me OH
Me
2.62
Me
Scheme 2.10. Unsuccessful attempts to elaborate 2.58
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these final results and the high cost-to-benefit in continuing the synthetic campaign in 
this fashion, the route was ultimately deemed a dead-end. 
2.6 — Concluding remarks 
 I have disclosed in this chapter details outlining the first-generation approaches 
towards the chemical synthesis of daphnane diterpene orthoesters. The retrosynthetic 
analysis provided reasons that a concise synthesis must first rapidly generate the 5-7-6 
tricyclic structure (in our case by coupling a five-membered ring and a six-membered 
ring with pendent functionality capable of immediately forming the seven-membered 
ring) and that a benzene nucleus might serve as a useful starting material for a 
stereocontrolled synthesis of the challenging six-membered C-ring. 
 Two tricyclic cores bearing structural relevance to DDOs could be readily 
prepared in preparative quantities in eleven and thirteen steps (LLS), respectively, from 
commercially available starting materials. Salient transformations include an efficient 
RCM that occurs only in the presence of a titanium(IV) reagent and conjugate reduction 
of a tetrasubstituted α,β-unsaturated cyclopentenone employing a simple combination of 
Mg0 and MeOH. Notably, it was discovered that the stereochemistry of the 5-7 ring 
fusion is dependent on the steric bulk of proximal functionality on the arene portion of 
the molecule. 
 Despite intensive efforts to employ a native tertiary alcohol as a stereochemical 
relay for C-C bond formation in the C-ring, this transform was met only with defeat 
within the systems explored in this chapter. 
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 While incredibly frustrating and disheartening to end at such a point so close to 
the desired target molecule, useful information was gleaned from these initial studies and 
dispatched in a more productive second-generation route. The most foretelling lesson, 
and quite a theme throughout the next chapter, is the remarkable stereocontrol these 
particular systems often afford, guided almost wholly by substrate control. 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2.7 — Experimental Procedures 
General Methods. Unless otherwise noted, all reactions were performed using flame-
dried glassware under an atmosphere of nitrogen. Air- and moisture-sensitive liquids and 
solutions were transferred via syringe or stainless steel cannula. Organic solutions were 
concentrated under reduced pressure by rotary evaporation. Reactions were monitored by 
thin layer chromatography (TLC) using SiliCycle glass plates pre-coated with silica gel 
(0.25-mm thickness; 60-Å pore size) impregnated with a fluorescent indicator (254 nm). 
TLC plates were visualized by exposure to ultraviolet light (UV) and staining with 
ethanolic solutions of phosphomolybdic acid (PMA), acidic solutions of vanillin, or 
aqueous solutions of potassium permanganate followed by heating. Flash column 
chromatography was performed on silica gel 60 (230-400 mesh) purchased from 
SiliCycle. Solid reagents were weighed out in air. Reaction work-ups and 
chromatographic purifications were performed on the bench top in air using reagent grade 
solvents.  
Materials.  Reagent grade solvents were purchased from Fisher Scientific and used 
without further purification.  Anhydrous dichloromethane (DCM), tetrahydrofuran 
(THF), acetonitrile (MeCN), diethyl ether (Et2O), and toluene (PhMe) was obtained by 
passing these previously degassed solvents through two columns of activated alumina 
prior to use. Chemicals were purchased from commercial sources and used at received. 
Instrumentation. 1H NMR and 13C NMR spectra were recorded at 117.42 kG (1H 500 
MHz, 13C 125MHz), 93.94 kG (1H 400 MHz, 13C 100 MHz), or 70.50 kG (1H 300 
MHz, 13C 75 MHz) at ambient temperature on Varian Agilent-500 MHz VNMRS, Varian 
Agilent-400 MHz VNMRS, and Varian Agilent Agilent-300 MHz VNMRS 
spectrometers. Hydrogen chemical shifts are expressed in parts per million (ppm) relative 
to the residual protio solvent resonance: CDCl3 δ 7.26, CD3OD δ 3.31, DMSO-d6 δ 2.50, 
acetone-d6 δ 2.05. For 13C spectra, the centerline of the solvent signal was used as internal 
reference: CDCl3 δ 77.16, CD3OD δ 49.00, DMSO-d6 δ 39.52, acetone-d6 δ 29.84, 
206.26. Data are reported as follows: chemical shifts, multiplicity (s =singlet, d =doublet, 
t = triplet, q = quartet, and m = multiplet), coupling constant in hertz (Hz), and 
integration. 
 Infrared (IR) spectra were recorded on a Thermo-Fisher Nicolet FT-IR with ATR 
and are reported in terms of frequency absorption (cm-1). 
 High resolution mass spectrometry (HR-MS) data was obtained on a Waters Qtof 
(hybrid quadrupolar/time-of-flight) API US system by electrospray (ESI) in the positive 
mode by Dr. Norman Lee of the Boston University Department of Chemistry Chemical 
Instrumentation Center (BU-CIC). 
 X-ray diffraction was performed on a Bruker CMOS diffractomer by Prof. James 
Golen at the University of Massachusetts, Dartmouth. 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In air, a 2 L round bottom flask equipped with a stir-bar was charged cyclopentane-1,3-
dione (2.21, 50.0 g, 0.51 mol, 1.0 eq), copper(I) tetra(acetonitrile) tetrafluoroborate (8.02 
g, 25.5 mmol, 0.05 eq), and β-methallyl chloride (90% technical, 111 mL, 1.02 mol, 2.0 
eq) and the flask was placed in a room temperature water bath. A slurry of SDS (29.41 g, 
29.4 mmol, 0.2 eq) in 1.0 N aq. NaOH (510 mL, 0.51 mol, 1.0 eq) was poured into the 
stirring admixture in a single portion. The initial clear brown solution became a light tan 
suspension after 5-10 minutes and the mixture was vigorously stirred for 24 h at room 
temperature. Upon completion, the reaction was diluted with 1 N aq. HCl (510 mL) and 
cooled to 0°C. The mixture was filtered over a sintered glass funnel and the flask and 
filter cake were washed with Et2O. The collectetd solid was dried under reduced pressure 
to afford the title compound as a flocculent off-white solid (45.43 g, 56% yield) that was 
used without further purification. 
1H-NMR (500 MHz, (CD3)2CO): 
δ 4.60 (dt, J = 10.4, 1.3 Hz, 2H), 2.80 (s, 2H), 2.49 (s, 4H), 1.67 (s, 3H) 
 
13C-NMR (126 MHz, CD3OD): 
δ 198.51, 144.00, 116.27, 110.42, 31.30, 29.69, 22.97 
 
FT-IR (ATR): 
3380, 2938, 1721, 1420 cm-1 
 
HRMS (ESI): 
[M + H]+ calcd for C9H12O2: 153.0916, found 153.0923 
OHO
Me
2.22
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In air, a 250 mL round bottom flask equipped with a stir-bar was charged 2.22 (5.0 g, 
32.85 mmol, 1.0 eq) and triphenylphosphine (11.20 g, 42.7 mmol, 1.3 eq). 150 mL 
CH2Cl2 was added and the resulting suspension was cooled in an ice-water bath. The 
reaction mixture was treated with carbon tetrabromide (14.163 g, 42.7 mmol, 1.3 eq) in 
even portions and allowed to warm to room temperature. Upon complete consumption of 
starting material the reaction was quenched with silica gel and concentrated under 
reduced pressure. The resulting free-flowing admixture was directly purified by flash 
column chromatography on silica gel (hexanes → 20% ether in hexanes) to afford the 
title compound as a clear, colorless liquid (6.132 g, 87% yield). 
 A 71% yield was obtained when the reaction was performed on a 45 g scale. 
1H-NMR (500 MHz, CDCl3): 
δ 4.76 (s, 1H), 4.65 (s, 1H), 2.96 (m, 4H), 2.57 (dt, J = 4.9, 2.4 Hz, 2H), 1.73 (s, 3H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 203.17, 157.47, 142.82, 140.55, 111.75, 35.82, 35.24, 32.44, 22.83 
 
FT-IR (ATR): 
3079, 2970, 2930, 1708, 1628, 1295 cm-1 
HRMS (ESI): 
[M + H]+ calcd for C9H11BrO2: 215.0012, found 215.0082 
BrO
Me
2.23
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A flame-dried 1L round bottom flask equipped with a large egg shaped teflon coated stir-
bar was charged TIPSCl (70 grams, 0.363 mol, 1.0 eq) and anhydrous MeCN (726 mL, 
0.5M) was added. The resulting solution was treated with 3-hydroxybenzaldehyde (2.13, 
46.55 grams, 0.381 mol, 1.05 eq) and imidazole (61.78 grams, 0.907 mol, 2.50 eq) in 
sequence and stirred at room temperature for 24 hours. Upon completion, the solvent was 
removed by rotary evaporation and the crude residue was taken up in 500 ml hexanes and 
500 ml Et2O and poured into a 2L separatory funnel charged with 500 ml 1N aq. HCl. 
The layers were separated and the organic phase was washed twice with 500 ml 1N aq. 
NaOH, 300 ml brine, dried over anhydrous sodium sulfate, and filtered. Removal of 
solvent under reduced pressure afforded crude TIPS-protected benzaldehyde as a clear, 
colorless oil which was used without further purification. 
 
1H-NMR (500 MHz, CDCl3):  
δ 9.95 (s, 1H), 7.45 (dt, J = 7.6, 1.3 Hz, 1H), 7.39 (t, J = 7.7 Hz, 1H), 7.36 (dd, J = 2.6, 
1.4 Hz, 1H), 7.15 (ddd, J = 8.0, 2.6, 1.2 Hz, 1H), 1.29 (m, 3H), 1.11 (d, J = 7.5 Hz, 18H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 192.12, 156.88, 138.03, 130.12, 126.37, 123.37, 119.64, 17.96, 12.73 
 
FT-IR (ATR):  
2946, 2868, 1694, 1600, 1584, 1483, 1447, 1287, 1003, 964, 883, 682 cm-1 
 
HRMS (ESI):  
[M + H]+ calcd for C16H26O2Si: 279.1780, found 279.1780 
O
OTIPS
2.63
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In air, a 2 L round bottom flask fitted with a large egg-shaped stir bar was charged 2.63 
(101 grams, 0.363 mol, 1.0 eq) and reagent grade acetone (726 mL, 0.5M) was added. 
The clear solution was treated with NBS (193.82 grams, 1.09 mol, 3.0 eq) in a single 
portion and the resulting suspension was cooled in an ice-water bath and rapidly stirred 
for 10 minutes. Concentrated HCl (~12.1 N, 33 mL, 0.399 mmol, 1.1 eq) was added in a 
single portion and the reaction became dark red. After 30 minutes, the reaction mixture 
was carefully quenched with triethylamine (56 mL) and rapidly stirred for 10 minutes, 
giving a light yellow suspension. The precipitate was filtered off and the resulting filtrate 
was concentrated by rotary evaporation. The crude residue was taken up in 1:1 Et2O/
hexanes (1 L) and washed with water (1 L), 1N aq. NaOH (2x500 mL), brine (300 mL), 
and dried over anhydrous sodium sulfate. Filtration and concentration under reduced 
pressure gave a crude oil that was passed through a pad of silica gel (hexanes elution). 
The resulting filtrate was concentrated under reduced pressure to afford a clear colorless 
oil that was used without further purification. 
 
1H-NMR (500 MHz, CDCl3):  
δ 10.28 (s, 1H), 7.48 (d, J = 8.7 Hz, 1H), 7.40 (d, J = 3.1 Hz, 1H), 6.99 (dd, J = 8.7, 3.1 
Hz, 1H), 1.32 – 1.21 (m, 3H), 1.09 (d, J = 7.5 Hz, 18H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 191.83, 156.09, 134.66, 134.15, 127.51, 120.19, 118.03, 17.94, 12.67 
 
FT-IR (ATR):  
3421, 2945, 2867, 1695, 1649, 1298 cm-1 
 
HRMS (ESI):  
[M + H]+ calcd for C16H25BrO2Si: 357.0885, found 357.0894 
O
OTIPS
2.64
Br
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A flame-dried 2 L round bottom flask equipped with a large egg-shaped stir bar was 
charged methyltriphenylphosphonium bromide (130 g, 0.363 mol, 1.0 eq) and the flask 
was thrice evacuated and backfilled with nitrogen. 1.2 L anhydrous THF was added and 
the resulting suspension was cooled to 0°C. n-BuLi (2.5 M in hexanes, 145 mL, 0.363 
mol, 1.0 eq) was added by syringe over 15 minutes and the resulting deep red solution 
was further stirred for 0.5 h. A solution of the crude 2.63 (assumed 0.363 mol) from the 
previous reaction dissolved in 100 mL THF was added by syringe over a 5 minute period. 
The reaction was stirred for 1 h and warmed to room temperature over an additional 3 h 
at which point the reaction was carefully  quenched with sat’d aq. NH4Cl with vigorous 
stirring. The resulting biphasic mixture was poured into a 2 L separatory funnel charged 
with hexanes and the layers were separated. The aqueous phase was extracted twice with 
hexanes and the combined organic extracts were washed with brine and dried over 
anhydrous sodium sulfate. Concentration afforded a crude material that was purified by 
flash column chromatography on silica gel (hexanes) to afford styrene 2.14 as a clear, 
colorless liquid (103 g, 80% yield over 3 steps). 
 
1H-NMR (500 MHz, CDCl3):  
δ 7.08 (dd, J = 17.3, 10.9 Hz, 1H), 6.86 (d, J = 2.9 Hz, 1H), 6.68 (d, J = 0.7 Hz, 1H), 5.59 
(dd, J = 17.3, 1.2 Hz, 1H), 5.32 (dd, J = 10.9, 1.2 Hz, 1H), 2.37 (s, 3H), 0.99 (s, 9H), 0.21 
(s, 6H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 154.62, 139.57, 138.97, 136.92, 122.19, 117.89, 116.55, 116.01, 25.82, 24.04, 18.36, 
-4.25 
 
FT-IR (ATR): 
2956, 2929, 2858, 1584, 1471, 1399, 1313, 1253, 1168, 995, 839, 781 cm-1 
 
HRMS (ESI): 
[M + H]+ calcd for C15H23BrOSi: 355.1093, found 355.1089 
OTIPS
Br
2.14
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A flame-dried 500 mL round bottom flask equipped with a large, egg shaped stir-bar was 
charged 2.14 (33.05 g, 93 mmol, 2.0 eq) and 50 mL anhydrous THF was added by 
syringe. The resulting solution was treated with magnesium turnings (5.65 g, 232 mmol, 
5.0 eq) in a single portion followed by addition of DIBAL-H (1.0 M in hexanes, 4.6 mL, 
4.6 mmol, 2 mol% wrt magnesium) by syringe. Vigorous gas evolution was immediately 
observed that subsided within 1-2 minutes. The reaction mixture was stirred in a water 
bath at room temperature overnight and upon completion the resulting Grignard reagent 
was diluted with 75 mL THF. 
 Separately, a second 500 mL round bottom flask equipped with a large, egg 
shaped stir-bar was flame-dried under vacuum and cooled to room temperature. The flask 
was charged with ZnCl2 (13.31 g, 97.65 mmol, 2.1 eq) and the solid was further dried by 
heating with a heat gun for 5 minutes under vacuum and cooling to room temperature. 
This drying process was repeated 2 more times. The flask was backfilled with nitrogen 
and 50 mL anhydrous THF was added by syringe. The suspension of ZnCl2 was cooled in 
an ice bath and the Grignard reagent was added by positive pressure cannulation using a 
quadruple layered nitrogen balloon. The flask containing the Grignard was rinsed with an 
additional portions of THF (25 mL total) to ensure the transfer was quantitative. The 
cooling bath was then removed and the resulting turbid brown-grey suspension was 
warmed to room temperature. 
 Separately, a solution of 2.23 (10.0 g, 46.5 mmol, 1.0 eq) and iPr-PEPPSI (0.316 
g, 0.465 mmol, 0.01 eq) in 125 mL anhydrous NMP was prepared and this solution was 
added by syringe to the aryl zinc reagent. During the course of the addition, the turbid 
suspension became a dark red solution and upon completion became a pale orange 
suspension. The reaction mixture was heated to 60°C overnight, cooled to room 
temperature, and quenched with 1 N aq. HCl. The layers were separated and the aqueous 
phase was extracted thrice with Et2O. The combined organic layers were washed with 1 
N aq. HCl and brine, dried over anhydrous magnesium sulfate, and concentrated under 
reduced pressure. The resulting crude residue was purified by flash column 
chromatography on silica gel (hexanes → 2% EtOAc in hexanes) to afford the title 
compound as a viscous yellow oil (17.37 g, 91% yield). 
 
1H-NMR (500 MHz, CDCl3): 
O
TIPSO
Me
2.25
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δ 7.11 (d, J = 2.3 Hz, 1H), 6.96 (d, J = 8.3 Hz, 1H), 6.82 (dd, J = 8.4, 2.4 Hz, 1H), 6.51 
(dd, J = 17.4, 10.9 Hz, 1H), 5.65 (d, J = 17.4 Hz, 1H), 5.24 (d, J = 10.9 Hz, 1H), 4.58 (s, 
1H), 4.40 (s, 1H), 2.79 (s, 4H), 2.59 – 2.51 (m, 2H), 1.55 (s, 3H), 1.28 (m, 3H), 1.12 (d, J 
= 7.5 Hz, 18H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 209.09, 171.89, 156.51, 142.40, 140.82, 136.02, 134.49, 129.05, 128.24, 119.60, 
116.72, 115.86, 111.20, 34.72, 32.54, 31.63, 22.93, 18.03, 12.80 
 
FT-IR (ATR): 
2950, 2867, 1715, 1598, 1488, 1291, 883 cm-1 
 
HRMS (ESI): 
[M + H]+ calcd for C26H38O2Si: 411.2719, found 411.2715 
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A flame-dried 2-necked flask equipped with a reflux condenser and a magnetic stir-bar 
was charged a solution of 2.25 (1 g, 2.43 mmol, 1.0 eq) in 40 mL PhMe. Titanium(IV) 
isopropoxide (1.44 mL, 4.86 mmol, 2.0 eq) was added by syringe at room temperature 
and the solution turned yellow. The reaction was sparged with nitrogen for 20 minutes 
before being brought to reflux. Grubbs’ II catalyst (0.021 g, 0.024 mmol, 0.01 eq) in 5 
mL PhMe was added in 1 mL aliquots every 20 minutes and upon complete addition of 
catalyst the reaction was further refluxed for 2 h. The reaction was cooled to room 
temperature and concentrated under reduced pressure. The resulting crude material was 
typically used without further purification. An analytically pure sample was obtained 
following flash column chromatography on silica gel (10% Et2O in hexanes) to afford 
2.26 as a brown oil. 
1H-NMR (500 MHz, CDCl3): 
δ 7.47 (d, J = 8.5 Hz, 1H), 6.82 (dd, J = 8.6, 2.6 Hz, 1H), 6.77 (d, J = 2.5 Hz, 1H), 6.27 
(s, 1H), 2.90 (dd, J = 6.4, 2.8 Hz, 2H), 2.82 (s, 2H), 2.58 – 2.52 (m, 2H), 2.04 (d, J = 1.4 
Hz, 3H), 1.34 – 1.24 (m, 3H), 1.12 (d, J = 7.4 Hz, 18H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 206.96, 165.54, 157.24, 140.84, 139.78, 135.78, 128.73, 127.14, 125.66, 121.20, 
118.19, 34.99, 27.54, 26.36, 26.29, 18.01, 12.77 
 
FT-IR (ATR): 3447, 2862, 1690, 1378, 864 cm-1
 
HRMS (ESI): 
[M + H]+ calcd for C24H34O2Si: 383.2406, found 383.2417 
O Me
OTIPS
2.26
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Crude 2.26 from the above reaction was dissolved in 100 mL reagent grade MeOH and 
treated with magnesium turnings (0.354 g, 14.58 mmol, 6.0 eq). The reaction was 
sonicated at 0°C and monitored by TLC. Upon complete consumption of starting material 
the reaction was poured into 1N aq. HCl and extracted thrice with EtOAc. The combined 
organic extracts were washed with brine and dried over anhydrous sodium sulfate. 
Concentration afforded a crude residue that dissolved in CH2Cl2 and treated with Dess-
Martin periodinane (1.03 g, 2.43 mmol, 1.0 eq) at room temperature. After 1 h the 
reaction was poured into sat’d aq. NaHCO3 and extracted with CH2Cl2. The combined 
organic extracts were dried over anhydrous sodium sulfate and concentrated under 
reduced pressure. Purification by flash column chromatography on silica gel (10% Et2O 
in hexanes) to afford the title compound as an orange oil (~4:1 mixture of inseparable 
diastereomers, 0.654 g, 70% yield over 3 steps). 
 
1H-NMR (major diastereomer, 500 MHz, CDCl3): 
δ 7.04 (d, J = 8.3 Hz, 1H), 6.67 (dd, J = 8.4, 2.6 Hz, 1H), 6.64 (d, J = 2.6 Hz, 1H), 6.15 
(s, 1H), 3.16 (td, J = 11.0, 6.1 Hz, 1H), 2.77 (dd, J = 17.6, 3.3 Hz, 1H), 2.60 – 2.48 
(overlap m, 1H), 2.56 (ddd, J = 12.3, 6.1, 2.5 Hz, 1H), 2.38 – 2.29 (overlap m, 1H), 2.25 
(dd, J = 12.8, 5.8 Hz, 1H), 2.16 (td, J = 14.5, 13.5, 7.5 Hz, 1H), 2.05 (qd, J = 12.4, 8.0 
Hz, 1H), 1.93 (s, 3H), 1.31 – 1.19 (m, 3H), 1.10 (d, J = 7.4 Hz, 18H) 
 
13C-NMR (major diastereomer, 126 MHz, CDCl3): 
δ 220.39, 154.62, 137.33, 136.70, 132.67, 127.23, 126.15, 123.05, 117.34, 52.25, 45.35, 
38.09, 37.61, 27.43, 26.23, 18.07, 12.79 
 
FT-IR (ATR):  
3435, 2967, 2867, 1740, 1603, 1497, 1463, 1295, 883 cm-1
 
HRMS (ESI): 
[M + H]+ calcd for C24H36O2Si: 385.2563, found 385.2574 
O Me
OTIPS
H
H
2.30
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A solution of hexamethyldisilazane (1.14 mL, 5.46 mmol, 2.1 eq) in 8 mL anhydrous 
THF was cooled to 0°C (ice-water bath) and n-BuLi (2.0 M in hexanes, 2.6 mL, 5.2 
mmol, 2.0 eq) was added rapidly dropwise by syringe. After 10 minutes, the solution was 
cooled to -78°C and a solution of 2.30 (1.0 g, 2.6 mmol, 1.0 eq) in 4 mL THF was added 
dropwise over several minutes. The mixture was stirred for 30 minutes and treated 
rapidly (within 1-2 seconds; slower addition is detrimental to the reaction outcome) with 
2,2,2-trifluoroethyl trifluoroacetate (1.73 mL, 13.0 mmol, 5.0 eq) via syringe. The 
reaction was warmed to room temperature over 1 h and upon complete consumption of 
starting material, as judged by TLC, the reaction mixture was poured into a separatory 
funnel charged with equal volumes sat’d aq. NH4Cl and EtOAc. The layers were 
separated and the aqueous layer was extracted twice with EtOAc. The combined organic 
layers were dried over anhydrous magnesium sulfate and filtered. 
 Concentration afforded a crude residue that was taken up in anhydrous THF (50 
mL), treated with potassium tert-butoxide (350 mg, 3.12 mmol, 1.2 eq) and 
paraformaldehyde (780 mg, 26.0 mmol, 10 eq), and heated to 60°C. After 30 minutes, the 
reaction was cooled to room temperature and quenched with sat’d aq. NH4Cl. The phases 
were separated and the aqueous layer was extracted twice with diethyl ether. The 
combined organic layers were dried over anhydrous magnesium sulfate and filtered.  
 Concentration afforded a crude residue that was taken up in reagent grade EtOH 
(30 mL) and treated with rhodium(III) chloride hydrate (12 mg, 2 mol%). The resulting 
mixture was heated to 100°C. Upon completion, as determined by TLC, the mixture was 
concentrated and directly purified by flash column chromatography on silica gel (10% 
Et2O in hexanes) to afford 2.32 as an orange syrup (0.72 g, 70% yield over 3 steps). 
1H-NMR (500 MHz, CDCl3): 
δ 7.67 (s, 1H), 6.93 (d, J = 8.2 Hz, 1H), 6.70 (d, J = 2.5 Hz, 1H), 6.66 (dd, J = 8.1, 2.5 
Hz, 1H), 6.24 (s, 1H), 3.75 (br s, 1H), 2.82 (dd, J = 18.7, 4.7 Hz, 1H), 2.48 (dt, J = 13.0, 
4.4 Hz, 1H), 2.33 (dd, J = 18.7, 13.0 Hz, 1H), 1.98 (s, 3H), 1.89 (s, 3H), 1.30 – 1.19 (m, 
3H), 1.10 (d, J = 7.4 Hz, 18H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 209.26, 154.66, 154.56, 142.77, 139.32, 136.82, 131.96, 126.64, 123.94, 122.96, 
O Me
OTIPS
H
H
Me
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117.30, 52.17, 47.96, 36.41, 27.61, 18.06, 12.77, 10.73 
 
FT-IR (ATR):  
2925, 2866, 1708, 1602, 1500, 1463, 1276, 970, 882, 856 cm-1 
 
HRMS (ESI):  
[M + H]+ calcd for C25H36O2Si: 397.2563, found 397.2574 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A solution of 2.32 (1.0 g, 2.5 mmol, 1.0 eq) in 10 mL THF was treated with acetic acid 
(0.715 mL, 12.5 mmol, 5.0 eq) and TBAF (1.0 M in THF, 7.5 mL, 7.5 mmol, 3.0 eq) at 
room temperature. Upon complete consumption of starting material, as judged by TLC, 
the reaction was poured into water and extracted thrice with EtOAc. The combined 
organic extracts were washed with brine, dried over anhydrous magnesium sulfate, and 
concentrated under reduced pressure. Purification by flash column chromatography on 
silica gel afforded 2.33 as a white solid (0.456 g, 76% yield). 
1H-NMR (500 MHz, CD3OD):  
δ 7.84 (s, 1H), 6.94 (d, J = 8.2 Hz, 1H), 6.61 (d, J = 2.6 Hz, 1H), 6.57 (dd, J = 8.2, 2.6 
Hz, 1H), 6.25 (s, 1H), 3.71 (d, J = 3.2 Hz, 1H), 2.72 (dd, J = 17.6, 3.7 Hz, 1H), 2.36 (dt, J 
= 13.3, 3.7 Hz, 1H), 2.34 – 2.25 (m, 1H), 1.97 (s, 3H), 1.85 (s, 3H) 
 
13C-NMR (126 MHz, CD3OD): 
δ 211.49, 157.52, 156.85, 143.26, 139.86, 137.94, 131.78, 127.79, 125.13, 119.32, 
113.88, 53.62, 49.22, 37.15, 27.63, 10.48 
 
FT-IR (ATR):  
3380, 2921, 2178, 2006, 1684, 1605, 1504, 1436, 1274 cm-1 
 
HRMS (ESI): 
[M + H]+ calcd for C16H16O2: 241.1229, found 241.1223 
O Me
OH
H
H
Me
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A mixture of  2.32 (1.0 g, 4.16 mmol, 1.0 eq) in 4:1 MeCN/water (55 mL) was treated 
with PIDA (1.47 g, 4.58 mmol, 1.1 eq) in portions over 2-3 minutes. Upon complete 
consumption of starting material, as judged by TLC, the reaction was poured onto silica 
gel/dichloromethane and the resulting slurry was concentrated under reduced pressure. 
The resulting free-flowing admixture was directly purified by flash column 
chromatography on silica gel (20-50% EtOAc in hexanes) to afford 2.34 as an orange 
foam (0.456 g, 43% yield). 
 
1H-NMR (500 MHz, CDCl3):  
δ 7.48 (s, 1H), 6.87 (d, J = 10.1 Hz, 1H), 6.22 (dd, J = 10.1, 1.9 Hz, 1H), 6.18 (s, 1H), 
5.95 (s, 1H), 3.22 (dt, J = 5.0, 2.5 Hz, 1H), 2.84 (dd, J = 18.6, 4.5 Hz, 1H), 2.22 (dt, J = 
12.0, 4.8 Hz, 1H), 2.08 – 1.96 (m, 2H), 1.88 (s, 3H), 1.82 (t, J = 1.9 Hz, 3H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 207.59, 185.18, 159.04, 153.19, 146.29, 143.54, 142.57, 130.44, 126.55, 121.30, 72.52, 
52.47, 45.25, 36.89, 25.73, 10.67 
 
FT-IR (ATR):  
3410, 2921, 2156, 2007, 1702, 1664, 1614 cm-1 
 
HRMS (ESI):  
[M + H]+ calcd for C16H16O3: 257.1178, found 257.1183 
O Me
O
H
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A flame-dried 1 L round bottom flask equipped with a large stir-bar was charged 3,5-
dimethylphenol (100 g, 819 mmol, 1.0 eq), imidazole (111.45 g, 1.64 mol, 2.0 eq), and 
TBSCl (123.44 g, 819 mmol, 1.0 eq). 500 mL anhydrous DMA was added by positive 
pressure cannula via a quadruple layered nitrogen balloon and the resulting biphasic 
mixture was vigorously stirred at room temperature for 6 h. Upon completion, the 
reaction mixture was poured into a 2 L separatory funnel charged with 500 mL 0.5 N HCl 
and 500 mL 1:1 ether-hexanes. The layers were separated and the aqueous phase was 
extracted with 500 mL 1:1 ether-hexanes. The combined organic extracts were washed 
with 500 mL 1 N aq. NaOH, 400 mL brine, and dried over anhydrous sodium sulfate. 
Concentration under reduced pressure afforded the title compound as a clear, pale yellow 
oil that was used without further purification.  
 A 2 L round bottom flask equipped with a large stir-bar and a reflux condenser 
was charged a portion of the material from the above reaction (101.37 g, 429 mmol, 1.0 
eq). 1.5 L cyclohexane was added and the resulting solution was treated with NBS (76.3 
g, 429 mmol, 1.0 eq) and AIBN (4.226 g, 25.74 mmol, 0.06 eq). The resulting suspension 
was shielded from light and heated to 80°C. After 4 h, the reaction was allowed to slowly 
cool to room temperature overnight. The reaction was concentrated under reduced 
pressure to approx. 1/3 volume and washed with water (5x), brine, and dried over 
anhydrous sodium sulfate. Concentration under reduced pressure afforded a crude oil that 
was dissolved in 850 mL MeCN and treated with NBS (76.3 g, 429 mmol, 1.0 eq). After 
4 h, the reaction was concentrated under reduced pressure and partioned between hexanes 
and water. The layers were separated the organic phase was washed water (2x), brine, and 
dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded an 
orange liquid that was purified by flash column chromatography on silica gel (hexanes) 
to afford the title compound as a clear, colorless liquid (100 g, 62% yield over three 
steps). 
 
1H-NMR (500 MHz, CDCl3):  
δ 6.79 (dd, J = 2.9, 0.6 Hz, 1H), 6.69 (dd, J = 2.8, 0.7 Hz, 1H), 4.57 (s, 2H), 2.37 (s, 3H), 
0.98 (s, 9H), 0.20 (s, 6H) 
 
13C-NMR (126 MHz, CDCl3): 
Me
BrBr
OTBS
2.50
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δ 154.65, 140.40, 138.06, 122.94, 120.40, 118.41, 34.66, 25.76, 23.97, 18.30, -4.30 
 
IR (ATR):  
2955, 2929, 2857, 1588, 1462, 1326, 1253, 1170, 999, 839, 782 cm-1 
 
HRMS (ESI):  
[M + Na]+ calcd for C14H22Br2OSi: 414.9704, found 414.9704 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A 1 L round bottom flask equipped with a large stir-bar was charged 2.50 (100 g, 254 
mmol, 1.0 eq) and 500 mL isopropanol was added. The resulting solution was treated 
with 2-nitropropane (34.56 mL, 381 mmol, 1.5 eq) followed by potassium tert-butoxide 
(42.75 g, 381 mmol, 1.5 eq). A large exotherm gradually occurred but the reaction did not 
reach reflux. After stirring at room temperature overnight, the resulting canary yellow 
suspension was filtered over a short pad of celite layered with sand. The filter cake was 
washed with hexanes and the filtrate was poured into a 2 L separatory funnel charged 
with sat’d aq. NH4Cl. The layers were separated and the aqueous phase was extracted 
thrice with hexanes. The combined organic extracts were washed with brine, dried over 
anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting crude 
material was azeotroped thrice with 100 mL portions of cyclohexane and dried on high 
vacuum. The resulting liquid was dissolved in 700 mL anhydrous THF and treated with 
methyltriphenylphosphonium bromide (99.8 g, 279 mmol, 1.1 eq) and sodium hydride 
(60% w/w, 11.17 g, 279 mmol, 1.1 eq) with cooling from a large water bath (caution: 
hydrogen evolution!). After 2 h, the reaction was quenched with sat’d aq. NH4Cl and the 
resulting biphasic mixture was concentrated under reduced pressure until the majority of 
THF was removed. The remaining mixture was poured into a separatory funnel and 
extracted thrice with hexanes. The combined organic extracts were washed with brine and 
filtered over a short pad of silica gel. The pad was washed with hexanes and the filtrate 
was concentrated to afford a crude liquid that was purified by flash column 
chromatography on silica gel (hexanes) to afford styrene 2.51 (58.2 g, 70% yield over 2 
steps, 43% over 5 steps) as a clear, colorless liquid. 
 
1H-NMR (500 MHz, CDCl3):  
δ 7.08 (dd, J = 17.3, 10.9 Hz, 1H), 6.86 (d, J = 2.9 Hz, 1H), 6.68 (d, J = 0.7 Hz, 1H), 5.59 
(dd, J = 17.3, 1.2 Hz, 1H), 5.32 (dd, J = 10.9, 1.2 Hz, 1H), 2.37 (s, 3H), 0.99 (s, 9H), 0.21 
(s, 6H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 154.62, 139.57, 138.97, 136.92, 122.19, 117.89, 116.55, 116.01, 25.82, 24.04, 18.36, 
-4.25 
 
Me
OTBS
Br
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IR (ATR):  
2956, 2929, 2858, 1584, 1471, 1399, 1313, 1253, 1168, 995, 839, 781 cm-1 
 
HRMS (ESI):  
[M + H]+ calcd for C15H23BrOSi: 327.0780, found 327.0764 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A 1 L round bottomed flask equipped with a large magnetic stir-bar was charged 31 g 
ZnCl2 (weighed out on bench top, open to air). The flask was evacuated on high vacuum 
and the flask was thoroughly flame-dried. The flask was then lowered into an oil bath 
preheated to 150°C and stirring was maintained at the highest stable setting in order to 
maximize collision of the stir-bar with clumps of ZnCl2. After heating overnight, the 
heating bath was removed and the flask was flame-dried to ensure removal of trace 
moisture. After cooling to room temperature the flask was backfilled with nitrogen and 
226 mL anhydrous THF was added. The resulting solution of ZnCl2 (1.0 M in THF, 226 
mL, 226.0 mmol, 2.2 eq) was stirred at room temperature until the aryl Grignard was 
ready to be added. 
 Separately, a 500 mL round bottom flask equipped with a large, egg-shaped stir-
bar was charged 2.51 (40.29 g, 123.1 mmol, 1.2 eq) and magnesium turnings (12.47 g, 
513.0 mmol, 5.0 eq). The admixture was layered with anhydrous THF and slowly stirred 
as DIBAL-H (1.0 M in toluene, 10.26 mL, 10.26 mmol, 2 mol% wrt magnesium) was 
added by syringe at room temperature. The mixture was then heated to 50°C for 1 h to 
afford the corresponding Grignard reagent as a black solution. The Grignard was taken up 
in a syringe and added to the solution of ZnCl2 with external cooling from a water bath. 
The flask containing the Grignard was rinsed with additional portions of THF (3 x 30 
mL) and these rinses were transferred to the ZnCl2 solution via syringe. After stirring for 
0.5 h, the resulting white suspension was treated with IPr-PEPPSI (0.348 g, 0.513 mmol, 
0.5 mol%) and neat 2.23 (22.06 g, 102.6 mmol, 1.0 eq) in sequence at room temperature 
and heated to 60°C (oil bath) for 24 h. Upon completion, the reaction was poured into 0.1 
N aq. HCl and the layers were separated. The aqueous layer was extracted thrice with 
Et2O and the combined organic layers were washed with brine and dried over anhydrous 
sodium sulfate. Concentration under reduced pressure afforded a red-black liquid that 
was purified by flash column chromatography on silica gel (0-10% Et2O in hexanes) to 
afford 2.52 as a dark oil. The oil was dissolved in hexanes and treated with activated 
charcoal and stirred at room temperature for 36 h. After filtration and concentration under 
reduced pressure, a yellow oil was obtained (22.5 g, 57% yield). 
 
 
O
TBSO
Me
Me
2.52
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1H-NMR (500 MHz, CDCl3):  
δ 6.91 (dt, J = 2.4, 0.6 Hz, 1H), 6.65 (dd, J = 2.4, 0.8 Hz, 1H), 6.42 (dd, J = 17.4, 10.9 
Hz, 1H), 5.61 (dd, J = 17.4, 1.1 Hz, 1H), 5.19 (dd, J = 10.9, 1.1 Hz, 1H), 4.56 (ddd, J = 
2.1, 1.4, 0.6 Hz, 1H), 4.32 (dq, J = 1.9, 0.8 Hz, 1H), 2.70 (ddt, J = 8.0, 5.6, 1.2 Hz, 4H), 
2.58 (dd, J = 5.0, 4.1 Hz, 2H), 2.07 (s, 3H), 1.58 (s, 3H), 1.00 (s, 9H), 0.23 (s, 6H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 208.56, 172.09, 155.30, 141.60, 141.46, 135.45, 134.27, 134.19, 134.09, 128.44, 
121.27, 115.57, 113.77, 111.38, 34.48, 31.63, 25.64, 22.75, 19.51, 18.14, -4.38 
 
IR (ATR):  
2957, 2930, 2858, 2249, 1702, 1596, 1471, 1310, 1175, 1158, 996, 910, 873, 839, 733 
cm-1 
 
HRMS (ESI):  
[M + H]+ calcd for C24H34O2Si: 383.2406, found 383.2397 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A 100 mL round bottom flask charged with 2.52 (1.24 g, 3.24 mmol, 1.0 eq) was 
azeotropically dried with 3 portions of cyclohexane. 30 mL anhydrous toluene was added 
and the resulting solution was treated with titanium(IV) isopropoxide (1.05 mL, 3.56 
mmol, 1.1 eq) and sparged with a triple layered nitrogen balloon for 20 minutes. The 
solution was heated to 100°C and a solution of Grubbs 2nd Generation catalyst (0.055 g, 
0.065 mmol, 0.02 eq) in 18 mL toluene was added to the heated solution over 3 h with 
continuous nitrogen sparging (1 mL every 10 minutes). Upon completion, the reaction 
was cooled to room temperature and quenched with 0.5 N aq. HCl. The layers were 
separated and the aqueous phase was extracted thrice with ether. The combined organic 
extracts were washed with brine, dried over anhydrous sodium sulfate, filtered, and 
concentrated under reduced pressure. 
 The resulting crude oil was dissolved in 65 mL reagent grade MeOH was treated 
with magnesium turnings (0.473 g, 19.44 mmol, 6.0 eq) and sonicated at 0°C. After 
complete consumption of magnesium (approx. 2 h), the reaction was concentrated under 
reduced pressure and treated with 1:1 CH2Cl2 / 0.5 N aq. HCl and vigorously stirred at 
room temperature until all solids had dissolved and two clear phases had formed. The 
biphasic mixture was poured into a separatory funnel and the layers were separated. The 
aqueous phase was extracted twice with CH2Cl2 and the combined organic extracts were 
dried over anhydrous sodium sulfate and filtered. The resulting filtrate was directly 
treated with Dess-Martin periodinane (1.374 g, 3.24 mmol, 1.0 eq) and stirred at room 
temperature for 0.5 h. The mixture was poured into a separatory funnel charged with 
sat’d aq. NaHCO3 and the layers were separated. The aqueous phase was extracted twice 
with CH2Cl2 and the combined organic extracts were dried over anhydrous sodium 
sulfate and concentrated. The resulting crude residue was purified by flash column 
chromatography on silica gel (elution 10% ether in hexanes) to afford the title compound 
as an orange wax (0.220 g, 20% yield over 3 steps). 
 
1H-NMR (500 MHz, CDCl3):  
δ 6.54 (d, J = 2.6 Hz, 1H), 6.41 (d, J = 2.6 Hz, 1H), 6.20 (d, J = 1.7 Hz, 1H), 3.83 (td, J = 
10.9, 8.3 Hz, 1H), 3.02 (dtd, J = 10.3, 3.7, 3.2, 1.9 Hz, 1H), 2.41 – 2.32 (overlap m, 4H), 
2.32 – 2.27 (m, 2H), 2.23 (ddd, J = 13.1, 3.3, 1.5 Hz, 1H), 2.11 – 1.99 (m, 2H), 1.85 (s, 
3H), 0.98 (s, 9H), 0.20 (s, 6H) 
O Me
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13C-NMR (126 MHz, CDCl3): 
δ 222.79, 153.26, 139.98, 139.91, 137.45, 133.36, 127.77, 120.16, 119.17, 59.51, 39.38, 
39.32, 31.88, 29.55, 26.02, 25.73, 21.34, 21.33, 18.18, -4.28 
 
IR (ATR):  
2956, 2930, 2886, 2858, 1735, 1595, 1472, 1328, 1306, 1252, 1162, 1022, 909, 839, 781, 
733 cm-1 
 
HRMS (ESI):  
[M + H]+ calcd for C22H32O2Si: 357.2250, found 357.2254 
!  118
 
 
 
A solution of hexamethyldisilazane (0.272 mL, 1.297 mmol, 2.1 eq) in 5 mL anhydrous 
THF was cooled to 0°C and treated with n-BuLi (2.0 M in hexanes, 0.617 mL, 1.235 
mmol, 2.0 eq). After 10 minutes, the solution was cooled to -78°C and treated dropwise 
with a solution of 2.55 (0.220 g, 0.617 mmol, 1.0 eq, azeotropically dried with 3 portions 
of cyclohexane prior to use) in 5 mL anhydrous THF. After 30 minutes, the reaction was 
treated with 2,2,2-trifluoroethyl trifluoroacetate (0.414 mL, 3.088 mmol, 5.0 eq) within 
1-2 seconds (note: rapid addition of this reagent is critical to the success of the 
acetylation) and warmed to room temperature. The reaction was quenched with sat’d aq. 
NH4Cl and extracted thrice with EtOAc. The combined organic extracts were washed 
with brine, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced 
pressure. 
 The resulting crude residue was azeotropically dried with 3 portions of 
cyclohexane and taken up in 10 mL anhydrous THF. Freshly powdered potassium 
carbonate (0.852 g, 6.17 mmol, 10.0 eq) and paraformaldehyde (0.185 g, 6.17 mmol, 10.0 
eq) were added and the resulting suspension was heated to 60°C. Upon completion (~1 
h), the reaction was quenched with sat’d aq. NH4Cl and extracted thrice with EtOAc. The 
combined organic extracts were washed with brine, dried over anhydrous sodium sulfate, 
filtered, and concentrated under reduced pressure.  
 The resulting crude residue was taken up in 10:1 EtOH/H2O (10 mL), treated with 
rhodium(III) chloride (0.013 g, 0.0617mmol, 0.1 eq) and heated to 100°C in a sealed 
scintillation vial. Upon completion (4 h), the reaction was poured into brine and extracted 
thrice with EtOAc. The combined organic extracts were dried over anhydrous sodium 
sulfate, filtered, and concentrated under reduced pressure. 
 The resulting crude material was dissolved in 10 mL MeCN and 2.5 mL H2O was 
added followed by PhI(OAc)2 (0.028 g, 0.087 mmol, 2.2 eq). The reaction was monitored 
by TLC and upon completion (~5 minutes), the mixture was concentrated under reduced 
pressure and directly purified by flash column chromatography on silica gel (CH2Cl2 → 
50% EtOAc in hexanes) to deliver the title compound as a white foam (0.025 g, 30% 
yield over 3 steps). 
 Single crystals suitable for X-ray diffraction were grown by slow diffusion of 
hexanes into a solution of 2.58 in EtOAc. 
 
O Me
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H
Me OH
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1H-NMR (500 MHz, CDCl3):  
δ 6.71 (dd, J = 2.9, 1.6 Hz, 1H), 6.16 (t, J = 1.5 Hz, 1H), 5.85 (s, 1H), 5.82 (s, 1H), 3.68 
(dt, J = 6.7, 2.3 Hz, 1H), 3.36 (d, J = 17.1 Hz, 1H), 2.85 (dt, J = 6.6, 4.2 Hz, 1H), 2.77 
(dd, J = 17.0, 4.4 Hz, 1H), 2.24 (s, 3H), 2.18 (s, 1H), 1.98 (s, 3H), 1.67 (s, 3H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 209.38, 185.77, 159.88, 156.19, 153.36, 150.52, 143.65, 127.64, 126.70, 124.44, 48.21, 
46.98, 32.45, 29.86, 29.28, 18.67, 10.46 
 
IR (ATR):  
3359, 2922, 2853, 1705, 1657, 1605, 1438, 1388, 1333 cm-1 
 
HRMS (ESI):  
[M + H]+ calcd for C17H18O3: 271.1334, found 271.1347 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2.8 — NMR Spectra 
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2.9 — X-ray crystallographic data 
A   colorless  BLOCK-like   specimen  of  C17H18O3,  approximate  dimensions  0.120  mm 
x 0.200 mm x 0.200 mm, was used for the X-ray crystallographic analysis. The X-ray 
intensity data were measured.
A total  of  2433 frames were collected.  The total  exposure time was 3.38 hours.  The 
frames were integrated with the Bruker SAINT software package using a narrow-frame 
algorithm.  The  integration  of  the  data  using  a  monoclinic  unit  cell  yielded  a  total 
of   10664   reflections  to  a  maximum  θ  angle  of   69.95°  (0.82   Å  resolution),  of 
which   2574  were  independent  (average  redundancy   4.143,  completeness  =   99.2%, 
Table 1: Data collection details for UMD790.
Axis dx/mm 2θ/° ω/° φ/° χ/° ° Frames s Å kV mA K
Ome
ga 39.946 109.27 109.22 160.00 -44.94 1.00 104 5.00 1.54184 50 1.0 200
Ome
ga 39.946 109.27 109.22 -120.00 -44.94 1.00 104 5.00 1.54184 50 1.0 200
Ome
ga 39.946 109.27 109.22 -40.00 -44.94 1.00 104 5.00 1.54184 50 1.0 200
Phi 39.946 79.27 77.24 0.00 -44.44 1.00 360 5.00 1.54184 50 1.0 200
Ome
ga 39.946 -10.51 -15.62 72.00 -62.19 1.00 70 5.00 1.54184 50 1.0 200
Ome
ga 39.946 109.27 109.22 120.00 -44.94 1.00 104 5.00 1.54184 50 1.0 200
Ome
ga 39.946 109.27 109.22 -80.00 -44.94 1.00 104 5.00 1.54184 50 1.0 200
Phi 39.946 -12.41 349.80 -156.00 44.44 1.00 200 5.00 1.54184 50 1.0 200
Ome
ga 39.946 109.27 109.22 80.00 -44.94 1.00 104 5.00 1.54184 50 1.0 200
Ome
ga 39.946 109.27 109.22 0.00 -44.94 1.00 104 5.00 1.54184 50 1.0 200
Ome
ga 39.946 109.27 -4.93 40.00 62.19 1.00 119 5.00 1.54184 50 1.0 200
Phi 39.946 109.27 13.57 -194.00 23.00 1.00 316 5.00 1.54184 50 1.0 200
Phi 39.946 109.27 107.24 -76.00 -44.44 1.00 280 5.00 1.54184 50 1.0 200
Phi 39.946 -64.27 41.58 0.00 -44.44 1.00 360 5.00 1.54184 50 1.0 200
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Rint = 3.68%, Rsig = 3.07%) and 2452 (95.26%) were greater than 2σ(F2). The final cell 
constants of a = 8.2865(10) Å, b = 8.8356(11) Å, c = 9.6062(12) Å, β = 101.791(6)°, 
volume  =   688.49(15)   Å3,  are  based  upon  the  refinement  of  the  XYZ-centroids 
of 8001 reflections above 20 σ(I) with 9.405° < 2θ < 139.9°. Data were corrected for 
absorption effects  using the multi-scan method (SADABS).  The ratio of minimum to 
maximum apparent  transmission  was  0.776.  The  calculated  minimum and  maximum 
transmission coefficients (based on crystal size) are 0.8710 and 0.9190. 
The  final  anisotropic  full-matrix  least-squares  refinement  on  F2  with   188   variables 
converged at R1 =  2.83%, for the observed data and wR2 =  6.89% for all  data.  The 
goodness-of-fit  was  1.050.  The  largest  peak  in  the  final  difference  electron  density 
synthesis was 0.140 e-/Å3 and the largest hole was -0.108 e-/Å3 with an RMS deviation 
of 0.026 e-/Å3. On the basis of the final model, the calculated density was 1.304 g/cm3 and 
F(000), 288 e-. 
Table 2. Sample and crystal data for UMD790.
Identification code UMD790
Chemical formula C17H18O3
Formula weight 270.31 g/mol
Temperature 200(2) K
Wavelength 1.54178 Å
Crystal size 0.120 x 0.200 x 0.200 mm
Crystal habit colorless BLOCK
Crystal system monoclinic
Space group P 1 21 1
Unit cell dimensions a = 8.2865(10) Å α = 90°
b = 8.8356(11) Å β = 101.791(6)°
c = 9.6062(12) Å γ = 90°
Volume 688.49(15) Å3
Z 2
Density (calculated) 1.304 g/cm3
Absorption coefficient 0.712 mm-1
F(000) 288
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Table 3. Data collection and structure refinement for UMD790.
Theta range for data collection 4.70 to 69.95°
Index ranges -10<=h<=10, -10<=k<=10, -11<=l<=11
Reflections collected 10664
Independent reflections 2574 [R(int) = 0.0368]
Coverage of independent reflections 99.2%
Absorption correction multi-scan
Max. and min. transmission 0.9190 and 0.8710
Refinement method Full-matrix least-squares on F2
Refinement program SHELXL-2014/6 (Sheldrick, 2014)
Function minimized Σ w(Fo2 - Fc2)2
Data / restraints / parameters 2574 / 2 / 188
Goodness-of-fit on F2 1.050
Δ/σmax 0.001
Final R indices 2452 data; I>2σ(I) R1 = 0.0283, wR2 = 0.0671
all data R1 = 0.0310, wR2 = 0.0689
Weighting scheme w=1/[σ2(Fo2)+(0.0237P)2+0.1208P]where P=(Fo2+2Fc2)/3
Absolute structure parameter -0.1(1)
Extinction coefficient 0.0100(20)
Largest diff. peak and hole 0.140 and -0.108 eÅ-3
R.M.S. deviation from mean 0.026 eÅ-3
Table 4. Atomic coordinates and equivalent isotropic atomic displacement 
parameters (Å2) for UMD790.
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
x/a y/b z/c U(eq)
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O1 0.7915(2) 0.5926(2) 0.99244(17) 0.0516(5)
O2 0.85392(18) 0.22056(16) 0.42766(15) 0.0344(4)
O3 0.2901(2) 0.4914(2) 0.4490(2) 0.0529(5)
C1 0.8165(3) 0.5826(3) 0.1212(2) 0.0359(5)
C2 0.7666(3) 0.6921(2) 0.2204(2) 0.0353(5)
C3 0.7989(3) 0.6334(2) 0.3505(2) 0.0353(5)
C4 0.8714(3) 0.4766(2) 0.3581(2) 0.0312(5)
C5 0.9136(3) 0.4580(2) 0.2105(2) 0.0339(5)
C6 0.9052(3) 0.3043(3) 0.1376(2) 0.0399(5)
C7 0.7364(3) 0.2384(2) 0.0896(2) 0.0367(5)
C8 0.6117(3) 0.2510(2) 0.1581(2) 0.0335(5)
C9 0.6031(2) 0.3275(2) 0.2909(2) 0.0293(4)
C10 0.7571(2) 0.3552(2) 0.4046(2) 0.0288(4)
C11 0.7202(3) 0.4103(2) 0.5460(2) 0.0320(5)
C12 0.5688(3) 0.4546(3) 0.5571(2) 0.0366(5)
C13 0.4275(3) 0.4427(3) 0.4396(3) 0.0366(5)
C14 0.4529(2) 0.3669(2) 0.3123(2) 0.0335(5)
C15 0.7004(3) 0.8452(3) 0.1748(3) 0.0494(6)
C16 0.7116(4) 0.1556(3) 0.9506(3) 0.0512(7)
C17 0.8632(3) 0.4210(3) 0.6695(2) 0.0453(6)
Table 5. Bond lengths (Å) for UMD790.
O1-C1 1.215(3) O2-C10 1.427(2)
O2-H2 0.87(2) O3-C13 1.238(3)
C1-C2 1.474(3) C1-C5 1.520(3)
C2-C3 1.329(3) C2-C15 1.492(3)
C3-C4 1.506(3) C3-H3A 0.95
C4-C5 1.537(3) C4-C10 1.556(3)
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C4-H4A 1.0 C5-C6 1.523(3)
C5-H5A 1.0 C6-C7 1.498(3)
C6-H6A 0.99 C6-H6B 0.99
C7-C8 1.338(3) C7-C16 1.499(3)
C8-C9 1.458(3) C8-H8A 0.95
C9-C14 1.348(3) C9-C10 1.520(3)
C10-C11 1.532(3) C11-C12 1.339(3)
C11-C17 1.498(3) C12-C13 1.455(3)
C12-H12A 0.95 C13-C14 1.446(3)
C14-H14A 0.95 C15-H15A 0.98
C15-H15B 0.98 C15-H15C 0.98
C16-H16A 0.98 C16-H16B 0.98
C16-H16C 0.98 C17-H17A 0.98
C17-H17B 0.98 C17-H17C 0.98
Table 6. Bond angles (°) for UMD790.
C10-O2-H2 107.9(19) O1-C1-C2 126.7(2)
O1-C1-C5 125.9(2) C2-C1-C5 107.27(17)
C3-C2-C1 108.82(19) C3-C2-C15 128.4(2)
C1-C2-C15 122.68(19) C2-C3-C4 113.94(19)
C2-C3-H3A 123.0 C4-C3-H3A 123.0
C3-C4-C5 102.56(16) C3-C4-C10 112.81(17)
C5-C4-C10 117.23(17) C3-C4-H4A 107.9
C5-C4-H4A 107.9 C10-C4-H4A 107.9
C6-C5-C1 114.68(18) C6-C5-C4 121.44(18)
C1-C5-C4 104.41(17) C6-C5-H5A 104.9
C1-C5-H5A 104.9 C4-C5-H5A 104.9
C7-C6-C5 116.14(18) C7-C6-H6A 108.3
C5-C6-H6A 108.3 C7-C6-H6B 108.3
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C5-C6-H6B 108.3 H6A-C6-H6B 107.4
C8-C7-C16 120.0(2) C8-C7-C6 125.6(2)
C16-C7-C6 114.42(19) C7-C8-C9 130.5(2)
C7-C8-H8A 114.8 C9-C8-H8A 114.8
C14-C9-C8 117.72(18) C14-C9-C10 120.96(18)
C8-C9-C10 121.24(17) O2-C10-C9 109.92(16)
O2-C10-C11 109.57(16) C9-C10-C11 113.43(16)
O2-C10-C4 105.28(15) C9-C10-C4 112.06(16)
C11-C10-C4 106.21(16) C12-C11-C17 121.4(2)
C12-C11-C10 121.58(19) C17-C11-C10 116.94(18)
C11-C12-C13 122.4(2) C11-C12-H12A 118.8
C13-C12-H12A 118.8 O3-C13-C14 121.2(2)
O3-C13-C12 121.6(2) C14-C13-C12 117.12(18)
C9-C14-C13 123.18(19) C9-C14-H14A 118.4
C13-C14-H14A 118.4 C2-C15-H15A 109.5
C2-C15-H15B 109.5 H15A-C15-H15B 109.5
C2-C15-H15C 109.5 H15A-C15-H15C 109.5
H15B-C15-H15C 109.5 C7-C16-H16A 109.5
C7-C16-H16B 109.5 H16A-C16-H16B 109.5
C7-C16-H16C 109.5 H16A-C16-H16C 109.5
H16B-C16-H16C 109.5 C11-C17-H17A 109.5
C11-C17-H17B 109.5 H17A-C17-H17B 109.5
C11-C17-H17C 109.5 H17A-C17-H17C 109.5
H17B-C17-H17C 109.5
Table 7. Torsion angles (°) for UMD790.
O1-C1-C2-C3 172.8(2) C5-C1-C2-C3 -10.1(2)
O1-C1-C2-C15 -10.3(4) C5-C1-C2-C15 166.8(2)
C1-C2-C3-C4 -1.1(2) C15-C2-C3-C4 -177.7(2)
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C2-C3-C4-C5 11.4(2) C2-C3-C4-C10 -115.6(2)
O1-C1-C5-C6 -31.0(3) C2-C1-C5-C6 151.87(17)
O1-C1-C5-C4 -166.3(2) C2-C1-C5-C4 16.6(2)
C3-C4-C5-C6 -147.8(2) C10-C4-C5-C6 -23.6(3)
C3-C4-C5-C1 -16.3(2) C10-C4-C5-C1 107.86(19)
C1-C5-C6-C7 -58.3(2) C4-C5-C6-C7 68.7(3)
C5-C6-C7-C8 -36.2(3) C5-C6-C7-C16 142.4(2)
C16-C7-C8-C9 -178.4(2) C6-C7-C8-C9 0.1(4)
C7-C8-C9-C14 158.0(2) C7-C8-C9-C10 -25.0(3)
C14-C9-C10-O2 130.5(2) C8-C9-C10-O2 -46.4(2)
C14-C9-C10-C11 7.4(3) C8-C9-C10-C11 -169.46(18)
C14-C9-C10-C4 -112.8(2) C8-C9-C10-C4 70.3(2)
C3-C4-C10-O2 -171.16(17) C5-C4-C10-O2 70.1(2)
C3-C4-C10-C9 69.4(2) C5-C4-C10-C9 -49.4(2)
C3-C4-C10-C11 -55.0(2) C5-C4-C10-C11 -173.79(17)
O2-C10-C11-C12 -134.5(2) C9-C10-C11-C12 -11.2(3)
C4-C10-C11-C12 112.3(2) O2-C10-C11-C17 49.0(2)
C9-C10-C11-C17 172.26(19) C4-C10-C11-C17 -64.2(2)
C17-C11-C12-C13 -178.8(2) C10-C11-C12-C13 4.8(3)
C11-C12-C13-O3 -176.1(2) C11-C12-C13-C14 5.8(3)
C8-C9-C14-C13 179.74(19) C10-C9-C14-C13 2.7(3)
O3-C13-C14-C9 172.2(2) C12-C13-C14-C9 -9.8(3)
Table 8. Anisotropic atomic displacement parameters (Å2) for UMD790.
The anisotropic atomic displacement factor exponent takes the form: 
-2π2[ h2 a*2 U11 + ... + 2 h k a* b* U12 ]
U11 U22 U33 U23 U13 U12
O1 0.0701(12) 0.0481(10) 0.0384(9) 0.0072(7) 0.0153(8) 0.0064(9)
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O2 0.0301(7) 0.0295(8) 0.0450(8) 0.0080(6) 0.0113(6) 0.0058(6)
O3 0.0297(9) 0.0540(11) 0.0766(12) -0.0181(9) 0.0150(8) 0.0051(8)
C1 0.0355(12) 0.0338(12) 0.0396(12) 0.0035(9) 0.0103(9) -0.0050(9)
C2 0.0345(11) 0.0303(11) 0.0408(11) 0.0008(9) 0.0073(8) -0.0032(9)
C3 0.0360(11) 0.0292(10) 0.0418(12) -0.0031(9) 0.0106(9) -0.0053(9)
C4 0.0265(10) 0.0315(11) 0.0356(11) 0.0026(8) 0.0060(8) -0.0024(8)
C5 0.0292(10) 0.0343(11) 0.0409(11) 0.0040(9) 0.0134(9) -0.0018(8)
C6 0.0414(12) 0.0368(12) 0.0468(13) 0.0028(10) 0.0218(10) 0.0066(10)
C7 0.0491(13) 0.0257(11) 0.0380(11) 0.0031(8) 0.0150(9) 0.0043(9)
C8 0.0355(11) 0.0282(10) 0.0359(10) 0.0000(8) 0.0054(8) -0.0029(9)
C9 0.0300(10) 0.0230(10) 0.0350(10) 0.0021(8) 0.0070(8) -0.0007(8)
C10 0.0243(10) 0.0274(10) 0.0350(10) 0.0036(8) 0.0071(8) 0.0035(8)
C11 0.0341(11) 0.0292(11) 0.0331(11) 0.0024(8) 0.0080(9) -0.0029(8)
C12 0.0375(12) 0.0351(11) 0.0398(11) -0.0050(9) 0.0139(9) -0.0004(9)
C13 0.0288(11) 0.0310(10) 0.0520(13) -0.0013(9) 0.0133(9) 0.0013(9)
C14 0.0263(10) 0.0321(10) 0.0407(11) -0.0009(8) 0.0032(8) -0.0001(8)
C15 0.0601(15) 0.0335(12) 0.0531(14) 0.0033(10) 0.0080(12) 0.0029(12)
C16 0.0728(18) 0.0397(14) 0.0457(14) -0.0050(11) 0.0230(12) -0.0023(12)
C17 0.0423(13) 0.0561(15) 0.0369(12) -0.0008(10) 0.0067(10) 0.0007(11)
Table 9. Hydrogen atomic coordinates and isotropic atomic displacement 
parameters (Å2) for UMD790.
x/a y/b z/c U(eq)
H2 0.794(3) 0.150(3) 0.455(3) 0.052
H3A 0.7780 0.6857 0.4315 0.042
H4A 0.9772 0.4779 0.4302 0.037
H5A 1.0315 0.4897 0.2232 0.041
H6A 0.9568 0.3137 0.0537 0.048
H6B 0.9723 0.2320 0.2040 0.048
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H8A 0.5127 0.2021 0.1129 0.04
H12A 0.5531 0.4952 0.6449 0.044
H14A 0.3593 0.3437 0.2404 0.04
H15A 0.7685 0.8917 0.1142 0.074
H15B 0.7025 0.9086 0.2588 0.074
H15C 0.5867 0.8357 0.1213 0.074
H16A 0.7998 0.0810 -0.0460 0.077
H16B 0.7139 0.2279 -0.1263 0.077
H16C 0.6047 0.1038 -0.0666 0.077
H17A 0.9169 0.3220 0.6863 0.068
H17B 0.8238 0.4525 0.7545 0.068
H17C 0.9424 0.4955 0.6483 0.068
Table 10. Hydrogen bond distances (Å) and angles (°) for UMD790.
Donor-H Acceptor-H Donor-Acceptor Angle
O2-H2...O3 0.87(2) 1.89(2) 2.740(2) 166.(3)
C4-H4A...O3 1.0 2.56 3.402(3) 141.2
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CHAPTER THREE 
Development of a scalable, stereocontrolled second-generation synthesis 
3.1 — Preliminary meditations and early reconnaissance 
 Having decided to move on from the synthesis described in the previous chapter, 
the next plan of action involved critical assessment of the victories and the defeats from 
the first-generation route (Figure 3.1). 
 The overall synthesis plan still remained largely appealing from a conceptual and 
tactical point-of-view however some pitfalls needed to be addressed. The decision to first 
elaborate the complete A-ring of the DDO skeleton (3.1)—though direct and efficient—
added a high level of risk (and potential reward) which did not pan out as expected. The 
most obvious work-around, since the Danheiser-Colby methylenation-olefin 
isomerization sequence was shown to be robust, is to elaborate the A-ring towards the 
end of the synthesis and thus prevent any abberant behavior from this sector of the 
molecule.  
 The RCM transform was still regarded as the most rapid way to form the seven 
membered B-ring and would be retained. The proposed quinol functionalization to 
O
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Figure 3.1. Critical assessment of first-generation tricycle & proposed synthons for second-generation route
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elaborate the complex C-ring stereopentad, though ultimately hexing in the previous 
synthesis, was worth further exploring if the A-ring was to be unveiled after this critical 
sequence was safely established. Lastly, a stereoselective vicinal difunctionalization of 
some masked cyclopentanone synthon needed to be developed to address the 5-7 ring 
fusion as early as possible in order to fully isolate the C-ring system and eliminate any 
possible downstream problems. 
 A short series of experiments (Schemes 3.1-3.2) to evaluate what exactly was 
needed for an improved second generation route began with the readily available ketone 
3.2, prepared in five steps as described in Chapter 2. Ketal protection (ethylene glycol, 
PPTS, PhMe, Dean-Stark) and TBAF deprotection afforded phenol 3.3 which upon 
exposure to singlet oxygen  afforded the quinol 3.4 as a ~3:1 mixture of diastereomers 1
(determined by crude 1H-NMR analysis). Notably, oxidative dearomatization employing 
hypervalent iodine as in previous experiments gave only complex mixtures. 
 I was cognizant that Li and co-workers noted in their model studies  that if C4 is 2
already oxidized to the corresponding tertiary alcohol and protected as a TMS ether the 
bulk of the protecting group acts as a stereocontrolling element in which singlet oxygen 
may approach only from the desired α-face of the molecule (3.5 → 3.6, Scheme 3.2). 
OTIPS
MeO
H
H
HO
OH OH
Me
H
H
O
O
O
Me
H
H
O
O
OH ~3:1 dr
PPTS, PhMe
Dean-Stark;
TBAF, THF
1O2
3.2 3.3 3.4
Scheme 3.1. Short feasibility study of a protected A-ring system
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However, enolate oxidation was found to be troublesome when I tried to correct the C4 
stereocenter in the first-generation route and so I was wary this would be an inconvenient 
if not laborious lengthening of the previous synthesis. Furthermore, following Li’s 
procedure, exposure of 3.4 to LiHMDS followed by HMPA and MeMgCl failed to afford 
the desired 1,4-addition product 3.6 as projected. 
 From here it became evident that further meditation on the mechanism of the 
proposed tertiary alkoxide directed conjugate addition was imperative. Likewise, the poor 
stereocontrol of the oxidative dearomatization step (3.3 → 3.4) and the opportunity to 
apply Li’s solution using a native blocking group would necessitate a redesign of the 
tricycle synthesis.  3
 As described in seminal studies by Liotta and Maryanoff,  tertiary (lithium) 4
alkoxides, generated in-situ by either treatment of p-quinols with a strong base (LDA or 
LiHMDS) or direct nucleophilic addition of an alkyllithium reagent to a quinone, upon 
exposure to an appropriate Grignard reagent in an aprotic polar (HMPA or DMPU) 
cosolvent at -78°C afford products of cis 1,4-addition resulting from oxygen-directed 
conjugate addition along with cis 1,4-diols from non-directed 1,2-addition. They found 
that the actual reactive intermediate is not a complex of quinol alkoxide and RMgX but 
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Scheme 3.2. (a) TMS-protecting group as stereocontrolling element (b) failed alkoxide-directed 1,4-addition
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rather a ternary complex comprised of a quinol alkoxide, a dialkylmagnesium reagent 
(R2Mg), and a Lewis acid (e.g. MgCl2), concluding: “although of the organomagnesium 
reagents present in solution may form complexes with the free alkoxide oxygen, only the 
dialkyl magnesium is reactive enough to transfer an alkyl substituent at -78°C”.4c 
 Despite these conclusions, application of this reaction manifold in natural product 
synthesis,2,  to the best of my knowledge, routinely proceeds through generation of a 5
perceived ‘naked’ alkoxide by treatment of the substrate with a strong lithium base 
followed by exposure to a chelating additive (presumably to sequester the counterion) 
followed by the desired Grignard reagent. In my experience, this procedure was not only 
laborious in practice but more importantly never afforded any desired product.  6
Nevertheless, this ‘naked’ alkoxide concept was the best place to begin exploratory work 
based on the available data. 
 A useful model system was first devised as shown in Scheme 3.3 beginning from 
inexpensive 3,4-dimethylphenol (3.8). Oxidative dearomatization employing singlet 
oxygen (1 atm O2, 5 mol% TPP, visible light from a CFL bulb)  smoothly delivered 7
quinol 3.8 after quenching of the intermediate peroxyquinol with dimethylsulfide. This 
reaction could be executed on multigram scale to procure useful quantities of a simple 
quinol system to evaluate conditions necessary for alkoxide-directed conjugate addition. 
 Initial reconnaissance began with the reasoning that a sodium alkoxide, generated 
by exposure to NaH, in combination with 15-crown-5, a strong sodium cation 
sequestering reagent, and finally MeMgCl would perhaps be the most powerful 
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conditions based on literature precedent. In the event, exposure of 3.9 to NaH (1.0 equiv), 
15-crown-5 (1.2 equiv) and MeMgCl (1.2 equiv) in THF at -78°C afforded ~50% 
conversion (based on crude 1H-NMR analysis) to the desired 1,4-adduct 3.10, to great 
satisfaction. 
 Significant gas evolution was noted upon quenching at -78°C and warming to 
room temperature. This observation implied NaH was ineffective as a base at cryogenic 
temperatures yet the reaction was still proceeding to an appreciable extent. A control 
experiment omitting NaH afforded similar results, confirming that a combination of 
MeMgCl and 15-crown-5 is an effective system for the directed 1,4-addition. Liotta and 
Marynoff noted rapid conversion occurs at -78°C but stalls at ~50% requiring warming to 
-25°C to increase conversion. Indeed, performing the same reaction and allowing 
warming to room temperature after 0.5 h gave full conversion of 3.9 as judged by TLC 
(72% isolated yield when performed on multigram scale). 
 It was also noted that as the reaction warms to room temperature, a precipitate 
slowly forms and at room temperature the reaction became a thick suspension. It was 
Me
OH
Me
OH
O
Me
Me
O2 (1 atm)
TPP (mol%)
CHCl3, rt
26W CFL;
then Me2S
(70% yield)3.8 3.9
conditions
OH
O
Me
Me
Me
3.10
NaH, 15-c-5; MeMgCl, THF, -78°C
15-c-5, MeMgCl, -78°C
15-c-5, MeMgCl, -78°C → rt
1:1
1:1
0:1 (72%)
conditions ratio of 3.9:3.10 (yield)
Scheme 3.3. Successful model system for alkoxide-directed conjugate addition of MeMgCl
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reasoned this precipitate is likely MgCl2 and implicated the role of 15-crown-5 to be 
more than simply generating a ‘naked’ alkoxide. Since Mg2+ and Na+ cations are similar 
in size, it is possible the crown ether additive effectively drives the Schlenk equilibrium 
of the Grignard reagent towards that of the dialkylmagnesium and the resulting MgCl2, 
sparingly soluble in THF, catalytically activates the substrate towards 1,4-addition, as 
originally noted by Liotta and Maryanoff (3.12, Scheme 3.4).  8
 A final optimization was made by replacing the costly crown ether with 1,4-
dioxane (≥ 3.0 equiv) as additive.  This common ether solvent afforded comparable 9
yields and renders the reaction considerably more practical and economical on large, 
preparative scales. Furthermore, to the best of my knowledge, this is the first example of 
its use in conjunction with a Grignard reagent as an effective combination for this little-
known but remarkably powerful reaction manifold. 
 At long last, with an ostensible solution to the critical opening step of the 
proposed C-ring functionalization, the next step was to identify a suitable cyclopentanone 
O
O
Me
Me
X
3.10
3.9
15-c-5
+
MeMgCl
Me2Mg
+
15-c-5·MgCl2
O
O
MeMeMg
Me
Me
MgCl2
3.10
3.11 3.12
MeMgCl
base
Scheme 3.4. Alkoxide-directed conjugate addition is predicated on Schlenk equilibrium of Grignard in solution
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synthon to complement Li and co-worker’s elegant system and settle upon a new general 
retrosynthetic analysis of DDOs. 
3.2 — Revised retrosynthetic analysis 
 The newly revised retrosynthesis is depicted in Figure 3.2. After careful 
consideration the known epoxy ketal 3.15 was chosen as a suitable cyclopentanone 
precursor capable of undergoing formal vicinal functionalization via a dication synthon in 
which both epoxide carbons would be joined with synthons of type 3.16 and 3.17.  
 The ethos of the previous synthetic route would be largely retained but now with 
greater lucidity: the five contiguous stereocenters of the C-ring (i.e. 3.16) would arise 
from from the corresponding achiral phenol via (1) oxidative dearomatization; (2) 
alkoxide-directed conjugate addition of methyl Gringard; (3) substrate controlled 1,2-
addition of isopropenyl Grignard; (4) tert-alcohol directed epoxidation; and (5) reductive 
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Me
Me
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Me
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H
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H
OH
O
Me O
OH
Ph Me
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OMe
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A-ring synthesis
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O
O
O
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Me
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H
[O]
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Me
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(2)
(3)
(4)
O
[H](5)
3.13
resiniferatoxin (RTX)
3.14
3.15
3.16
3.17
Figure 3.2. Revised retrosynthetic analysis
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vinyl epoxide ring opening. This sequence would rely on a confluence of remarkable 
substrate-controlled events, mostly relayed from the stereochemical information 
contained within the tertiary C9 alcohol of the quinol. 
 The final two steps provide a solution to a prominent problem in DDO synthesis, 
i.e. the controlled introduction of the C8 and C14 stereocenters. As noted in the previous 
chapter, from the outset of this project I was not exactly sure how to secure the trans-
fusion at the 6-7 ring juncture as this formally calls for a trans-selective anti-
Markovnikov hydration of a trisubstituted olefin.  
 Since the genesis of the original synthetic plan detailed in the first chapter the 
conception of two likely modes by which such a transformation could be realized. An 
appropriate vinyl epoxide  could be regio- and stereoselectively reduced by either an 10
SN2-like ionic hydride addition or a titanocene mediated  radical epoxide opening/11
stereoselective HAT process.  
 With access to 3.14—which contains a complex stereoheptad common to all 
DDOs—orthoester formation, A-ring elaboration, and allylic oxidation/esterification 
could first yield a concise synthesis of the flag-ship daphnane resiniferatoxin (RTX, 3.13) 
en route to higher-order DDOs.  12
3.3 — Early success in a proof-of-concept campaign 
 Unlike the challenges met with the previous generation synthesis, an initial foray 
into implementing the newly designed route was met with smooth success. The chemistry 
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shown in Schemes 3.5-3.6 was in fact successfully realized in less than a fortnight from a 
single batch of starting material. 
 Beginning with the known epoxy ketal 3.15, prepared in three steps following 
literature methods,  addition of the aryl Grignard 3.18 in the presence of 5 mol% CuI 13
furnished secondary alcohol 3.19 in 33% yield (~700 mg prepared). Oxidation (IBX, 
EtOAc, ) and exposure of the resulting crude ketone to methallylmagnesium chloride 14
afforded the tertiary alcohol 3.20 in 75% overall yield (>20:1 dr), confirming the utility 
of 3.15 as a vicinal dication synthon. 
 Formation of the B-ring by RCM was initially met with low conversions (1-2 
mol% Grubbs II, PhMe, reflux). Surmising the ketal of 3.20 was behaving similarly to its 
ketone counterpart from the previous route, inclusion of Ti(Oi-Pr)4 was attempted but led 
to the formation of undesired side-products. Eventually it was found that simply 
increasing the catalyst loading to 10 mol% (added in several aliquots over the course of 2 
h) led to complete consumption of 3.20. Notably, attempts to protect 3.20 as its TMS 
ether prior to RCM failed but could be accomplished at room temperature (TMSCl, 
imidazole, DMA) after RCM.  15
O
O
O
OTMS
H
O
O Me
OH
1. CuI, THF, 0°C
(~30% yield)
IBX, EtOAc, 80°C
β-methallylMgCl
THF, -78°C
(70% yield, 2 steps
>20:1 dr)
Grubbs II (10 mol%)
PhMe, 110°C, N2;
concentrate;
TMSCl, imidazole
DMA, rt
then add LiOH·H2O
(71-80% yield,
one-pot)
MgBr
TBSO
2.
3.
4.
O O
OTBS
O O
OTBS
Me
OH
OH
3.15 3.19 3.20 3.21
3.18
Scheme 3.5. Early success in the synthesis of a second-generation tricycle
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 Early reconnaissance intimated the lability of the TBS aryl ether to Brønsted base 
and it was found that following completion of the RCM, a solvent switch to DMA and 
addition of TMSCl and imidazole uneventfully protected the tertiary alcohol (not shown) 
which was not isolated but directly exposed to an excess of LiOH·H2O (10.0 equiv). This 
one-pot procedure  circumvented an unnecessary isolation and phenol 3.21 was obtained 16
in good yield (71-80%). 
 Exposure of 3.21 to singlet oxygen as described in Scheme 3.1 afforded the 
quinol 3.22 as a single diastereomer (33% yield) after quenching with dimethylsulfide 
(Scheme 3.6). As proposed by Li and coworkers, the tertiary TMS ether appears to be 
acting as a stereocontrolling element in which dioxygen preferentially approaches from 
the α-face of the tricycle. 
 I was heartened that this five-step (from 3.15) quinol synthesis not only proceeded 
with unexpected efficiency but also greatly improved upon earlier efforts in terms of 
stereocontrol and step count. Moreover, I was elated to find that upon exposure of 3.22 to 
methylmagnesium chloride in the presence of 1,4-dioxane, alkoxide-directed 1,4-addition 
occurred without incident to give rise to enone 3.23 as a single diastereomer! 
O2 (1 atm)
TPP (mol%)
CHCl3, rt
26W CFL;
then Me2S
(33% yield
>20:1 dr)
OTMS
H
O
O Me
O
OH
MeMgCl
1,4-dioxane
THF, -78 → rt
(~40% yield
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H
O
O Me
O
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Me5.
6.
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MeCN, rt
isopropenylMgBr
THF, 0°C
m-CPBA, CDCl3, rt
7.
8.
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O
O Me
Me
TMSO
H
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MeO
3.21
3.22 3.23 3.24
Scheme 3.6. Stereocontrolled oxidative dearomatization and alkoxide-directed conjugate addition
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 The initial proof-of-concept phase was capped with a short series of experiments 
(Scheme 3.6): the tertiary alcohol could be protected (TMSCl, imidazole) and exposure to 
isopropenylmagnesium bromide afforded the product of 1,2-addition as a single, 
unassigned diastereomer (2 mg scale). Treatment of this material with m-CPBA gave full 
conversion to a product with the undesired constitution of 3.24 based on crude 1H-NMR 
analysis (~0.5 mg scale). This unforeseen misstep suggested a modification in overall 
choreography would be required. Regardless, I was buoyed by the overall success of the 
redesign and began a fresh material campaign with the intention of procuring large 
quantities of 3.23. 
3.4 — Route optimization and decagram scale synthesis of a key stereotetrad 
 Although the epoxy ketal (±)-3.15 is a known compound  and has been 17
previously prepared in enantiopure form, ,  in practice its preparation was not trivial. 18 19
Epoxidation of the ketal derived from cyclopentenone employing either m-CPBA or 
DMDO is straight-forward but ketalization of cyclopentenone with ethylene glycol under 
classical conditions (cat. p-TsOH, PhMe, Dean-Stark, reflux) is complicated by the 
volatility of the starting material and the formation of large quantities of polymeric, tar-
like material.   20
 Generally, the requisite cyclopentene is prepared by dehydrohalogenation of the 
corresponding α-haloketal which in turn can be prepared from feedstock chemical 
cyclopentanone via a halogenative ketalization reaction.  However, the majority of 21
conditions employed were either not economical due to the stoichiometric bromide 
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source employed, gave inferior yields to those reported, or were simply impractical to be 
run on large scale. In the end, a new three-step synthesis of (±)-3.15 was developed 
(Scheme 3.7). 
 The required α-bromoketal (not shown) is prepared in a single step by treatment 
of a solution of cyclopentanone (1.0 equiv), ethylene glycol (8.0 equiv), and NBS (1.2 
equiv) in THF (0.5 M) with TMSCl (1.5 eq) at room temperature.  The reaction is 22
generally complete in less than 5 minutes and was routinely executed on 0.5 mol scale. 
Following extractive work-up the crude material is heated with DBU (2.0 equiv, neat, 
100°C) and the desired elimination product is directly distilled from the reaction pot to 
afford 3.26 in 80% yield over 2 steps (Scheme 3.7). 3.26 is smoothly epoxidized using in-
situ generated DMDO  (Oxone®, acetone/MeCN, Na2EDTA, sat’d aq. NaHCO3) to 23
afford the racemic epoxy ketal (±)-3.15 in 80% yield after short-path distillation (64% 
overall yield, ≥ 25 g prepared/batch). 
 The synthesis of styrene 3.29 underwent a multitude of variations that culminated 
in an optimized three-step sequence provided in Scheme 3.8. Although 2-bromo-5-
hydroxybenzaldehyde 3.28 is commercially available,  the purchased material was often 24
O
OO HO
OH
NBS, TMSCl
THF, rt
DBU, neat, 100°C
then distillation
Oxone®, Na2EDTA
sat’d aq. NaHCO3
acetone/MeCN, rt
O
O
O
1.
2.
3.
80%, 2 steps
0.5 mol scale
80% yield
(64%, 3 steps)
3.25 3.26 (±)-3.15
Scheme 3.7. Optimized 3-step synthesis of epoxy ketal 3.15
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found to contain dark impurities that gave colored products that were difficult to remove 
by aqueous work-up and chromatography. 
 Following a literature procedure  3.28 was readily prepared by treatment of 25
commercially available 3-hydroxybenzaldehyde 3.27  with bromine in CH2Cl2 at room 26
temperature (56% yield, 25-100 g batches). This material is sparingly soluble in CH2Cl2 
and the resulting precipitate can be isolated by simple filtration (>95% pure by 1H-NMR 
analysis). Protection of 3.28 (TBSCl, imidazole, DMA) proceeds uneventfully (92 g 
scale) and following aqueous work-up can be used without further purification. Wittig 
olefination with methyltriphenylphosphonium bromide and NaH in THF at room 
temperature proceeds smoothly and an optimized work-up involving first aqueous 
extraction with hexanes, concentration and resuspension in hexanes, filtration to remove 
precipitated triphenylphosphine oxide, and finally filtration over a plug of silica gel 
(hexanes elution) affords analytically pure styrene 3.29 (72% yield, 40% over 3 steps) in 
≥ 100 g quantities. 
 Though 3.29 is a known compound  it is worth mentioning that this large scale 27
preparation is inexpensive, robust, and requires no column chromatography. It is 
estimated ≥ 1 kg of this styrene has likely been produced during the course of this thesis 
project. 
O
OH
1. Br2, CH2Cl2, rt
(56% yield)
O
OH
Br
2. TBSCl, imidazole, DMA, rt
3. MePPh3Br, NaH, THF, rt
OTBS
Br
(72% yield, 2 steps)
≥ 100 g/batch
chromatography-free3.27 3.28 3.29
Scheme 3.8. Optimized 3-step synthesis of bromostyrene 3.29
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 The optimization of the copper(I) catalyzed opening of (±)-3.15 with aryl 
Grignard 3.18 was at first puzzling. The ~30% yield could not be increased in initial runs 
and a variety of conditions were initally screened with no success. The purity of epoxide 
starting material was next questioned and although the crude material was routinely 
deemed pure by 1H-NMR analysis it was eventually discovered that purification by short-
path distillation was absolutely critical to the success of the reaction.  Employing freshly 28
distilled (±)-3.15, secondary alcohol 3.19 was routinely isolated in ~80% yield (~25 g 
prepared/batch) using 5 mol% CuI and 1.5 eq 3.18 (THF, 0°C → rt). It was found that 
doubling the reaction scale resulted in a reduced yield (62% yield, 42 g prepared, see 
Scheme 3.9). 
 Although an abundance of oxidation manifolds are available for the catalytic and 
stoichiometric oxidation of secondary alcohols to the corresponding carbonyl, the use of 
IBX in hot EtOAc remains in my opinion the most operationally simple and convenient. 
The greatest advantage is the poor solubility of IBX in nearly all organic solvents at room 
temperature and following filtration and removal of solvent, the resulting ketone (derived 
from 3.19, not shown) is obtained in purity sufficient to be used in downstream reactions 
(~25 g batches).  29
 A brief survey of conditions for methallylation found that exposure of the crude 
ketone derived from 3.19 to methallylmagnesium chloride (freshly prepared from 
inexpensive β-methallylchloride and magnesium turnings in THF at 0°C) at -78°C 
satisfactorily afforded tertiary alcohol 3.20 with good stereocontrol (>20:1 dr) in 74% 
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yield (25 g scale) from 3.19 (Scheme 3.9). One-pot Barbier-type reactions under both 
anhydrous  and aqueous  conditions as well as performing the reaction at warmer 30 31
temperatures gave inferior yields and lower diastereoselectivity.  32
 The RCM-protection-deprotection sequence (3.20 → 3.21) required little 
optimization from the discovery conditions; a two-flask procedure was found to be more 
convenient since on scale-up (30-35 g batches) a multi-necked flask was necessary which 
could be not directly applied to a rotary evaporator. 
 It is worth noting that throughout the duration of this thesis project a considerable 
effort went into optimizing the RCM to minimize the quantity of catalyst used. This was 
primarily out of a consideration of cost  since the RCM was employed so early in the 33
synthesis that large quantities would be needed for multiple material campaigns. 
Coincidentally, just as I discovered that 10 mol% of Grubbs II catalyst was optimal for 
the conversion of 3.20 to 3.21 (a considerable increase from the 1st-generation route) a 
variety of vendors now began offering the venerable ruthenium complex at greatly 
reduced price.  A single 10 g bottle of Grubbs II purchased for $350 from Oxchem 34
allowed for the RCM to be performed on a total of 65 g of 3.20. ,  35 36
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[42 g scale]
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3.19 3.20 3.21
MgBr
TBSO
3.18
Scheme 3.9. Optimized 5-step synthesis of phenol 3.21 from 3.15
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 Several motivations went into the optimization of the dearomatization of 3.21 to 
3.22 (Table 3.1). Chief amongst these included consideration of reaction rate and product 
purity. Although the proof-of-concept conditions afforded the desired product, the 
reaction rate was sluggish, requiring multiple days, which allowed for competitive 
formation of side products before the reaction could reach full conversion. The use of 
tetraphenylporphyrin (TPP) as the photosensitizer led to the isolation of product that was 
colored even after repeated chromatography and stirring with activated charcoal.   37
 The three most common catalysts used to generate singlet oxygen are TPP, 
methylene blue (MB), and rose bengal (RB);  the advantage of the latter two is their high 38
polarities allow them to easily removed by chromatography on silica gel and give 
products devoid of colored contaminants. Of the three, however, TPP possesses the 
highest quantum yield (11% ) and was found to be the most productive of the three 39
catalysts when performing the reaction in chloroform under an atmosphere of dioxygen. 
In fact, it was found that both MB and RB were completely ineffective under these 
conditions. These initial results were odd considering the popularity of MB and RB in 
singlet oxygen chemistry. 
 The photon source was briefly considered but the UV-vis spectra of TPP, MB, and 
RB record maximum absorptions of ~420 nm,  ~665 nm,  and ~560 nm respectively,  40 41 42
indicating that a simple white-light source is sufficient for generating the excited states of 
either catalysts. Thus, high-power metal-halide lamps were dismissed for practical 
reasons. The advent of light-emitting diodes (LEDs) in modern photochemistry  as 43
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inexpensive and practical sources of light in the visible spectrum led to their use for the 
remainder of the optimization studies. The light-penetration these LEDs provide is 
notably better than the CFL bulb originally employed but MB and RB still remained 
ineffective as catalysts. 
 Although TPP and MB are both highly soluble in chlorinated solvents, RB is 
poorly soluble. A solvent screen was next performed and, to my surprise and delight, 
addition of MeOH as cosolvent (1:1 with CHCl3 or CH2Cl2) led to the observed 
production of 3.22 using MB or RB as catalyst (1-2 mol%). This solvent-dependence for 
the [4+2] cycloaddition of singlet oxygen to p-alkyl phenols employing either MB or RB 
as photocatalyst is, to the best my knowledge, unprecedented. Mechanistically, it can be 
surmised that despite the high solubility of dioxygen in chlorinated solvents, the overall 
polarity of the medium is critical in mediating the dearomatization event;  a more 44
convincing piece of data is that of the polar solvents screened (using MB) only MeOH 
and CF3CH2OH were competent in converting 3.21 to 3.22, implying that not only 
reaction polarity but perhaps a hydrogen-bonding interaction between substrate and 
solvent, solvent and singlet oxygen, or some other permutation is crucial for 
dearomatization to occur. An increase in the lifetimes of singlet and triplet excited states 
resulting from  a protic reaction medium also cannot be ruled out as a contributing factor. 
 While investigating the optimization of the reaction rate it was discovered that 
lowering the reaction temperature greatly increases the rate of singlet oxygen addition to 
3.21, which initially seemed counterintuitive. However, this is a known, observed 
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phenomena in the reactivity of singlet oxygen.1,  Irradiation of 3.21 with white LEDs 45
under an atmosphere of dioxygen at -40°C led to full conversion of starting material after 
five days (10 g scale). Although this was still seen as a considerably long reaction time, 
irradiation at room temperature for over a week led not only to incomplete consumption 
of starting material but also the formation of undesired side products.  
 Although MB is an effective photocatalyst, at the reaction concentrations 
employed (< 0.1 M, 2 mol% MB) the opacity of the reaction mixture is appreciable and 
light penetration of the reaction media is poor. Fortunately, at similar catalyst loadings 
and concentrations, RB gives clear solutions wherein light penetration is considerably 
enhanced. Irradiation of 3.21 with RB (1 mol%) in 1:1 CHCl3-MeOH at -40°C with white 
LEDs while bubbling air continuously through the solution  reduced the reaction time to 46
48 h and afforded 3.22 in 59% yield (17 g scale) following in-situ reduction with 
triphenylphosphine.  47
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O
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OH
conditions
catalyst (mol%)
TPP (5%)
MB (2%)
MB (2%)
MB (2%)
MB (2%)
RB (1%)
% yield
33%
NR
NR
20%
50%
59%
solvent
CHCl3
CHCl3
CHCl3
MeOH
CH2Cl2-MeOH (1:1)
CHCl3-MeOH (1:1)
temp (°C)
rt
rt
rt
rt
-20
-40
time (h)
48
—
—
24
120
48
[O] / [H]
O2 / Me2S
O2 / —
O2 / —
O2 / thiourea
O2 / thiourea
air / PPh3
hv source
26W CFL
26W CFL
white LEDs
white LEDs
white LEDs
white LEDs
3.21 3.22
Table 3.1. Optimization of singlet-oxygen dearomatization
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 It is worth mentioning that although the use of continuous-flow photoreactors  48
were not investigated during these studies, there is no doubt that their future application 
will lead to greater productivity for this important transformation in terms of yield, 
reaction rate, and material throughput. 
 The optimization of this oxidative dearomatization led to a scalable and 
reproducible procedure that afforded material of sufficient purity for facile growth of 
single crystals suitable for X-ray diffraction. These X-ray diffraction studies confirmed 
the relative configuration of the C9 tertiary alcohol and a key stereotriad established in 
only six steps from 3.15 (Scheme 3.10). 
 The alkoxide-directed 1,4-addition of methylmagnesium chloride to 3.22, 
gratifyingly, did not require intense optimization. In fact, a reaction performed on 13.4 g 
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Scheme 3.10. Scalable synthesis of sterotetrad 3.23 & confirmation of stereocontrolled events by X-ray diffraction
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scale (65% yield) employed near-identical conditions used in the proof-of-concept phase 
(3.0 eq MeMgCl, 15.0 eq 1,4-dioxane, THF, -78°C → rt). At the end of the first material 
campaign, decagram quantities of 3.23 were procured from which single crystals suitable 
for X-ray diffraction were grown. These studies confirmed the addition of the methyl 
Grignard with direction from the C9 tertiary alcohol of 3.22 to stereoselectively install 
the angular C18 methyl (Scheme 3.10). With large quantities of 3.23 in hand, I was eager 
to move forward onto the completion of the DDO C-ring. 
3.5 — An unexpected stereochemical outcome during the preparation of a complex 
stereoheptad 
 Reconnaissance gained during the proof-of-concept phase (Section 3.3) showed 
that after silylation and 1,2-addition of isopropenylmagnesium bromide, exposure to m-
CPBA afforded a compound with presumably the constitution of 3.24 (Scheme 3.6). The 
1,2-addition proceeded with good stereocontrol but the major diastereomer was left 
unassigned although it was reckoned that the size and position of the TMS ether provided 
sufficient bulk to direct the addition to afford the desired equatorial alcohol (Scheme 
3.11).  It was rationalized that the bulk of the TMS group also blocked the approach of 49
m-CPBA to α-face of the C4,8 trisubstituted alkene, as shown in the assembly 3.33.  A 50
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Scheme 3.11. Stereo- and regiochemical rationale for isopropenyl epoxidation
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protection-deprotection sequence could jeopardize the TMS ether at C4 in addition to 
lengthening the overall sequence. 
 In order to correctly install the isopropenyl group via substrate-control it was 
envisioned that an electrostatic model for intermolecular addition could be applied.  Jasti 51
and co-workers have shown in their elegant syntheses of cycloparaphenylenes that 
deprotonation of p-quinols with NaH followed by addition of an aryllithium reagent 
affords syn 1,4-diols with excellent diastereoselectivity.  The authors invoke a model 52
involving electrostatic repulsion of the sodium alkoxide to induce substrate control over 
the approach of the nucleophile. Although this type of stereoinduction has only been 
shown to proceed with p-quinols and not γ-hydroxycyclohexenones such as 3.23, it was 
thought that a similar mode of reactivity could be invoked. 
 As shown in Scheme 3.12, the electrostatic model 3.35 would control the 1,2-
addition and the resulting tertiary alcohol could direct epoxidation of the C8-C14 alkene 
from the bottom face of the molecule via the assembly 3.36 to afford vinyl epoxide 3.37. 
Successful implementation of this pathway would lend credence to the use of native 
functionality to concisely construct the DDO C-ring. 
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Scheme 3.12. Proposed models for axial delivery of isopropenylMgBr & directed epoxidation
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 There was concern regarding the acidic α-protons of enone 3.23 in employing 
NaH prior to Grignard addition in that enolate formation would preclude successful 1,2-
addition. Reasoning that a magnesium alkoxide would provide an ionic pair of similar 
size and static nature, a procedure was devised in which inverse addition of a solution of 
3.23 to a pre-cooled solution of isopropenylmagnesium bromide would rapidly 
deprotonate the tertiary alcohol and undergo 1,2-addition faster than enolate formation. 
Indeed, it was found that dropwise addition of a THF solution of 3.23 to a solution of 
isopropenylmagnesium bromide at -78°C allowed the isolation of a single diastereomer 
arising from 1,2-addition. Switching the solvent to CH2Cl2 and performing the inverse 
addition at room temperature afforded 1,2-adduct 3.38 in 30% yield as a single 
diastereomer.  53
 3.38 was found to be unstable neat or in solution for short periods of time and 
after rapid chromatography was treated with NaHCO3 and m-CPBA in CH2Cl2 at room 
temperature to afford 3.37 as a single diastereomer in quantitative yield (1.8 g scale). 
With ample quantities of 3.37 in hand, the stage was set to explore the key final reductive 
epoxide opening which would complete the desired DDO stereoheptad. 
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Scheme 3.13. 1,2-addition of isopropenylMgBr to 3.23 & selective epoxidation of the resulting adduct
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 Discovery of conditions to effect the proposed vinyl epoxide opening was not 
straightforward. I was particularly keen on employing a palladium-catalyzed Tsuji 
reduction  to accomplish the challenging C8-C14 functionalization. The mechanism 54
involves (1) Pd(0) oxidative addition to the vinyl epoxide forming Pd(II)(π-allyl)(L)2 
intermediate 3.39; (2) formation of a Pd(II)(π-allyl)(hydrido)(L) intermediate 3.40 
following decarboxylation of a Pd-formate complex; and (3) stereoretentive reductive 
elimination to afford 3.14 (Scheme 3.14). Unfortunately, employing a slew of palladium 
precatalysts, ligands, and hydride sources at different temperature regimes failed to 
provide even a trace of the desired product. 
 Of the multitude of ionic hydride reactions employed, clean conversion was only 
observed employing either diisobutylaluminum hydride (CH2Cl2, -78°C) or lithium 
aluminum hydride (THF, -78°C); a third condition, employing catalytic RhCl3 in MeOH 
was found to also give full conversion of starting material. Although in the above cases 
the vinyl epoxide moiety was indeed regioselectively cleaved, the C8 methine proton of 
3.14 could not be identified from any of the compounds generated, implying 
intramolecular epoxide openings from either of the pendant tertiary alcohols at C4, C9, or 
C13 were operative.   55
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Scheme 3.14. Mechanistic proposal for Pd(0)-catalyzed Tsuji reduction of vinyl epoxide 3.37
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 The potential of opening the vinyl epoxide in 3.37 via a radical mechanism was 
next investigated (Scheme 3.15). Exposure of titanocene dichloride (10.0 eq) to an excess 
of manganese powder in degassed THF followed by addition of 1,4-cyclohexadiene and 
3.37 at room temperature led to the formation of a product with the correct connectivity 
of 3.14 in 29% yield with excellent stereocontrol (>20:1 dr).  
 Preliminary NMR data (1H, 13C, gCOSY, HSQCAD, gHMBCAD) confirmed the 
constitution of stereoheptad 3.14 and the successful installation of the vicinal methine 
protons at C8 and C14. However, to my great dismay, 2D-NOESY data later obtained 
showed strong through-space correlations between the C8 methine proton and the C10 
methine proton (Scheme 3.16). The relative configuration of the isolated C8,14,13 
stereotriad was found to be correct based on NOESY correlations but the unexpected C8-
C10 correlation questioned the overall relative configuration of the obtained compound 
and intimated the necessary structural reassignment of 3.14 to its C8,14,13 diastereomer 
3.43 and thus the retroactive reassignment of 3.37 to 3.42. 
 Regrettably, I had in previous weeks successfully grown single crystals of the 
epoxide starting material that were suitable for X-ray diffraction but had left them 
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Scheme 3.15. Mechanism of titanocene-mediated radical epoxide opening
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forgotten on my desk as I was occupied with the spectral structural assignment of the 
epoxide opening product. The very next day I went down to the X-ray lab and within six 
hours was able to solve the X-ray crystal structure thus confirming the need to 
retroactively reassign the structure of 3.37 as 3.42 which greatly bolsters the spectral 
reassignment of 3.14 to 3.43 (Scheme 3.16). 
 At this juncture in the synthesis, several moments were needed to re-situate and 
evaluate the overall implications of this unexpected stereochemical outcome (Scheme 
3.17). The 1,2-addition of isopropenylmagnesium bromide it turned out had actually 
approached 3.23 equatorially (3.35), opposite the axial -OTMS group, to afford the 
corresponding tertiary axial alcohol. This axial alcohol, based on the X-ray structure of 
3.42, is well situated to direct the approach of m-CPBA from the β-face of the 
trisubstituted C8-C14 alkene (3.44). 
OTMS
H
O
O Me
Me
OH
OH
O
Me
Cp2TiCl2, Mn0
1,4-C6H8, THF, rt
(29% yield
>20:1 dr)
X-ray
OTMS
H
O
O
OH
Me
Me
H
OH
Me
OH
OTMS
H
O
O
OH
Me
Me
H
OH
Me
OH
H
NOESY
3.42 3.43
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 A series of potential work-arounds were quickly conceived in order to get the 
synthesis back on track (Scheme 3.18). The general hope was if the isopropenyl group 
could be installed correctly, the resulting syn-1,4-diol system (3.38) would be competent 
in directing epoxidation from the bottom face of the molecule to selectively afford the 
desired vinyl epoxide 3.37. 
 While the axial addition of Grignard reagents to cyclic carbonyls is difficult,  56
selectivity can be controlled with bulky Lewis acidic additives such as Yamamoto’s MAD 
reagent system.  Conversely, the axial approach of hydride nucleophiles to 57
cyclohexanones is preferred.  Although difficult, the resulting secondary allylic alcohol 58
could in principle engage in directing an oxidant from the bottom face  although this 59
precludes the successful installation of the isopropenyl moiety.  
 An unproved way around this hurdle involves a three-step sequence comprising 
(1) Luche reduction (with axial selectivity); (2) conversion of the resulting equatorial 
secondary alcohol to the bulky N,N-diisopropylcarbamate; and (3) stereospecific 
lithiation-borylation-oxidation following elegant work by Aggarwal and co-workers  60
could install the desired functionality at C13 although this would be considerably more 
laborious. 
 Finally, an even more risky sequence was conceived involving (1) hydrolytic 
opening of epoxide 3.42 from the more accessible secondary position; (2) protection of 
the resulting secondary alcohol; (3) Mukaiyama stereoinversion  of the C13 tertiary 61
alcohol; (4) orthoester formation; and (5) ionic hydrogenation  of the axial tertiary 62
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alcohol at C8. This last sequence, although treacherous, would at least fully assemble the 
C-ring and was worth contemplating since 3.42 had already succumbed to gram-scale 
synthesis. 
 While considerable time was next invested in exploring methods for the axial 
installation of the isopropenyl group, it was eventually discovered while recycling the 
recovered starting material from the earlier conversion of 3.23 → 3.46 (Scheme 3.19) that 
the stockpiled material—‘single-spot’ pure by TLC—was actually contaminated with an 
unknown compound which possessed an identical Rf value to 3.23. 
 Using this stockpiled material (at the time unknown to possess an unassigned 
contaminant) to explore the proposed Luche reduction discussed above (Scheme 3.18) it 
was found that following exposure of 3.23 (rsm) to sodium borohydride and cerium 
trichloride heptahydrate in MeOH at -78°C and warming to room temperature, allylic 
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Scheme 3.18. Proposed work-arounds for correcting stereochemical outcome
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alcohol 3.47 was smoothly formed along with what was believed to be unreacted 3.23. As 
mentioned, this was not unreacted 3.23 but actually the desired 1,2-addition product 3.38. 
The diastereoselectivity upon inverse addition of pure 3.23 to isopropenylmagnesium 
bromide is in fact closer to unity and the two C13 diastereomers, interestingly, possess a 
difference in Rf value of ~0.5. 
 With access to bonafide 3.38, it was assumed that alcohol directed epoxidation 
with m-CPBA would occur with familiar fidelity (Scheme 3.13). However, the equatorial 
alcohol at C13 was incapable of directing epoxidation to the desired C8-C14 alkene 
(Scheme 3.20). Exposure of 3.38 to m-CPBA afforded a mixture of regio- and 
stereoisomers resulting from nonspecific oxidation of both C8-C14 and C6-C7 alkenes. 
Molecular modeling showed that the C13 equatorial alcohol is poorly disposed for 
directed epoxidation and the axial C9 alcohol derived from oxidative dearomatization is 
considerably better positioned for directing epoxidation to the trisubstituted C6,7 alkene. 
Allylic alcohol 3.47 was also a poor substrate for this transformation and other reaction 
manifolds such as Sharpless-type epoxidations gave similarly inferior results. 
 A myriad of other dead-end ideas were also attempted on these systems, some of 
which are catalogued in Scheme 3.21.  These efforts involved attempted hydration/63
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esterification of the C8-C14 alkene either directly employing photoredox catalysis  or 64
via the intermediacy of bromohydrins; the use of carbon dioxide to generate transient 
carbonic acids which could cyclize under the intermediacy of either a halonium ion  or a 65
photoredox generated radical cation; and alternative oxidative transforms to attempt to 
access some oxidation pattern which could be eventually converted to 3.14 (i.e. diol 3.63 
or α-hydroxyketone 3.49).  
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Scheme 3.21. Some failed approaches in elaborating C13 diastereomers 3.38 or 3.47
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3.6 — Successful quinol fuctionalization requires a highly specific choreography 
 The successful results from the above section are summarized for clarity of 
discussion in Scheme 3.22. Two complex stereoheptads 3.42 and 3.43 possessing 
incorrect relative configuration at C8, C14, and C13 were rapidly generated from the 
enone 3.23. In sum, these results validate a concise approach to the DDO C-ring based on 
a quinol functionalization sequence. A powerful radical epoxide opening that occurs with 
radical inversion and stereospecific HAT at a tertiary carbon hallmark a method for a net 
trans-selective, anti-Markovnikov reductive hydration of a trisubstituted olefin, itself 
conjugated to another trisubstituted alkene, through the intermediacy of a vinyl epoxide.  
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Scheme 3.22. 10-step synthesis of complex stereoheptad 3.43 with incorrect relative configuration at C4,8,13
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 However, in order to make the necessary corrections, it became evident a highly 
specific, yet to be determined, choreography of events would be required to fashion the 
desired C-ring stereopentad. The titanocene-mediated radical epoxide opening was shown 
to occur with radical inversion and so it was presumed a correctly installed epoxide 
should in principle behave with fidelity.  The most obvious adjustment would involve a 66
progression of 3.23 → epoxy ketone 3.65 → 1,2-addition → 3.14 (Scheme 3.23). 
 Alcohol-directed nucleophilic epoxidation of γ-hydroxycyclohexenones as well as 
p-quinols is well-precedented.  However, exposure of enone 3.23 to commonly 67
employed conditions led to variable mixtures of regioisomers resulting from 1,4- and 1,6-
addition of the nucleophilic peroxide source, with the 1,6-adduct 3.66 as the dominant 
product (Table 3.2). It was thought that if 3.66 was forming faster than 3.65 under these 
conditions then perhaps under more forceful conditions the potentially more useful bis-
epoxide 3.67 would form; however this compound was never observed under all 
conditions screened. 
 This initial survey was discouraging but it was eventually discovered that a 
combination of catalytic pyrrolidine and aqueous hydrogen peroxide  provided a 68
moderate yield of 3.65 (40% yield) with good control (10:1 rr, >20:1 dr). A short 
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Scheme 3.23. A work-around via a hydroxyl-directed nucleophilic epoxidation
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optimization campaign demonstrated that although the reaction proceeds with good 
selectivity, it was slugglish and not responsive to the addition of excess of amine and 
peroxide, but notably the remainder of the mass balance was usually unreacted 3.23 
which could be recycled. 
 Switching the solvent from THF to MeOH dramatically increased the rate of 
conversion  and a stoichiometry of 1.0 equivalent pyrrolidine and 1.3 equivalents 30% 69
aqueous hydrogen peroxide  was found to deliver the epoxy ketone 3.65 in 61% yield 70
(>10:1 rr, >20:1 dr) on a gram scale.  71
 1,2-Addition of isopropenylmagnesium bromide to 3.65 was anticipated to 
proceed with selectivity for the undesired axial alcohol. This supposition is based on the 
lack of selectivity of prior systems but also molecular models of the epoxy ketone 
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—
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Table 3.2. Iminium-activation enables a stereocontrolled, hydroxyl-directed nucleophilic epoxidation
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showed preferred geometry in which nucleophiles would likely advance from the convex 
α-face of the molecule. 
 More concrete data was obtained following exposure of 3.65 to sodium 
borohydride; the axial alcohol 3.69 was obtained in 95% yield as a single diastereomer, 
the relative configuration at C13 supported by NOESY experiments. If addition of 
hydride proceeded from the convex face of the molecule, the massively larger 
isopropenyl Grignard reagent would most certainly proceed with the same selectivity. 
However, attempts to prove this were met with the propensity for 3.65 to decompose 
under the reaction conditions employed (Scheme 3.24). 
 Meanwhile, treatment of 3.69 with Cp2TiCl in the presence of 1,4-cyclohexadiene 
afforded triol 3.71 with the desired stereochemistry at C8 and C14. This result was 
gratifying in that 3.71 contains six out of the seven desired stereocenters, including the 
critical methine proton at C8. Celebration was short-lived however in that the reaction 
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itself was variable in yield, reproducibility, and purity.  Furthermore, elaboration of 3.71 72
to triisopropyl benzoate 3.72 via Mitsunobu inversion  was unsuccessful, eliminating the 73
chance to stereospecifically install the remaining isopropenyl group by Aggarwal’s 
method (supra). Notably, treatment of epoxy ketone 3.65 under identical conditions led to 
β-hydroxyketone 3.68 wherein reductive epoxide opening via intermediacy of a titanium 
enolate is dominant. 
 Since the epoxy ketone 3.65 favors delivery of nucleophiles from the convex face, 
a new conceptual model was needed to establish the challenging C13 stereocenter 
(Scheme 3.25). It was reasoned that rather than solely regarding 3.65 as an equivalent to 
the classical electrophilic synthon 3.73 if it could be converted the atypical nucleophilic 
synthon 3.74, approach of an appropriate electrophilic oxidant should also prefer 
approach from the convex face of the molecule and solve the C13 stereochemistry 
problem. 
 This was conceived to occur through either of three possible ways (Scheme 3.25). 
One would proceed through Horner-Wadsworth-Emmons olefination of 3.65 followed by 
reduction to give the allylic alcohol 3.75. A little-known procedure described by Nozaki 
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and co-workers  would afford isomerization product 3.37. Alternatively, Wittig 74
olefination with isopropyltriphenylphosphonium bromide followed by epoxidation and 
base-induced β-syn elimination  could also ostensibly afford 3.37. Lastly, it was 75
eventually realized that 3.37 is the product of an ene-reaction between the fully 
substituted alkene of 3.77 and singlet oxygen. 
 The first process was seen as lengthy and precarious in regards to the sensitive 
doubly vinylic epoxide of 3.75. Likewise, β-syn elimination of bis-epoxide 3.76 
possesses similar elements of uncertainty. The singlet oxygen ene-reaction of 3.77 was 
speculated to be the most likely to succeed due to mildness of the reaction conditions as 
well as the well-established relative rates of alkene photooxidation  and so the 76
preparation of 3.77 was prioritized (Table 3.3). 
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 Treatment of 3.65 with an excess of isopropyltriphenylphosphonium bromide and 
potassium tert-butoxide in THF at room temperature confirmed the tetrasubtituted alkene 
3.77 could be formed,  albeit in only moderate conversion and yield (46% isolated). A 77
cleaner reaction profile could be obtained by switching the base to potassium hydride  78
and a further boost in yield was obtained by switching the reaction solvent to Et2O. Under 
these conditions, full conversion was obtained after 18 h at room temperature and 3.77 
was reproducibly isolated in 78-85% yield (50-200 mg scale), setting the stage for the 
second singlet-oxygen reaction employed in this synthesis. 
 In the event, irradiation of an oxygenated solution of 3.77 in the presence of 
methylene blue (1 mol%) with white LEDs at 0°C for 2.5 h followed by in-situ reduction 
with triphenylphosphine smoothly delivered the vinyl epoxide 3.37 in 80-90% yield as a 
single diastereomer over several runs (50-180 mg scales). Small amounts of the C13 
diastereomer 3.78 were also formed during this process (<10% yield) but could be easily 
purged by flash chromatography.   79
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3.7 — Concluding remarks 
 This chapter documents the development of a short (ten steps from known starting 
materials), stereocontrolled second-generation synthesis of a complex 5-7-6 tricycle with 
seven contiguous stereocenters—six of which directly correspond to stereocenters present 
in all known DDOs. 
 After a difficult campaign and a maze of subtle stereochemical snafus, the 
originally proposed vinyl epoxide 3.37 had finally succumbed to synthesis. Notably, the 
successful route to 3.37 required three iterative uses of either neutral or reduced diatomic 
oxygen to install the required O-appendages of the C-ring with high stereoinduction. 
 Indeed, exceptional stereocontrol—in both anticipated and unexpected cases—
proved to be a reoccurring theme throughout the studies detailed in this chapter. The 
revamped synthetic strategy relied heavily on native functionality either to direct or to 
dissuade the bimolecular facial approach of reagents with high fidelity. In some events 
the proposed outcomes came to fruition after considerable experimentation; in several 
other cases, design flaws which were not conceived a priori led to unexpected, undesired, 
and completely opposite stereochemical outcomes but usually with good to exquisite 
OTMS
H
O
O Me
OH
Me
O
Me
Me O2, methylene blue
CH2Cl2-MeOH, 0°C
white LEDs
then add PPh3
OTMS
H
O
O Me
OH
Me
O
OH
Me
OTMS
H
O
O Me
OH
Me
O
OH
Me
<10% yield80-90% yield3.77
3.783.37
Scheme 3.26. Diastereoselective singlet-oxygen ene-reaction of 3.77
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levels of control, highlighting a sophisticated and inherent reactivity of the DDO 
architecture, even in signficantly simplified systems.  
 The successful elaboration of the C-ring from a flat, achiral benzene nucleus gives 
good support for generating complex stereopolyads from simple aromatic precursors and 
may in the future prove general for the preparation DDOs, in addition to other complex 
cyclohexane-containing chemical motifs. 
 Ultimately, considerable insight into the assembly of the dense DDO core 
architecture was gleaned by establishing a strategy driven by minimization of protecting 
group and functional group interconversions which necessitated the ability to employ 
native functionality and substrate control in critical, stereodetermining events. While 
somewhat successful in following these ideals, detours and necessary corrections allowed 
for the development of distinct choreographies for stereodivergent outcomes in p-quinol 
functionalization. 
 The following chapter continues along these same lines, outlining the intended 
plans and unexpected outcomes in the pursuit of a short total synthesis of (±)-
resiniferatoxin, and what lessons and solutions can be learned and proposed, respectively. 
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3.8 — Experimental Procedures 
General Methods. Unless otherwise noted, all reactions were performed using flame-
dried glassware under an atmosphere of nitrogen. Air- and moisture-sensitive liquids and 
solutions were transferred via syringe or stainless steel cannula. Organic solutions were 
concentrated under reduced pressure by rotary evaporation. Reactions were monitored by 
thin layer chromatography (TLC) using SiliCycle glass plates pre-coated with silica gel 
(0.25-mm thickness; 60-Å pore size) impregnated with a fluorescent indicator (254 nm). 
TLC plates were visualized by exposure to ultraviolet light (UV) and staining with 
ethanolic solutions of phosphomolybdic acid (PMA), acidic solutions of vanillin, or 
aqueous solutions of potassium permanganate followed by heating. Flash column 
chromatography was performed on silica gel 60 (230-400 mesh) purchased from 
SiliCycle. Solid reagents were weighed out in air. Reaction work-ups and 
chromatographic purifications were performed on the bench top in air using reagent grade 
solvents.  
Materials.  Reagent grade solvents were purchased from Fisher Scientific and used 
without further purification. Anhydrous dichloromethane (DCM), tetrahydrofuran (THF), 
acetonitrile (MeCN), diethyl ether (Et2O), and toluene (PhMe) was obtained by passing 
these previously degassed solvents through two columns of activated alumina prior to 
use. Chemicals were purchased from commercial sources and used at received. 
Instrumentation. 1H NMR and 13C NMR spectra were recorded at 117.42 kG (1H 500 
MHz, 13C 125MHz), 93.94 kG (1H 400 MHz, 13C 100 MHz), or 70.50 kG (1H 300 
MHz, 13C 75 MHz) at ambient temperature on Varian Agilent-500 MHz VNMRS, Varian 
Agilent-400 MHz VNMRS, and Varian Agilent Agilent-300 MHz VNMRS 
spectrometers. Hydrogen chemical shifts are expressed in parts per million (ppm) relative 
to the residual protio solvent resonance: CDCl3 δ 7.26, CD3OD δ 3.31, DMSO-d6 δ 2.50, 
acetone-d6 δ 2.05. For 13C spectra, the centerline of the solvent signal was used as internal 
reference: CDCl3 δ 77.16, CD3OD δ 49.00, DMSO-d6 δ 39.52, acetone-d6 δ 29.84, 
206.26. Data are reported as follows: chemical shifts, multiplicity (s =singlet, d =doublet, 
t = triplet, q = quartet, and m = multiplet), coupling constant in hertz (Hz), and 
integration. 
 Infrared (IR) spectra were recorded on a Thermo-Fisher Nicolet FT-IR with ATR 
and are reported in terms of frequency absorption (cm-1). 
 High resolution mass spectrometry (HR-MS) data was obtained on a Waters Qtof 
(hybrid quadrupolar/time-of-flight) API US system by electrospray (ESI) in the positive 
mode by Dr. Norman Lee of the Boston University Department of Chemistry Chemical 
Instrumentation Center (BU-CIC). 
 X-ray diffraction was performed on a Bruker AXS X8 Proteum-R 
diffractometer with assistance from Dr. Jeffrey Bacon (Boston University). 
!  203
 
A 500 mL round bottom flask equipped with a magnetic stir-bar was charged 3,4-
dimethylphenol (10.0 g, 81.855 mmol, 1.0 eq) and TPP (0.110 g, 0.179 mmol, 0.002 eq). 
300 mL CHCl3 was added and the resulting deep purple solution was vigorously sparged 
with dioxygen before being irradiated with a 26 W CFL bulb at room temperature under 
an atmosphere of dioxygen for 6 days. The reaction was treated with dimethylsulfide 
(6.011 mL, 81.855 mmol, 1.0 eq) at room temperature and upon complete consumption 
of the intermediate peroxide, the reaction was concentrated under reduced pressure and 
purified by flash column chromatography on silica gel (25% → 50% EtOAc in hexanes) 
to afford p-quinol 3.9 as a viscous olive green oil (8.975 g, 80% yield). Spectroscopic 
data was identical to that reported in the literature.  80
 A flame-dried 250 mL round bottom flask equipped with a large magnetic stir-bar 
was charged 3.9 (3.5 g, 25.33 mmol, 1.0 eq) and 1,4-dioxane (6.48 mL, 76.0 mmol, 3.0 
eq). 100 mL THF was added and the resulting solution was cooled to -78°C; 
methylmagnesium chloride (3.0 M in THF, 25.33 mL, 76.0 mmol, 3.0 eq) was added 
dropwise and the resulting mixture was vigorously stirred for 0.5 h before being warmed 
to room temperature over 1 h. The reaction was diluted with ether and quenched with 
Glauber’s salt and celite (1:1). After vigorously stirring for 10 minutes the resulting 
suspension was filtered over a medium porosity fritted-glass funnel. The filter cake was 
washed with ether and EtOAc and the collected filtrate was concentrated under reduced 
pressure. Purification by flash column chromatography on silica gel (50% EtOAc in 
hexanes) afforded the title compound as a pale yellow solid (2.8 g, 72% yield). 
1H-NMR (500 MHz, CDCl3): 
δ 5.77 (d, J = 1.5 Hz, 1H), 2.49 (dd, J = 17.0, 4.8 Hz, 1H), 2.36 (ddd, J = 17.0, 6.5, 0.6 
Hz, 1H), 2.20 (td, J = 6.8, 4.8 Hz, 1H), 2.18 (s, 1H), 1.99 (s, 3H), 1.46 (s, 3H), 1.05 (d, J 
= 6.9 Hz, 3H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 198.64, 164.23, 126.32, 72.77, 42.92, 40.26, 26.07, 19.33, 15.00 
 
IR (ATR):  
3515, 2940, 2867, 1250, 842 cm-1 
OH
O
Me
Me
Me
3.10
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HRMS (ESI): 
[M + H]+ calc’d for C9H14O2: 155.1072; found 155.1073 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In air, a 3 L round bottom flask equipped with a large magnetic stir-bar was charged NBS 
(106.8 g, 0.6 mol, 1.2 eq). 1.0 L THF was added followed by ethylene glycol (224 mL, 
4.0 mol, 8.0 eq). The resulting solution was treated with cyclopentanone (42.1 g, 0.5 mol, 
1.0 eq) followed by TMSCl (95.2 mL, 0.75 mol, 1.5 eq). The reaction was stirred for 1 h 
at room temperature, during which time the reaction transitions from a deep red solution 
to an opaque, biphasic mixture. THF was removed under reduced pressure and the 
remaining reaction mixture was partioned between Et2O (500 mL) and sat’d aq. NaHCO3 
(1.0 L). The layers were separated and the aqueous phase was extracted twice with Et2O 
(2 x 300 mL). The combined organic extracts were washed with sat’d aq. Na2S2O3, sat’d 
aq. NaHCO3, and brine; dried over anhydrous sodium sulfate; and concentrated under 
reduced pressure. The resulting crude oil was charged to a 500 mL round bottom flask 
and a large magnetic stir-bar was added followed by DBU (150 mL, 1.0 mol, 2.0 eq). The 
reaction mixture was heated to 100°C (oil bath) for 48 h and cooled to 50°C. A short path 
distillation head was added and the reaction mixture was directly distilled under reduced 
pressure to afford the 3.26 as a clear, colorless liquid (50.45 g, 80% yield). Spectroscopic 
data was identical to that reported in the literature.  81
 In air, a 2 L Erlenmeyer flask equipped with a magnetic stir-bar was charged 
Oxone® (141 g, 0.459 mol, 2.05 eq) and 560 mL 0.0004 M aq. Na2EDTA was added. The 
mixture was stirred until all the Oxone® was dissolved and 840 mL sat’d aq. NaHCO3 
was added slowly. The pH of the solution, initially 1-2, became 7-8 and no exotherm was 
observed. A 2 L Erlenmeyer flask equipped with a magnetic stir-bar was charged 3.26 
(28.26 g, 0.224 mol, 1.0 eq) as a solution in 140 mL acetone and 140 mL MeCN (both 
reagent grade). The buffered Oxone® solution was added all at once to the solution of 
3.26 and the resulting mixture was vigorously stirred at room temperature for 17 h. As the 
reaction progressed a white salt-like precipitate developed. The reaction mixture was 
diluted with water (420 mL), poured into a separatory funnel, and extracted thrice with 
CH2Cl2. The combined organic extracts were dried over anhydrous sodium sulfate and 
concentrated under reduced pressure. Purification by short-path distillation under reduced 
pressure afforded the desired epoxy ketal as a clear, colorless liquid (25.65 g, 80% yield). 
Spectroscopic data was identical to that reported in the literature.17,18 
O
O
O
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A two-necked 2 L round bottom flask equipped with a large magnetic-stir bar and a 1 L 
pressure equalizing dropper funnel was charged 3-hydroxybenzaldehyde (100 g, 819 
mmol, 1.0 eq) followed by CH2Cl2 (1.0 L). The dropper funnel was charged a solution of 
bromine (42 mL, 819 mmol, 1.0 eq) in 800 mL CH2Cl2 which was added dropwise to the 
reaction suspension at room temperature. Upon completion of the addition the reaction 
was stirred for an additional 1.5 h then filtered over a fritted-glass funnel. The filter cake 
was washed with hexanes, briefly air-dried, and further dried under reduced pressure 
overnight to afford known 3.28 as a fluffy white solid (91.7 g, 56% yield) that was used 
without further purification. Spectroscopic data was identical to commerically available 
material (Oakwood). 
 A 1 L round bottom flask was charged a large magnetic stir-bar and 3.28 (91.7 g, 
465.2 mmol, 1.0 eq). 225 mL anhydrous DMA was added followed by sequential addition 
of TBSCl (75.63 g, 501.7 mmol, 1.1 eq) and imidazole (93.165 g, 1.368 mol, 3.0 eq). The 
resulting reaction mixture was vigorously stirred at room temperature for 24 h. The 
reaction was poured into a separatry funnel charged with Et2O/hexanes (1:1, 1.0 L) and 
1.0 N aq. HCl (1.0 L). The layers were separated and the organic phase was washed 
sequentially with brine (500 mL), sat’d aq. NaHCO3 (1.0 L), and brine (500 mL). The 
organic extract was dried over anhydrous sodium sulfate and concentrated under reduced 
pressure to afford an orange liquid that was used without further purification. 
 A 2 L round bottom flask was charged a large magnetic stir-bar and crude material 
from the previous step (assumed 465.2 mmol, 1.0 eq). 1.2 L anhydrous THF was added 
and the resulting solution was lowered into an ambient temperature water bath and 
treated with methyltriphenylphosphonium bromide (179 g, 501.7 mmol, 1.1 eq) with 
vigorous and consistent stirring. The resulting suspension was treated with sodium 
hydride (60% w/w, 20 g, 501.7 mol, 1.1 eq) in 4 even portions over 1 h and the reaction 
mixture was stirred at ambient temperature for 24 h. Upon completion the reaction was 
quenched with sat’d aq. NH4Cl and the layers were separated. The aqueous phase was 
extracted twice with hexanes and the combined organic extracts were washed with water 
and brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure.  
 The resulting crude residue was taken up in hexanes and vigorously stirred for 10 
min. The suspension was filtered over a medium-porosity fritted-glass funnel charged 
with a thin layer of silica gel. The filter cake was washed thoroughly with hexanes and 
the collected filtrate was concentrated under reduced pressure. A 1 L sintered-glass funnel 
OTBS
Br
3.29
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was charged ~900 mL silica gel and attached to a 4 L side-armed flask. Light house 
vacuum was applied and the silica gel was layered with sand. The crude material was 
poured onto the funnel-column using hexanes to aid the transfer. While maintaining mild 
house vacuum, 4 L of hexanes was run through the funnel-column and the resulting clear, 
colorless filtrate was collected and concentrated under reduced pressure to afford styrene 
3.29 as a clear, colorless oil (104.7 g, 72% yield over 2 steps). Spectroscopic data was 
identical to that reported in the literature.27 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A suspension of magnesium turnings (4.147 g, 170.6 mmol, 2.0 eq) and 3.29 (40.086 g, 
128.0 mmol, 1.5 eq) in 60 mL anhydrous THF was treated with DIBAL-H (1 M in PhMe, 
3.36 mL, 3.36 mmol, 0.04 eq) and stirred at room temperature overnight with external 
cooling from a water bath. The resulting Grignard reagent was diluted with 50 mL THF 
and added to a suspension of copper(I) iodide (0.812 g, 4.265 mmol, 0.05 eq) in 60 mL 
THF at 0°C via positive pressure cannulation from a quadruple-layered N2 balloon. The 
flask containing the Grignard reagent was rinsed with THF (15 mL) to ensure the transfer 
was quantitative. After stirring for 10 min, freshly distilled 3.15 (12.125 g, 85.295 mmol, 
1.0 eq) was added dropwise by syringe and the resulting mixture was stirred at 0°C for 2 
h before being warmed to room temperature. After 4 h, the reaction was quenched with 
sat’d aq. NH4Cl/conc. NH4OH (9:1, 200 mL) and vigorously stirred until two clear 
phases formed. The biphasic mixture was poured into a 1 L separatory funnel charged 
with ether (200 mL). The layers were separated and the aqueous phase was extracted 
twice with ether (2 x 200 mL). The combined organic extracts were washed with sat’d aq. 
NH4Cl and brine, dried over anhydrous sodium sulfate, and concentrated under reduced 
pressure. Purification by flash column chromatography on silica gel (gradient 0% → 25% 
EtOAc in hexanes) afforded alcohol 3.19 as a yellow oil (25.92 g, 81% yield). 
 
1H-NMR (500 MHz, CDCl3): 
δ 7.17 (d, J = 8.4 Hz, 1H), 7.05 (dd, J = 17.2, 10.9 Hz, 1H), 6.92 (d, J = 2.6 Hz, 1H), 
6.76 (dd, J = 8.5, 2.6 Hz, 1H), 5.54 (dd, J = 17.2, 1.5 Hz, 1H), 5.27 (dd, J = 10.9, 1.5 Hz, 
1H), 4.09 - 3.98 (m, 4H), 3.22 (td, J = 9.8, 9.4, 7.1 Hz, 1H), 2.08 (d, J = 7.6 Hz, 1H), 2.06 
- 1.95 (m, 3H), 1.62 - 1.53 (m, 1H), 0.98 (s, 9H), 0.20 (s, 6H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 154.16, 138.90, 135.19, 132.55, 126.80, 119.97, 117.70, 116.24, 114.60, 81.10, 65.47, 
65.23, 46.17, 33.40, 27.37, 25.86, 18.34, -4.21 
 
IR (ATR):  
3454, 2930, 2886, 2858, 1603, 1492, 1472, 1291, 1254, 1191, 967, 856, 839, 781 cm-1 
 
O O
OTBS
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HRMS (ESI): 
[M + Na]+ calcd for C21H32O4Si: 399.1968; found 399.1975 
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A solution of 3.19 (25.44 g, 67.56 mmol, 1.0 eq) in 300 mL reagent grade EtOAc was 
treated with IBX (28.38 g, 101.34 mmol, 1.5 eq) and the resulting suspension was heated 
to 80°C for 18 h. The reaction was cooled to room temperature and filtered over a pad of 
celite, washing the cake with additional EtOAc. The filtrate was concentrated under 
reduced pressure and the resulting crude residue was filtered over a short pad of silica gel 
(eluting with 10% EtOAc in hexanes). The filtrate was concentrated to afford the title 
compound as a pale yellow oil that was used without further purification. 
 A flame-dried 500 mL round bottom flask equipped with a large egg-shaped stir-
bar was charged magnesium turnings (8.2 g, 337.8 mmol, 5.0 eq) and the flask was 
evacuated/backfilled with nitrogen (total 3 iterations). 250 mL anhydrous THF was added 
and the resulting suspension was cooled to 0°C and treated with ß-methallyl chloride (33 
mL, 337.8 mmol, 5.0 eq) by syringe pump over the course of 1 h. The mixture was 
further stirred for 1 h at room temperature. Separately, a 1 L round bottom flask equipped 
with a large magnetic stir-bar was charged crude material from the above IBX oxidation 
(assumed 67.56 mmol, 1.0 eq) and 250 mL THF. The resulting clear yellow solution was 
cooled to -78°C (dry ice/acetone) and the freshly prepared Grignard reagent was added 
over 10-15 min by positive pressure cannulation employing a quadruple layered N2 
balloon. After the addition was complete the reaction was stirred at -78°C for 1.5 h and 
quenched with Glauber’s salt-celite (1:1). The cooling bath was removed and the 
resulting suspension was warmed to room temperature with vigorous stirring, filtered 
over a medium porosity sintered-glass funnel, and concentrated under reduced pressure. 
The resulting crude residue was purified by flash column chromatography on silica gel 
(2.5% EtOAc in hexanes) to afford alcohol 3.20 as a clear yellow oil (21.59 g, 74% yield, 
2 steps). 
 
1H-NMR (500 MHz, CDCl3): 
δ 7.49 (d, J = 8.6 Hz, 1H), 7.06 (dd, J = 17.2, 10.9 Hz, 1H), 6.89 (d, J = 2.6 Hz, 1H), 6.76 
(dd, J = 8.6, 2.7 Hz, 1H), 5.50 (dd, J = 17.1, 1.6 Hz, 1H), 5.25 (dd, J = 10.7, 1.5 Hz, 1H), 
4.73 (dd, J = 2.6, 1.2 Hz, 1H), 4.61 (dd, J = 2.2, 1.1 Hz, 1H), 4.08 (td, J = 7.1, 5.2 Hz, 
1H), 4.04 – 3.90 (m, 3H), 3.47 (t, J = 9.2 Hz, 1H), 2.39 (d, J = 13.9 Hz, 1H), 2.28 (d, J = 
0.8 Hz, 1H), 2.13 (ddd, J = 13.0, 10.3, 4.8 Hz, 1H), 2.05 (d, J = 14.0 Hz, 1H), 2.03 – 1.93 
O O
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(m, 2H), 1.88 (ddd, J = 13.0, 9.1, 6.6 Hz, 1H), 1.59 (s, 3H), 0.98 (s, 9H), 0.20 (s, 6H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 154.18, 143.28, 139.62, 136.01, 131.11, 130.72, 119.45, 118.03, 117.35, 116.20, 114.71, 
82.40, 64.99, 45.16, 41.54, 33.18, 28.06, 25.88, 24.43, 18.38, -4.19 
 
IR (ATR):  
3559, 3071, 2929, 2886, 2858, 1603, 1491, 1472, 1290, 1253, 1177, 966, 839, 781 cm-1 
 
HRMS (ESI):  
[M + Na]+ calcd for C25H38O4Si: 453.2437; found 453.2428 
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A 2-necked 2 L round bottom flask equipped with a reflux condenser and a magnetic stir-
bar was charged 3.20 (29.8 g, 69.2 mmol, 1.0 eq). 1.0 L anhydrous PhMe was added and 
the resulting solution was sparged with nitrogen for 20 minutes before being heated to 
reflux with continuous nitrogen sparging. Grubbs II catalyst (5.87 g, 6.92 mmol, 0.1 eq) 
was dissolved in 120 mL PhMe and added to the reaction mixture in 20 mL aliquots 
every 0.5 h. Upon completion, as judged by thin-layer chromatography, the reaction was 
cooled to room temperature, transferred to a single-necked 2 L round bottom flask, and 
concentrated under reduced pressure. The resulting residue was dissolved in 90 mL DMA 
and imidazole (23.55 g, 346 mmol, 5.0 eq) and TMSCl (13.17 mL, 103.8 mmol, 1.5 eq) 
were added at room temperature. After 18 h, lithium hydroxide monohydrate (29 g, 692 
mmol, 10.0 eq) was added at room temperature and the reaction was further stirred for 
1.5 h. The reaction was poured into 5% aq. LiCl and extracted thrice with ether. The 
combined organic extracts were washed with water, brine, dried over anhydrous sodium 
sulfate, and filtered over a short pad of silica gel. Concentration of the filtrate under 
reduced pressure afforded a crude residue that was purified by flash column 
chromatography on silica gel (CH2Cl2 → 5-10% EtOAc in hexanes) to afford phenol 3.21 
as a viscous brown syrup (24.7 g, 98% yield). 
 
1H-NMR (500 MHz, CDCl3): 
δ 7.04 (d, J = 8.3 Hz, 1H), 6.63 (dd, J = 8.3, 2.8 Hz, 1H), 6.56 (d, J = 2.7 Hz, 1H), 6.22 
(s, 1H), 4.60 (s, 1H), 4.06 – 3.96 (m, 4H), 3.20 (dd, J = 10.4, 7.9 Hz, 1H), 2.51 (d, J = 
16.9 Hz, 1H), 2.24 – 2.15 (m, 2H), 2.06 (ddd, J = 12.8, 10.7, 4.5 Hz, 1H), 1.94 (s, 3H), 
1.85 (dtd, J = 11.8, 8.1, 7.6, 4.3 Hz, 1H), 1.77 (ddd, J = 12.9, 8.8, 5.5 Hz, 1H), -0.15 (s, 
9H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 153.35, 138.53, 138.31, 131.22, 127.99, 126.53, 118.20, 115.96, 112.56, 88.84, 65.52, 
64.91, 48.77, 40.19, 33.23, 27.17, 22.85, 2.01 
 
IR (ATR):  
3399, 2953, 2887, 1607, 1504, 1437, 1246, 1147, 1043, 840 cm-1 
OTMS
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HRMS (ESI):  
[M + H]+ calcd for C20H28O4Si: 361.1835; found 361.1837 
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A solution of 3.21 (17 g, 47.15 mmol, 1.0 eq) in 200 mL CHCl3-MeOH (1:1) was treated 
with rose bengal (0.48 g, 0.47 mmol, 0.01 eq) and cooled to -40°C (cryo-cool). Air was 
continuously bubbled through the solution as it was irradiated with white LEDs for 48 h. 
Upon complete consumption of starting material, as judged by TLC, the reaction was 
treated with triphenylphosphine (13.6 g, 51.86 mmol, 1.1 eq) and warmed to room 
temperature. The reaction was concentrated under reduced pressure and the resulting 
crude residue was taken up in CH2Cl2 and treated with silica gel. The mixture was 
concentrated under reduced pressure to afford a free-flowing admixture that was directly 
purified by flash column chromatography on silica gel (50% Et2O in hexanes) to afford 
quinol 3.22 as a yellow-orange solid (10.5 g, 59% yield). 
 Single crystals suitable for X-ray diffraction were obtained by slow diffusion of 
hexanes into a solution of 3.22 in EtOAc. 
1H-NMR (500 MHz, CDCl3): 
δ 6.79 (d, J = 10.0 Hz, 1H), 6.11 (dd, J = 10.1, 1.8 Hz, 1H), 6.04 (d, J = 2.6 Hz, 1H), 5.92 
(s, 1H), 4.00 – 3.89 (m, 4H), 2.74 – 2.66 (m, 2H), 2.34 (d, J = 18.5 Hz, 1H), 2.04 (s, 1H), 
1.96 (d, J = 1.4 Hz, 3H), 1.89 – 1.81 (m, 1H), 1.67 – 1.57 (m, 2H), 1.45 – 1.36 (m, 1H), 
0.01 (s, 9H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 186.99, 158.62, 150.75, 142.55, 125.40, 125.19, 125.01, 116.65, 82.66, 71.62, 65.71, 
64.68, 58.12, 38.39, 32.85, 27.23, 22.53, 1.66 
 
IR (ATR):  
3394, 2953, 2179, 2033, 1657, 1608, 1244, 1129, 839 cm-1 
 
HRMS (ESI):  
[M + Na]+ calcd for C20H28O5Si: 399.1604; found 399.1613 
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A solution of quinol 3.22 (13.44 g, 35.7 mmol, 1.0 eq) and 1,4-dioxane (46 mL, 535 
mmol, 15.0 eq) in 250 mL anhydrous THF was cooled to -78°C and treated dropwise 
with methylmagnesium chloride (3.0 M in THF, 35.7 mL, 107.1 mmol, 3.0 eq). The 
resulting suspension was stirred for 0.5 h and warmed to room temperature over 1 h. The 
reaction was quenched with sat’d aq. NH4Cl, poured into a separatory funnel, and 
extracted thrice with EtOAc. The combined organic extracts were washed with brine, 
dried over anhydrous sodium sulfate, and concentrated under reduced pressure. 
Purification by flash column chromatography on silica gel (CH2Cl2 → 30% EtOAc in 
hexanes) afforded enone 3.23 as a yellow foam (9.08 g, 65% yield). 
 Single crystals suitable for X-ray diffraction were obtained by slow diffusion of 
hexanes into a solution of 3.23 in EtOAc. 
 
1H-NMR (500 MHz, CDCl3): 
δ 5.94 – 5.91 (m, 1H), 5.70 (s, 1H), 4.00 – 3.89 (m, 4H), 2.72 (dd, J = 16.8, 5.4 Hz, 2H), 
2.57 (dd, J = 13.0, 6.4 Hz, 1H), 2.49 (dt, J = 7.1, 4.7 Hz, 1H), 2.32 – 2.21 (m, 2H), 2.11 
(s, 1H), 2.10 – 2.01 (m, 1H), 1.94 (dd, J = 13.4, 2.0 Hz, 1H), 1.91 (d, J = 1.4 Hz, 3H), 
1.84 – 1.78 (m, 1H), 1.71 (ddd, J = 13.6, 9.1, 6.8 Hz, 1H), 1.05 (d, J = 7.0 Hz, 3H), 0.00 
(s, 9H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 199.33, 158.47, 142.54, 125.70, 124.88, 116.26, 83.88, 74.86, 65.67, 64.65, 61.00, 
42.44, 38.66, 37.43, 33.93, 27.11, 22.88, 16.36, 1.66 
 
IR (ATR):  
3438, 2956, 1662, 1637, 1245, 1126, 838 cm-1 
 
HRMS (ESI): 
[M + H]+ calcd for C21H32O5Si: 393.2097; found 393.2102 
OTMS
H
O
O Me
O
OH
Me
3.23
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A flame-dried 500 mL round bottom flask equipped with a magnetic stir-bar was charged 
isopropenylmagnesium bromide (0.5 M in THF, 110 mL, 55 mmol, 4.0 eq). The Grignard 
reagent was diluted with 130 mL anhydrous CH2Cl2 and the resulting solution was treated 
at room temperature with 3.23 (5.4 g, 13.76 mmol, 1.0 eq) dissolved in 45 mL anhydrous 
CH2Cl2 over 1 min with rapid stirring. After 20 min the reaction was quenched with 
Glauber’s salt-celite (1:1) and the resulting suspension was filtered and the filtrate was 
concentrated under reduced pressure. The resulting crude residue was raidly purified by 
flash column chromatography on silica gel (CH2Cl2 → 20% → 50% EtOAc in hexanes) 
to afford the title compound as light yellow foam (1.88 g, 31% yield) followed by an 
inseparable mixture of recovered starting material and 3.38 as white foam (3.38 g). 
1H-NMR (300 MHz, CDCl3): 
δ 5.82 (t, J = 1.3 Hz, 1H), 5.56 (s, 1H), 5.08 (dd, J = 1.7, 0.8 Hz, 1H), 4.85 (t, J = 1.5 Hz, 
1H), 4.01 – 3.87 (m, 4H), 2.60 – 2.46 (m, 2H), 2.38 (ddd, J = 12.7, 6.6, 3.9 Hz, 1H), 2.21 
(d, J = 17.7 Hz, 1H), 1.90 – 1.85 (m, 1H), 1.84 (d, J = 1.3 Hz, 3H), 1.79 (dd, J = 1.5, 0.7 
Hz, 3H), 1.76 – 1.62 (m, 1H), 1.53 (d, J = 12.7 Hz, 1H), 1.47 – 1.39 (m, 2H), 1.04 (d, J = 
6.7 Hz, 3H), 0.02 (s, 9H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 150.91, 143.94, 135.59, 132.31, 127.47, 117.48, 109.66, 83.60, 73.74, 72.15, 65.73, 
64.70, 58.18, 38.79, 37.87, 33.21, 31.46, 26.85, 24.14, 19.24, 16.39, 1.93 
 
IR (ATR):  
3476, 2912, 1236, 1099, 838 cm-1 
 
HRMS (ESI): 
[M + H]+ calcd for C24H38O5Si: 457.2386, found 457.2391 
OTMS
O
O Me
Me
H
OH
OH
Me
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A portion of recovered material from the above Grignard addition (1.81 g) dissolved in 
50 mL reagent grade MeOH was cooled to -78°C and treated with cerium trichloride (1.7 
g, 6.92 mmol) and NaBH4 (0.209 g, 5.53 mmol) in sequence. After 40 min the reaction 
was warmed to room temperature and carefully quenched with sat’d aq. NH4Cl. The 
mixture was poured into a separatory funnel and extracted thrice with EtOAc. The 
combined organic extracts were washed with brine, dried over anhydrous sodium sulfate, 
and concentrated under reduced pressure. The resulting crude residue was taken up in 
hexanes and filtered over a sintered-glass funnel. The filtrate was concentrated to afford 
the desired C13 diastereomer 3.38 as a white foam. Secondary alcohol 3.47 was collected 
from the funnel as a white powder. 
Data for 3.38: 
1H-NMR (500 MHz, CDCl3): 
δ 5.84 (dt, J = 2.8, 1.4 Hz, 1H), 5.43 (s, 1H), 5.08 – 5.05 (m, 1H), 4.95 (t, J = 1.7 Hz, 
1H), 3.98 – 3.87 (m, 4H), 2.60 (d, J = 18.2 Hz, 1H), 2.45 (dd, J = 12.4, 6.6 Hz, 1H), 2.21 
(d, J = 17.8 Hz, 1H), 1.90 – 1.86 (m, 1H), 1.85 (d, J = 1.4 Hz, 3H), 1.82 (dd, J = 1.5, 0.8 
Hz, 3H), 1.79 – 1.71 (m, 1H), 1.69 – 1.61 (m, 2H), 1.61 – 1.55 (m, 2H), 1.40 – 1.18 (m, 
3H), 0.99 (d, J = 6.7 Hz, 3H), 0.05 (s, 9H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 147.37, 141.26, 135.00, 133.69, 127.98, 117.54, 115.01, 83.84, 76.39, 73.95, 65.73, 
64.72, 58.10, 38.17, 37.59, 33.35, 32.80, 27.12, 23.85, 17.74, 16.09, 1.98 
 
IR (ATR):  
3413, 2955, 1678, 1449, 1245, 1126, 1035, 990, 840, 738 cm-1 
 
HRMS (ESI):  
[M + Na]+ calcd for C24H38O5Si: 457.2386; found 457.2386 
OTMS
H
O
O Me
OH
Me
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Data for 3.47 (NMR sample prepared by dissolving 30 mg 3.47 in 0.6 mL CDCl3 + 0.1 
mL d6-DMSO): 
1H-NMR (500 MHz, CDCl3/d6-DMSO): 
δ 5.52 (d, J = 1.3 Hz, 1H), 5.27 (s, 1H), 3.85 (dt, J = 10.7, 5.3 Hz, 1H), 3.73 – 3.62 (m, 
4H), 2.28 (d, J = 17.5 Hz, 1H), 2.15 (dd, J = 12.9, 6.2 Hz, 1H), 2.03 (s, 1H), 1.89 (d, J = 
17.5 Hz, 1H), 1.64 – 1.57 (m, 1H), 1.55 (s, 3H), 1.48 (tdd, J = 14.3, 6.5, 4.3 Hz, 2H), 
1.37 (dtd, J = 10.6, 5.4, 4.5, 2.5 Hz, 4H), 0.97 (ddd, J = 12.8, 11.8, 10.5 Hz, 1H), 0.75 (d, 
J = 6.6 Hz, 3H), -0.25 (s, 9H) 
 
13C-NMR (126 MHz, CDCl3/d6-DMSO): 
δ 139.35, 134.69, 132.04, 127.40, 116.80, 83.03, 73.19, 66.80, 65.05, 64.05, 56.86, 36.95, 
36.35, 33.87, 32.73, 26.29, 23.25, 16.23, 1.26 
 
IR (ATR):  
3406, 2964, 2209, 2022, 1244, 1123, 1032, 837 cm-1
 
HRMS (ESI):  
[M + Na]+ calcd for C21H34O5Si: 417.2073; found 417.2086 
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A solution of 3.42 (1.8 g, 4.14 mmol, 1.0 eq) in 60 mL reagent grade CH2Cl2 was treated 
with NaHCO3 (0.695 g, 8.28 mmol, 2.0 eq) and m-CPBA (70% w/w, 1.12 g, 4.55 mmol, 
1.1 eq) at room temperature. After 0.5 h the reaction was poured into a separatory funnel 
charged with sat’d aq. NaHCO3. The layers were separated and the aqueous phase was 
extracted twice with CH2Cl2. The combined organic extracts were dried over anhydrous 
sodium sulfate and concentrated under reduced pressure to afford epoxide 3.42 (1.8 g, 
97% yield) as an amorphous white solid. 
 Single crystals suitable for X-ray diffraction were obtained by slow evaporation of 
a solution of 3.42 in EtOAc. 
 
1H-NMR (500 MHz, CDCl3): 
δ 5.15 (s, 1H), 5.11 (dd, J = 2.7, 1.4 Hz, 1H), 4.93 – 4.89 (m, 1H), 4.02 – 3.87 (m, 4H), 
2.87 (d, J = 1.2 Hz, 1H), 2.70 (s, 1H), 2.64 (ddd, J = 17.7, 2.8, 1.3 Hz, 1H), 2.35 (dd, J = 
12.5, 5.9 Hz, 1H), 2.31 (d, J = 17.7 Hz, 1H), 2.13 (d, J = 0.7 Hz, 1H), 2.02 – 1.93 (m, 
3H), 1.85 (s, 3H), 1.83 (s, 3H), 1.74 (d, J = 13.4 Hz, 1H), 1.71 – 1.63 (m, 3H), 1.13 (ddd, 
J = 13.4, 2.4, 1.4 Hz, 1H), 0.95 (d, J = 6.4 Hz, 3H), 0.08 (s, 9H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 148.71, 142.33, 124.14, 117.19, 110.54, 83.64, 73.83, 70.80, 66.87, 65.78, 64.67, 64.03, 
57.54, 38.38, 37.90, 35.59, 28.57, 27.32, 23.17, 18.98, 16.03, 2.51 
 
IR (ATR):  
3491, 2928, 2875, 1433, 1243, 1157, 1117, 1094, 1041, 982, 837, 728 cm-1 
 
HRMS (ESI):  
[M + Na]+ calcd for C24H38O6Si: 473.2335; found 473.2340 
OTMS
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A solution of Cp2TiCl2 (0.548 g, 2.2 mmol, 10.0 eq) in 40 mL reagent grade THF was 
sparged with argon for 20 min and treated with Mn0 powder (0.605 g, 11.0 mmol, 50.0 
eq). The resulting suspension was sonicated with argon sparging for 5 min. The resulting 
lime green suspension was treated with 3.42 (0.100 g, 0.22 mmol, 1.0 eq) in a single 
portion and vigorously stirred at room temperature with argon sparging for an additional 
10 min. The reaction was stirred at room temperature under an atmosphere of Ar for 18 h, 
diluted with EtOAc, and filtered over a short pad of celite. The celite cake was rinsed 
with CH2Cl2 and the collected filtrate was concentrated under reduced pressure. 
Purification by flash column chromatography on silica gel (CH2Cl2 → 20% → 50% 
EtOAc in hexanes) afforded stereoheptad 3.43 (0.029 g, 29% yield) as a white foam. 
 
1H-NMR (500 MHz, CDCl3): 
δ 5.97 (s, 1H), 5.19 (s, 1H), 4.96 (s, 1H), 4.43 (d, J = 5.7 Hz, 1H), 4.01 – 3.87 (m, 4H), 
2.65 – 2.59 (m, 1H), 2.46 – 2.36 (m, 2H), 2.28 (dd, J = 10.4, 8.8 Hz, 1H), 2.13 – 1.98 (m, 
7H), 1.86 (dt, J = 2.5, 1.3 Hz, 3H), 1.82 (dd, J = 1.4, 0.7 Hz, 3H), 1.79 – 1.71 (m, 2H), 
1.57 (ddd, J = 12.8, 9.3, 2.0 Hz, 1H), 1.02 (d, J = 6.7 Hz, 3H), 0.13 (s, 9H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 149.81, 134.15, 121.90, 118.45, 111.62, 83.23, 77.72, 77.24, 68.18, 65.72, 64.86, 60.33, 
53.59, 41.48, 37.86, 31.38, 30.29, 29.23, 21.33, 19.51, 18.56, 2.64 
 
IR (ATR):  
3443, 2950, 2814, 2180, 2004, 1726, 1455, 1246, 1124, 841 cm-1 
 
HRMS (ESI):  
[M + Na]+ calcd for C24H40O6Si: 475.2492; found 475.2491 
OTMS
H
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A solution of 3.23 (3.75 g, 9.55 mmol, 1.0 eq) in 90 mL MeOH was treated with 
pyrrolidine (0.784 mL, 9.55 mmol, 1.0 eq) and stirred for 5 min. 30% aq. H2O2 (1.27 mL, 
12.42 mmol, 1.3 eq) was then added to the solution at room temperature. The resulting 
solution was vigorously stirred at room temperature for 24 h in the dark. The reaction was 
poured into a separatory funnel charged with sat’d aq. Na2S2O3 and EtOAc. The layers 
were separated and the aqueous phase was extracted twice with EtOAc. The combined 
organic extracts were washed with water and brine, dried over anhydrous sodium sulfate, 
and concentrated under reduced pressure. The crude material was rapidly purified by 
flash column chromatography on silica gel (CH2Cl2 → 20% EtOAc in hexanes) to afford 
epoxy ketone 3.65 as a white foam (2.3 g, 59% yield) along with recovered 3.23 (1 g, 
27%) as a white foam. 
 
1H-NMR (500 MHz, CDCl3): 
δ 5.38 (s, 1H), 4.05 – 3.85 (m, 4H), 3.24 (s, 1H), 2.92 (dt, J = 13.2, 6.5 Hz, 1H), 2.74 (t, J 
= 13.4 Hz, 1H), 2.44 – 2.37 (m, 1H), 2.27 (d, J = 9.0 Hz, 3H), 1.97 – 1.78 (m, 4H), 1.75 
(s, 3H), 1.64 (dt, J = 10.4, 6.7 Hz, 1H), 1.05 (d, J = 7.2 Hz, 3H), 0.07 (s, 9H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 206.87, 142.79, 123.65, 116.71, 83.53, 73.36, 73.20, 66.54, 65.36, 64.19, 53.61, 41.86, 
41.60, 37.29, 32.56, 23.86, 21.30, 19.08, 2.35 
 
IR (ATR):  
3445, 2957, 2887, 2187, 1733, 1247 cm-1 
 
HRMS (ESI):  
[M + Na]+ calcd for C21H32O6Si: 431.1866, found 431.1884 
OTMS
H
O
O Me
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A solution of 3.65 (0.090 g, 0.22 mmol, 1.0 eq) in MeOH-CH2Cl2 (5:1, 12 mL) was 
cooled to -78°C and treated with excess sodium borohydride (spatula tip). The reaction 
was warmed to room temperature and monitored by thin-layer chromatography. The 
reaction was quenched with sat’d aq. NH4Cl and poured into EtOAc. The mixture was 
diluted with water and the organic layer was washed with brine, dried over anhydrous 
sodium sulfate, and concentrated under reduced pressure. The crude residue was purified 
by flash column chromatography on deactivated silica gel (1% Et3N in CH2Cl2 → 20% 
EtOAc in hexanes + 1% Et3N) to afford alcohol 3.69 as a white foam (0.085 g, 95% 
yield). 
 
1H-NMR (500 MHz, CDCl3): 
δ 5.40 (d, J = 1.9 Hz, 1H), 4.18 (dd, J = 10.4, 3.1 Hz, 1H), 4.06 – 3.98 (m, 2H), 3.98 – 
3.83 (m, 2H), 3.20 (d, J = 2.7 Hz, 1H), 2.52 – 2.41 (m, 2H), 2.38 (dd, J = 15.4, 1.2 Hz, 
1H), 2.25 (dd, J = 14.3, 1.9 Hz, 1H), 2.11 (s, 1H), 2.06 (d, J = 10.4 Hz, 1H), 2.02 – 1.92 
(m, 1H), 1.92 – 1.80 (m, 2H), 1.72 (s, 3H), 1.71 – 1.62 (m, 2H), 1.41 (dddd, J = 14.3, 4.3, 
3.0, 1.1 Hz, 1H), 0.95 (d, J = 6.6 Hz, 3H), 0.16 (s, 9H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 140.44, 125.17, 116.77, 84.99, 71.63, 66.91, 65.66, 65.56, 64.84, 64.09, 53.31, 40.59, 
33.82, 32.58, 27.21, 23.56, 21.07, 17.93, 2.76 
 
IR (ATR):  
3424, 2968, 2887, 2245, 1714, 1247, 1165, 1090, 841, 733 cm-1 
 
HRMS (ESI):  
[M + Na]+ calcd for C21H34O6Si: 433.2022; found 433.2011 
OTMS
H
O
O Me
OH
Me
O
OH
3.69
!  223
 
A 25 mL round bottom flask equipped with a magnetic stir-bar was charged 
isopropyltriphenylphosphonium bromide (0.943 g, 2.45 mmol, 5.0 eq) and 8 mL Et2O 
was added. The resulting white suspension was treated with potassium hydride (50% w/
w, 0.196 g, 2.45 mmol, 5.0 eq) at room temperature and vigorously stirred for 2 h. The 
resulting deep red suspension was treated with 3.37 (0.200 g, 0.49 mmol, 1.0 eq) and 
vigorously stirred at room temperature for 18 h. The reaction was filtered through a short 
plug of silica gel layered with celite and sand and eluted with Et2O. The collected filtrate 
was concentrated under reduced pressure and the resulting crude residue was purified by 
flash column chromatography on silica gel (CH2Cl2 → 10-20% Et2O in hexanes) to 
afford tetrasubstituted alkene 3.77 as a white solid (0.18 g, 85% yield). 
 
1H-NMR (500 MHz, CDCl3): 
δ 5.43 (d, J = 1.8 Hz, 1H), 4.04 – 3.94 (m, 2H), 3.93 – 3.86 (m, 2H), 3.85 (s, 1H), 2.42 
(dd, J = 12.9, 6.3 Hz, 1H), 2.34 (dtd, J = 12.1, 6.1, 5.5, 4.0 Hz, 1H), 2.28 (s, 1H), 2.21 
(td, J = 14.8, 14.1, 1.7 Hz, 2H), 2.08 (dd, J = 13.9, 4.4 Hz, 1H), 2.04 – 1.91 (m, 2H), 1.83 
(d, J = 1.9 Hz, 3H), 1.82 – 1.76 (m, 1H), 1.74 (d, J = 1.8 Hz, 3H), 1.73 (d, J = 1.2 Hz, 
3H), 1.63 (ddd, J = 14.3, 9.6, 7.1 Hz, 1H), 0.97 (d, J = 6.6 Hz, 3H), 0.04 (s, 9H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 139.66, 129.15, 126.70, 126.43, 117.00, 83.97, 72.81, 68.39, 65.85, 65.32, 64.25, 53.25, 
41.09, 34.67, 32.83, 30.70, 23.64, 21.49, 21.45, 19.77, 18.53, 2.39 
 
IR (ATR):  
3403, 2960, 2880, 1438, 1246, 1148, 1107, 840 cm-1 
 
HRMS (ESI):  
[M + Na]+ calcd for C24H38O5Si: 457.2386; found 457.2384 
OTMS
H
O
O Me
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Me
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A 20 mL scintillation vial equipped with a magnetic stir-bar was charged a solution of 
3.77 (0.172 g, 0.395 mmol, 1.0 eq) in 1:1 CH2Cl2-MeOH (8 mL) and dioxygen was 
bubbled through the solution for 5 min. The solution was treated with methylene blue 
(1.3 mg, 0.004 mmol, 0.01 eq) and cooled to 0°C. The reaction mixture was irradiated 
with 4 white LED corn bulbs under an atmosphere of dioxygen for 2.5 h and treated with 
triphenylphosphine (0.104 g, 0.395 mmol, 1.0 eq). After stirring at 0°C for 0.5 h the 
reaction was concentrated under reduced pressure and the resulting crude material was 
dissolved in CH2Cl2 and quickly passed through a plug of deactivated silica gel, eluting 
with Et2O. The resulting filtrate was concentrated under reduced pressure and the 
resulting crude material was purified by flash column chromatography on deactivated 
silica gel (1% Et3N + 20-50% Et2O in hexanes) to afford first C13 diastereomer 3.78 
(0.003 g, 5% yield) as a colorless film followed by the desired epoxide 3.37 as a white 
foam (0.161 g, 90% yield). 
Data for 3.37: 
1H-NMR (500 MHz, CDCl3): 
δ 5.24 (d, J = 1.9 Hz, 1H), 5.10 (s, 1H), 5.04 (s, 1H), 4.06 – 3.96 (m, 2H), 3.93 – 3.85 (m, 
2H), 3.30 (d, J = 1.5 Hz, 1H), 2.75 (dd, J = 12.5, 7.3 Hz, 1H), 2.66 (s, 1H), 2.34 (d, J = 
13.5 Hz, 1H), 2.24 – 2.14 (m, 2H), 2.10 (ddd, J = 13.0, 6.6, 2.4 Hz, 1H), 1.86 (s, 3H), 
1.85 – 1.79 (m, 1H), 1.74 (s, 3H), 1.62 (ddd, J = 14.3, 9.8, 5.9 Hz, 1H), 1.50 (t, J = 13.4 
Hz, 1H), 1.40 (dd, J = 14.0, 11.9 Hz, 1H), 1.03 (d, J = 6.6 Hz, 3H), 0.07 (s, 9H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 146.34, 139.93, 125.93, 117.35, 113.42, 83.34, 74.03, 71.43, 70.90, 69.71, 65.42, 64.35, 
52.11, 39.81, 36.83, 34.68, 32.39, 24.60, 21.77, 18.43, 18.25, 2.38 
 
IR (ATR): 3521, 2956, 2926, 2853, 2027, 1246, 1126, 840 cm-1 
 
HRMS (ESI): 
[M + Na]+ calcd for C24H38O6Si: 473.2335; found 473.2334 
OTMS
H
O
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Data for 3.38: 
 
1H-NMR (500 MHz, CDCl3): 
δ 5.40 (d, J = 1.9 Hz, 1H), 5.17 (d, J = 0.8 Hz, 1H), 4.92 (t, J = 1.5 Hz, 1H), 4.03 (dddd, J 
= 9.5, 6.8, 5.7, 3.6 Hz, 2H), 3.99 – 3.87 (m, 2H), 3.09 (d, J = 1.4 Hz, 1H), 2.54 (ddt, J = 
13.3, 11.0, 6.6 Hz, 1H), 2.49 – 2.44 (m, 3H), 2.40 (s, 1H), 2.24 (dd, J = 14.4, 2.0 Hz, 1H), 
2.10 (s, 1H), 2.04 – 1.94 (m, 1H), 1.91 (dd, J = 13.3, 2.1 Hz, 1H), 1.88 – 1.81 (overlap m, 
1H), 1.87 (s, 3H), 1.72 (s, 3H), 0.97 (d, J = 6.6 Hz, 3H), 0.18 (s, 9H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 148.08, 140.57, 125.13, 116.76, 110.75, 85.04, 72.91, 71.19, 70.12, 65.70, 65.16, 64.10, 
53.28, 40.45, 37.88, 32.59, 29.43, 23.57, 21.06, 18.73, 17.94, 2.75 
 
IR (ATR):  
3508, 2951, 2881, 1435, 1316, 1247, 1152, 955, 842 cm-1 
 
HRMS (ESI):  
[M + Na]+ calcd for C24H38O6Si: 473.2335; found 473.2336 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3.10 — X-ray crystallographic data 
Computing details 
Data collection: APEX3 (Bruker, 2016); cell refinement: SAINT V8.38A (Bruker, 2016); data 
reduction: SAINT V8.38A (Bruker, 2016); program(s) used to solve structure: ShelXT (Sheldrick, 
2015); program(s) used to refine structure: SHELXL (Sheldrick, 2015); molecular graphics: Olex2 
(Dolomanov et al., 2009); software used to prepare material for publication: Olex2 (Dolomanov 
et al., 2009). 
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(lvn3392_0m) 
Crystal data 
C20H28O5Si F(000) = 808
Mr = 376.51 Dx = 1.264 Mg m-3
Monoclinic, P21/c Cu Ka radiation, l = 1.54178 Å
a = 8.6336 (2) Å Cell parameters from 9564 reflections
b = 12.1702 (3) Å q = 4.3–66.4°
c = 19.0194 (5) Å m = 1.27 mm-1
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Data collection 
 
Refinement 
 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes)  are estimated 
using the full covariance matrix. The cell esds are taken into account individually in the 
estimation of esds in distances, angles and torsion angles; correlations between esds in cell 
parameters are only  used when they are defined by crystal symmetry.  An approximate (isotropic) 
b = 98.067 (1)° T = 100 K
V = 1978.64 (8)  Å3 Prism, colorless
Z = 4 0.18 × 0.17 × 0.11 mm
Bruker Proteum-R  
diffractometer
3243 independent reflections
Radiation source: rotating anode 3102 reflections with I > 2s(I)
Montel Rint = 0.041
f and w scans qmax = 66.7°, qmin = 4.3°
Absorption correction: multi-scan  
SADABS2016/2 (Bruker,2016/2) was used for 
absorption correction. wR2(int) was 0.1646 before 
and 0.0623 after correction. The Ratio of minimum to 
maximum transmission is 0.8915. The l/2 correction 
factor is Not present.
h = -10®10
Tmin = 0.671, Tmax = 0.753 k = -14®14
46826 measured reflections l = -22®20
Refinement on F2 Primary atom site location: dual
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2s(F2)] = 0.033 H-atom parameters constrained
wR(F2) = 0.077 w = 1/[s2(Fo2) + 2.102P]   
where P = (Fo2 + 2Fc2)/3
S = 1.13 (D/s)max < 0.001
3243 reflections Dρmax = 0.27 e Å-3
240 parameters Dρmin = -0.28 e Å-3
0 restraints
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treatment of cell esds is used for estimating esds involving l.s. planes. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq
Si01 0.24874 (5) 0.44516 (4) 0.64443 (2) 0.01647 (12)
O1 0.31799 (13) 0.32846 (9) 0.61857 (6) 0.0154 (3)
O4 0.60687 (14) 0.39899 (10) 0.69444 (6) 0.0189 (3)
O2 0.34998 (13) -0.00689 (10) 0.58964 (6) 0.0181 (3)
H2 0.2735 -0.0502 0.5833 0.027*
O5 0.71117 (14) 0.22854 (10) 0.68159 (6) 0.0204 (3)
O3 -0.09222 (15) 0.14921 (11) 0.40694 (7) 0.0270 (3)
C8 0.12715 (19) 0.13453 (14) 0.65134 (9) 0.0164 (3)
H8 0.0236 0.1192 0.6600 0.020*
C9 0.15025 (19) 0.13262 (13) 0.57635 (9) 0.0151 (3)
C10 0.30667 (19) 0.09663 (14) 0.55497 (9) 0.0154 (3)
C7 0.23008 (19) 0.15459 (14) 0.70947 (9) 0.0157 (3)
C5 0.43291 (19) 0.24833 (14) 0.64333 (8) 0.0145 (3)
C6 0.39651 (19) 0.19107 (14) 0.71027 (8) 0.0156 (3)
H6A 0.4651 0.1258 0.7188 0.019*
H6B 0.4238 0.2416 0.7509 0.019*
C14 0.0241 (2) 0.14803 (14) 0.52674 (9) 0.0184 (4)
H14 -0.0717 0.1686 0.5422 0.022*
C1 0.59491 (19) 0.30474 (14) 0.65052 (9) 0.0168 (4)
C4 0.44756 (19) 0.17260 (14) 0.58048 (8) 0.0156 (3)
H4 0.5371 0.1224 0.5968 0.019*
C13 0.0268 (2) 0.13486 (15) 0.45092 (9) 0.0207 (4)
C3 0.5068 (2) 0.25115 (15) 0.52654 (9) 0.0207 (4)
H3A 0.4186 0.2903 0.4983 0.025*
H3B 0.5662 0.2107 0.4939 0.025*
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C2 0.6144 (2) 0.33244 (15) 0.57356 (9) 0.0201 (4)
H2A 0.7246 0.3230 0.5659 0.024*
H2B 0.5825 0.4093 0.5622 0.024*
C20 0.1819 (2) 0.14116 (15) 0.78225 (9) 0.0198 (4)
H20A 0.1868 0.2125 0.8063 0.030*
H20B 0.2529 0.0895 0.8101 0.030*
H20C 0.0748 0.1127 0.7776 0.030*
C15 0.6974 (2) 0.37003 (15) 0.76146 (9) 0.0209 (4)
H15A 0.6295 0.3423 0.7954 0.025*
H15B 0.7585 0.4335 0.7828 0.025*
C11 0.2993 (2) 0.07918 (14) 0.47619 (9) 0.0188 (4)
H11 0.3908 0.0530 0.4592 0.023*
C12 0.1734 (2) 0.09792 (15) 0.42878 (9) 0.0218 (4)
H12 0.1790 0.0871 0.3797 0.026*
C16 0.8028 (2) 0.28114 (15) 0.74064 (9) 0.0214 (4)
H16A 0.8998 0.3126 0.7267 0.026*
H16B 0.8311 0.2287 0.7802 0.026*
C19 0.2520 (2) 0.45301 (15) 0.74255 (9) 0.0209 (4)
H19A 0.1868 0.3942 0.7580 0.031*
H19B 0.2112 0.5244 0.7551 0.031*
H19C 0.3598 0.4445 0.7662 0.031*
C17 0.3500 (2) 0.56541 (15) 0.61105 (10) 0.0254 (4)
H17A 0.4566 0.5705 0.6366 0.038*
H17B 0.2925 0.6327 0.6188 0.038*
H17C 0.3544 0.5564 0.5602 0.038*
C18 0.0430 (2) 0.44381 (17) 0.60004 (10) 0.0270 (4)
H18A 0.0411 0.4312 0.5490 0.041*
H18B -0.0063 0.5146 0.6075 0.041*
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Atomic displacement parameters (Å2) 
H18C -0.0144 0.3849 0.6202 0.041*
U11 U22 U33 U12 U13 U23
Si01 0.0198 (2) 0.0162 (2) 0.0138 (2) 0.00224 
(19)
0.00413 
(17)
0.00165 
(18)
O1 0.0162 (6) 0.0166 (6) 0.0132 (5) 0.0019 (5) 0.0010 (4) 0.0008 (5)
O4 0.0222 (6) 0.0157 (6) 0.0170 (6) -0.0006 (5) -0.0031 (5) -0.0030 (5)
O2 0.0167 (6) 0.0163 (6) 0.0210 (6) -0.0002 (5) 0.0018 (5) 0.0006 (5)
O5 0.0165 (6) 0.0194 (6) 0.0234 (6) 0.0023 (5) -0.0038 (5) -0.0046 (5)
O3 0.0252 (7) 0.0302 (7) 0.0224 (7) -0.0059 (6) -0.0079 (5) 0.0051 (6)
C8 0.0143 (8) 0.0155 (8) 0.0201 (9) 0.0010 (7) 0.0054 (7) 0.0005 (7)
C9 0.0154 (8) 0.0124 (8) 0.0175 (8) -0.0026 (7) 0.0024 (6) -0.0016 (7)
C10 0.0154 (8) 0.0159 (8) 0.0147 (8) -0.0002 (7) 0.0015 (6) -0.0013 (7)
C7 0.0190 (8) 0.0127 (8) 0.0162 (8) 0.0023 (7) 0.0051 (7) 0.0012 (6)
C5 0.0144 (8) 0.0151 (8) 0.0135 (8) 0.0008 (7) 0.0006 (6) -0.0006 (7)
C6 0.0167 (8) 0.0168 (8) 0.0129 (8) 0.0006 (7) 0.0004 (6) -0.0006 (7)
C14 0.0163 (8) 0.0177 (9) 0.0208 (9) -0.0014 (7) 0.0012 (7) -0.0007 (7)
C1 0.0168 (8) 0.0154 (8) 0.0175 (8) 0.0003 (7) 0.0001 (6) -0.0027 (7)
C4 0.0140 (8) 0.0183 (9) 0.0148 (8) -0.0008 (7) 0.0030 (6) -0.0030 (7)
C13 0.0227 (9) 0.0174 (9) 0.0204 (9) -0.0066 (7) -0.0024 (7) 0.0017 (7)
C3 0.0225 (9) 0.0250 (9) 0.0156 (8) -0.0059 (8) 0.0063 (7) -0.0038 (7)
C2 0.0185 (8) 0.0229 (9) 0.0195 (9) -0.0045 (7) 0.0043 (7) -0.0013 (7)
C20 0.0224 (9) 0.0213 (9) 0.0167 (8) 0.0027 (7) 0.0063 (7) 0.0024 (7)
C15 0.0229 (9) 0.0208 (9) 0.0168 (9) -0.0025 (7) -0.0046 (7) -0.0011 (7)
C11 0.0212 (9) 0.0180 (9) 0.0178 (8) -0.0035 (7) 0.0051 (7) -0.0041 (7)
C12 0.0282 (10) 0.0240 (10) 0.0131 (8) -0.0067 (8) 0.0023 (7) -0.0028 (7)
C16 0.0204 (9) 0.0234 (9) 0.0186 (9) -0.0022 (7) -0.0032 (7) -0.0009 (7)
C19 0.0263 (9) 0.0188 (9) 0.0183 (9) 0.0020 (7) 0.0059 (7) -0.0011 (7)
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Geometric parameters (Å, º) 
C17 0.0338 (10) 0.0210 (9) 0.0226 (9) 0.0030 (8) 0.0081 (8) 0.0037 (8)
C18 0.0261 (10) 0.0317 (11) 0.0231 (9) 0.0085 (8) 0.0030 (8) 0.0025 (8)
Si01—O1 1.6428 (12) C4—H4 1.0000
Si01—C19 1.8650 (17) C4—C3 1.541 (2)
Si01—C17 1.8616 (19) C13—C12 1.460 (3)
Si01—C18 1.857 (2) C3—H3A 0.9900
O1—C5 1.423 (2) C3—H3B 0.9900
O4—C1 1.414 (2) C3—C2 1.552 (2)
O4—C15 1.442 (2) C2—H2A 0.9900
O2—H2 0.8400 C2—H2B 0.9900
O2—C10 1.447 (2) C20—H20A 0.9800
O5—C1 1.432 (2) C20—H20B 0.9800
O5—C16 1.431 (2) C20—H20C 0.9800
O3—C13 1.243 (2) C15—H15A 0.9900
C8—H8 0.9500 C15—H15B 0.9900
C8—C9 1.468 (2) C15—C16 1.502 (3)
C8—C7 1.340 (2) C11—H11 0.9500
C9—C10 1.528 (2) C11—C12 1.331 (3)
C9—C14 1.350 (2) C12—H12 0.9500
C10—C4 1.551 (2) C16—H16A 0.9900
C10—C11 1.506 (2) C16—H16B 0.9900
C7—C6 1.502 (2) C19—H19A 0.9800
C7—C20 1.509 (2) C19—H19B 0.9800
C5—C6 1.522 (2) C19—H19C 0.9800
C5—C1 1.547 (2) C17—H17A 0.9800
C5—C4 1.529 (2) C17—H17B 0.9800
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C6—H6A 0.9900 C17—H17C 0.9800
C6—H6B 0.9900 C18—H18A 0.9800
C14—H14 0.9500 C18—H18B 0.9800
C14—C13 1.454 (2) C18—H18C 0.9800
C1—C2 1.534 (2)
O1—Si01—C19 112.88 (7) C4—C3—H3A 111.0
O1—Si01—C17 111.68 (7) C4—C3—H3B 111.0
O1—Si01—C18 102.79 (8) C4—C3—C2 103.85 (13)
C17—Si01—C19 111.05 (9) H3A—C3—H3B 109.0
C18—Si01—C19 109.56 (8) C2—C3—H3A 111.0
C18—Si01—C17 108.49 (9) C2—C3—H3B 111.0
C5—O1—Si01 139.40 (10) C1—C2—C3 105.84 (14)
C1—O4—C15 108.02 (13) C1—C2—H2A 110.6
C10—O2—H2 109.5 C1—C2—H2B 110.6
C16—O5—C1 108.22 (13) C3—C2—H2A 110.6
C9—C8—H8 115.1 C3—C2—H2B 110.6
C7—C8—H8 115.1 H2A—C2—H2B 108.7
C7—C8—C9 129.77 (15) C7—C20—H20A 109.5
C8—C9—C10 120.59 (14) C7—C20—H20B 109.5
C14—C9—C8 118.08 (15) C7—C20—H20C 109.5
C14—C9—C10 120.66 (15) H20A—C20—H20B 109.5
O2—C10—C9 108.05 (13) H20A—C20—H20C 109.5
O2—C10—C4 103.61 (13) H20B—C20—H20C 109.5
O2—C10—C11 107.63 (13) O4—C15—H15A 111.3
C9—C10—C4 115.44 (14) O4—C15—H15B 111.3
C11—C10—C9 112.95 (14) O4—C15—C16 102.49 (13)
C11—C10—C4 108.49 (13) H15A—C15—H15B 109.2
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C8—C7—C6 125.80 (15) C16—C15—H15A 111.3
C8—C7—C20 120.06 (15) C16—C15—H15B 111.3
C6—C7—C20 114.14 (14) C10—C11—H11 117.8
O1—C5—C6 111.98 (13) C12—C11—C10 124.48 (16)
O1—C5—C1 107.75 (13) C12—C11—H11 117.8
O1—C5—C4 106.53 (13) C13—C12—H12 119.5
C6—C5—C1 114.80 (13) C11—C12—C13 121.08 (16)
C6—C5—C4 115.30 (14) C11—C12—H12 119.5
C4—C5—C1 99.42 (13) O5—C16—C15 103.90 (13)
C7—C6—C5 115.87 (13) O5—C16—H16A 111.0
C7—C6—H6A 108.3 O5—C16—H16B 111.0
C7—C6—H6B 108.3 C15—C16—H16A 111.0
C5—C6—H6A 108.3 C15—C16—H16B 111.0
C5—C6—H6B 108.3 H16A—C16—H16B 109.0
H6A—C6—H6B 107.4 Si01—C19—H19A 109.5
C9—C14—H14 118.2 Si01—C19—H19B 109.5
C9—C14—C13 123.66 (16) Si01—C19—H19C 109.5
C13—C14—H14 118.2 H19A—C19—H19B 109.5
O4—C1—O5 107.02 (13) H19A—C19—H19C 109.5
O4—C1—C5 113.73 (13) H19B—C19—H19C 109.5
O4—C1—C2 112.12 (14) Si01—C17—H17A 109.5
O5—C1—C5 108.78 (13) Si01—C17—H17B 109.5
O5—C1—C2 111.83 (14) Si01—C17—H17C 109.5
C2—C1—C5 103.41 (13) H17A—C17—H17B 109.5
C10—C4—H4 105.7 H17A—C17—H17C 109.5
C5—C4—C10 117.19 (13) H17B—C17—H17C 109.5
C5—C4—H4 105.7 Si01—C18—H18A 109.5
C5—C4—C3 102.60 (13) Si01—C18—H18B 109.5
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C3—C4—C10 118.72 (14) Si01—C18—H18C 109.5
C3—C4—H4 105.7 H18A—C18—H18B 109.5
O3—C13—C14 121.69 (17) H18A—C18—H18C 109.5
O3—C13—C12 121.16 (16) H18B—C18—H18C 109.5
C14—C13—C12 117.06 (15)
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(lvn3399_0m_a) 
Crystal data
Data collection
 
Refinement
C21H32O5Si Z = 2
Mr = 392.55 F(000) = 424
Triclinic, P¯1 Dx = 1.251 Mg m-3
a = 7.6717 (3) Å Cu Ka radiation, l = 1.54178 Å
b = 8.9908 (4) Å Cell parameters from 9941 reflections
c = 15.7910 (7) Å q = 2.9–66.6°
a = 100.155 (2)° m = 1.23 mm-1
b = 101.862 (2)° T = 100 K
g = 94.273 (2)° Prism, colorless
V = 1042.27 (8)  Å3 0.17 × 0.10 × 0.08 mm
Bruker APEX-II CCD  
diffractometer
3659 independent reflections
Radiation source: rotating anode 3356 reflections with I > 2s(I)
Montel Rint = 0.041
f and w scans qmax = 66.8°, qmin = 2.9°
Absorption correction: multi-scan  
SADABS2016/2 (Bruker,2016/2) was used for 
absorption correction. wR2(int) was 0.0868 before 
and 0.0522 after correction. The Ratio of minimum 
to maximum transmission is 0.8818. The l/2 
correction factor is Not present.
h = -9®9
Tmin = 0.664, Tmax = 0.753 k = -10®10
29791 measured reflections l = -18®18
Refinement on F2 0 restraints
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Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes)  are estimated 
using the full covariance matrix. The cell esds are taken into account individually in the 
estimation of esds in distances, angles and torsion angles; correlations between esds in cell 
parameters are only  used when they are defined by crystal symmetry.  An approximate (isotropic)  
treatment of cell esds is used for estimating esds involving l.s. planes. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2s(F2)] = 0.033 H-atom parameters constrained
wR(F2) = 0.082 w = 1/[s2(Fo2) + (0.0335P)2 + 0.7035P]   
where P = (Fo2 + 2Fc2)/3
S = 1.04 (D/s)max < 0.001
3659 reflections Dρmax = 0.36 e Å-3
250 parameters Dρmin = -0.29 e Å-3
x y z Uiso*/Ueq
Si1 0.58656 (5) 0.29721 (4) 0.12926 (2) 0.01459 (11)
O1 0.68414 (13) 0.40096 (11) 0.22623 (6) 0.0132 (2)
O2 0.95820 (13) 0.79931 (11) 0.39629 (6) 0.0152 (2)
H2 1.0241 0.7756 0.3608 0.023*
O4 1.11343 (14) 0.32560 (12) 0.35400 (7) 0.0199 (2)
O5 0.91325 (14) 0.17576 (11) 0.23757 (7) 0.0193 (2)
O3 0.26854 (13) 0.81737 (12) 0.31683 (7) 0.0190 (2)
C9 0.69709 (18) 0.72607 (14) 0.28021 (9) 0.0115 (3)
C2 0.86122 (18) 0.44005 (15) 0.27963 (9) 0.0118 (3)
C13 0.41619 (18) 0.76935 (15) 0.32986 (9) 0.0139 (3)
C8 0.79717 (18) 0.72883 (15) 0.21023 (9) 0.0124 (3)
H8 0.7673 0.8018 0.1744 0.015*
C14 0.53066 (19) 0.76946 (15) 0.26669 (9) 0.0140 (3)
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H14 0.4856 0.8019 0.2131 0.017*
C10 0.79397 (18) 0.69766 (15) 0.37008 (9) 0.0116 (3)
C7 0.92402 (18) 0.64371 (15) 0.18954 (9) 0.0124 (3)
C3 0.84474 (18) 0.53285 (15) 0.36847 (9) 0.0124 (3)
H3 0.9682 0.5457 0.4068 0.015*
C1 0.92672 (19) 0.29569 (16) 0.31041 (9) 0.0160 (3)
C12 0.48597 (19) 0.70256 (16) 0.40931 (9) 0.0156 (3)
H12A 0.4606 0.5903 0.3937 0.019*
H12B 0.4239 0.7394 0.4567 0.019*
C11 0.68923 (19) 0.74780 (16) 0.44279 (9) 0.0136 (3)
H11 0.7312 0.6946 0.4925 0.016*
C4 0.7360 (2) 0.41568 (16) 0.40411 (10) 0.0184 (3)
H4A 0.6064 0.4084 0.3774 0.022*
H4B 0.7545 0.4434 0.4691 0.022*
C15 0.7227 (2) 0.91939 (17) 0.47975 (10) 0.0189 (3)
H15A 0.8503 0.9482 0.5069 0.028*
H15B 0.6518 0.9453 0.5242 0.028*
H15C 0.6873 0.9744 0.4318 0.028*
C5 0.8121 (2) 0.26453 (17) 0.37619 (10) 0.0200 (3)
H5A 0.8864 0.2343 0.4281 0.024*
H5B 0.7136 0.1822 0.3479 0.024*
C6 0.98719 (18) 0.51344 (15) 0.23176 (9) 0.0131 (3)
H6A 1.1025 0.5506 0.2744 0.016*
H6B 1.0114 0.4336 0.1852 0.016*
C16 1.01742 (19) 0.67461 (17) 0.11828 (9) 0.0161 (3)
H16A 0.9675 0.7584 0.0929 0.024*
H16B 0.9996 0.5831 0.0720 0.024*
H16C 1.1459 0.7024 0.1436 0.024*
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Atomic displacement parameters (Å2) 
C19 0.3940 (2) 0.40114 (19) 0.09094 (11) 0.0268 (4)
H19A 0.3137 0.4044 0.1320 0.040*
H19B 0.3283 0.3487 0.0320 0.040*
H19C 0.4384 0.5051 0.0887 0.040*
C21 0.5004 (2) 0.10278 (17) 0.13929 (11) 0.0239 (3)
H21A 0.6002 0.0410 0.1479 0.036*
H21B 0.4120 0.0550 0.0853 0.036*
H21C 0.4438 0.1103 0.1899 0.036*
C18 1.2104 (2) 0.2229 (2) 0.30793 (11) 0.0271 (4)
H18A 1.3042 0.1855 0.3494 0.033*
H18B 1.2668 0.2714 0.2671 0.033*
C20 0.7299 (2) 0.27901 (18) 0.04655 (10) 0.0233 (3)
H20A 0.7755 0.3805 0.0407 0.035*
H20B 0.6585 0.2236 -0.0106 0.035*
H20C 0.8308 0.2233 0.0662 0.035*
C17 1.0679 (2) 0.09690 (19) 0.25851 (13) 0.0296 (4)
H17A 1.0997 0.0436 0.2043 0.035*
H17B 1.0476 0.0223 0.2957 0.035*
U11 U22 U33 U12 U13 U23
Si1 0.0151 (2) 0.0126 (2) 0.0141 (2) 0.00022 
(14)
0.00074 
(15)
0.00094 
(14)
O1 0.0116 (5) 0.0136 (5) 0.0131 (5) 0.0012 (4) 0.0008 (4) 0.0018 (4)
O2 0.0115 (5) 0.0171 (5) 0.0151 (5) -0.0027 (4) 0.0040 (4) -0.0010 (4)
O4 0.0161 (5) 0.0203 (5) 0.0219 (5) 0.0067 (4) -0.0002 (4) 0.0042 (4)
O5 0.0216 (6) 0.0140 (5) 0.0215 (5) 0.0074 (4) 0.0019 (4) 0.0022 (4)
O3 0.0116 (5) 0.0226 (5) 0.0217 (5) 0.0039 (4) 0.0035 (4) 0.0005 (4)
C9 0.0139 (7) 0.0074 (6) 0.0124 (6) 0.0000 (5) 0.0028 (5) 0.0008 (5)
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Geometric parameters (Å, º) 
C2 0.0096 (6) 0.0126 (7) 0.0126 (6) 0.0017 (5) 0.0008 (5) 0.0026 (5)
C13 0.0112 (7) 0.0107 (6) 0.0171 (7) -0.0018 (5) 0.0022 (5) -0.0021 (5)
C8 0.0134 (7) 0.0122 (6) 0.0119 (6) 0.0008 (5) 0.0019 (5) 0.0042 (5)
C14 0.0153 (7) 0.0130 (7) 0.0135 (6) 0.0020 (5) 0.0025 (5) 0.0030 (5)
C10 0.0105 (7) 0.0122 (6) 0.0114 (6) 0.0001 (5) 0.0018 (5) 0.0019 (5)
C7 0.0119 (7) 0.0138 (7) 0.0102 (6) -0.0015 (5) 0.0016 (5) 0.0009 (5)
C3 0.0134 (7) 0.0135 (7) 0.0106 (6) 0.0031 (5) 0.0014 (5) 0.0037 (5)
C1 0.0159 (7) 0.0130 (7) 0.0179 (7) 0.0032 (6) 0.0005 (6) 0.0030 (5)
C12 0.0138 (7) 0.0164 (7) 0.0179 (7) 0.0004 (6) 0.0073 (6) 0.0030 (6)
C11 0.0143 (7) 0.0154 (7) 0.0116 (6) 0.0016 (5) 0.0043 (5) 0.0020 (5)
C4 0.0238 (8) 0.0170 (7) 0.0171 (7) 0.0028 (6) 0.0078 (6) 0.0069 (6)
C15 0.0187 (8) 0.0188 (7) 0.0175 (7) 0.0008 (6) 0.0059 (6) -0.0025 (6)
C5 0.0238 (8) 0.0165 (7) 0.0218 (8) 0.0040 (6) 0.0048 (6) 0.0091 (6)
C6 0.0120 (7) 0.0133 (7) 0.0144 (7) 0.0028 (5) 0.0040 (5) 0.0022 (5)
C16 0.0160 (7) 0.0193 (7) 0.0140 (7) 0.0014 (6) 0.0051 (6) 0.0036 (6)
C19 0.0232 (8) 0.0264 (8) 0.0253 (8) 0.0035 (7) -0.0048 (7) 0.0028 (7)
C21 0.0232 (8) 0.0165 (7) 0.0293 (8) -0.0022 (6) 0.0050 (7) 0.0000 (6)
C18 0.0234 (8) 0.0311 (9) 0.0271 (8) 0.0120 (7) 0.0055 (7) 0.0031 (7)
C20 0.0290 (9) 0.0223 (8) 0.0160 (7) -0.0015 (7) 0.0044 (6) -0.0003 (6)
C17 0.0234 (9) 0.0194 (8) 0.0443 (10) 0.0098 (7) 0.0052 (7) 0.0015 (7)
Si1—O1 1.6420 (10) C12—H12B 0.9900
Si1—C19 1.8601 (16) C12—C11 1.5386 (19)
Si1—C21 1.8672 (16) C11—H11 1.0000
Si1—C20 1.8662 (16) C11—C15 1.533 (2)
O1—C2 1.4261 (16) C4—H4A 0.9900
O2—H2 0.8400 C4—H4B 0.9900
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O2—C10 1.4403 (16) C4—C5 1.547 (2)
O4—C1 1.4387 (18) C15—H15A 0.9800
O4—C18 1.4223 (19) C15—H15B 0.9800
O5—C1 1.4119 (17) C15—H15C 0.9800
O5—C17 1.4377 (19) C5—H5A 0.9900
O3—C13 1.2330 (18) C5—H5B 0.9900
C9—C8 1.4719 (19) C6—H6A 0.9900
C9—C14 1.349 (2) C6—H6B 0.9900
C9—C10 1.5343 (18) C16—H16A 0.9800
C2—C3 1.5349 (18) C16—H16B 0.9800
C2—C1 1.5468 (18) C16—H16C 0.9800
C2—C6 1.5238 (19) C19—H19A 0.9800
C13—C14 1.458 (2) C19—H19B 0.9800
C13—C12 1.503 (2) C19—H19C 0.9800
C8—H8 0.9500 C21—H21A 0.9800
C8—C7 1.339 (2) C21—H21B 0.9800
C14—H14 0.9500 C21—H21C 0.9800
C10—C3 1.5572 (18) C18—H18A 0.9900
C10—C11 1.5549 (18) C18—H18B 0.9900
C7—C6 1.5094 (19) C18—C17 1.497 (2)
C7—C16 1.5063 (19) C20—H20A 0.9800
C3—H3 1.0000 C20—H20B 0.9800
C3—C4 1.5469 (19) C20—H20C 0.9800
C1—C5 1.540 (2) C17—H17A 0.9900
C12—H12A 0.9900 C17—H17B 0.9900
O1—Si1—C19 103.35 (6) C3—C4—H4A 111.0
O1—Si1—C21 111.22 (6) C3—C4—H4B 111.0
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O1—Si1—C20 114.75 (6) C3—C4—C5 103.73 (11)
C19—Si1—C21 109.26 (8) H4A—C4—H4B 109.0
C19—Si1—C20 109.23 (8) C5—C4—H4A 111.0
C20—Si1—C21 108.81 (7) C5—C4—H4B 111.0
C2—O1—Si1 137.67 (9) C11—C15—H15A 109.5
C10—O2—H2 109.5 C11—C15—H15B 109.5
C18—O4—C1 108.68 (11) C11—C15—H15C 109.5
C1—O5—C17 105.96 (11) H15A—C15—H15B 109.5
C8—C9—C10 119.20 (12) H15A—C15—H15C 109.5
C14—C9—C8 118.06 (12) H15B—C15—H15C 109.5
C14—C9—C10 122.09 (12) C1—C5—C4 105.69 (11)
O1—C2—C3 107.07 (11) C1—C5—H5A 110.6
O1—C2—C1 108.35 (11) C1—C5—H5B 110.6
O1—C2—C6 111.81 (11) C4—C5—H5A 110.6
C3—C2—C1 99.48 (10) C4—C5—H5B 110.6
C6—C2—C3 116.30 (11) H5A—C5—H5B 108.7
C6—C2—C1 112.91 (11) C2—C6—H6A 108.1
O3—C13—C14 121.39 (13) C2—C6—H6B 108.1
O3—C13—C12 122.45 (13) C7—C6—C2 116.85 (11)
C14—C13—C12 116.13 (12) C7—C6—H6A 108.1
C9—C8—H8 115.2 C7—C6—H6B 108.1
C7—C8—C9 129.59 (13) H6A—C6—H6B 107.3
C7—C8—H8 115.2 C7—C16—H16A 109.5
C9—C14—C13 123.58 (13) C7—C16—H16B 109.5
C9—C14—H14 118.2 C7—C16—H16C 109.5
C13—C14—H14 118.2 H16A—C16—H16B 109.5
O2—C10—C9 106.38 (10) H16A—C16—H16C 109.5
O2—C10—C3 107.54 (10) H16B—C16—H16C 109.5
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O2—C10—C11 104.47 (10) Si1—C19—H19A 109.5
C9—C10—C3 114.24 (11) Si1—C19—H19B 109.5
C9—C10—C11 111.51 (11) Si1—C19—H19C 109.5
C11—C10—C3 111.97 (11) H19A—C19—H19B 109.5
C8—C7—C6 125.88 (12) H19A—C19—H19C 109.5
C8—C7—C16 120.06 (12) H19B—C19—H19C 109.5
C16—C7—C6 114.06 (12) Si1—C21—H21A 109.5
C2—C3—C10 117.46 (11) Si1—C21—H21B 109.5
C2—C3—H3 104.8 Si1—C21—H21C 109.5
C2—C3—C4 101.93 (11) H21A—C21—H21B 109.5
C10—C3—H3 104.8 H21A—C21—H21C 109.5
C4—C3—C10 121.35 (11) H21B—C21—H21C 109.5
C4—C3—H3 104.8 O4—C18—H18A 111.2
O4—C1—C2 109.80 (11) O4—C18—H18B 111.2
O4—C1—C5 110.31 (12) O4—C18—C17 102.81 (13)
O5—C1—O4 106.41 (11) H18A—C18—H18B 109.1
O5—C1—C2 110.85 (11) C17—C18—H18A 111.2
O5—C1—C5 115.02 (12) C17—C18—H18B 111.2
C5—C1—C2 104.45 (11) Si1—C20—H20A 109.5
C13—C12—H12A 109.5 Si1—C20—H20B 109.5
C13—C12—H12B 109.5 Si1—C20—H20C 109.5
C13—C12—C11 110.59 (11) H20A—C20—H20B 109.5
H12A—C12—H12B 108.1 H20A—C20—H20C 109.5
C11—C12—H12A 109.5 H20B—C20—H20C 109.5
C11—C12—H12B 109.5 O5—C17—C18 102.78 (12)
C10—C11—H11 107.8 O5—C17—H17A 111.2
C12—C11—C10 111.99 (11) O5—C17—H17B 111.2
C12—C11—H11 107.8 C18—C17—H17A 111.2
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C15—C11—C10 112.72 (11) C18—C17—H17B 111.2
C15—C11—C12 108.51 (11) H17A—C17—H17B 109.1
C15—C11—H11 107.8
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(lvn3451_0ma) 
Crystal data 
 
Data collection 
 
Refinement 
C24H38O6Si F(000) = 976
Mr = 450.63 Dx = 1.261 Mg m-3
Monoclinic, P2/c Cu Ka radiation, l = 1.54178 Å
a = 20.2977 (7) Å Cell parameters from 9769 reflections
b = 8.6669 (3) Å q = 5.6–66.6°
c = 14.1436 (5) Å m = 1.18 mm-1
b = 107.441 (2)° T = 100 K
V = 2373.73 (15)  Å3 Prism, colourless
Z = 4 0.36 × 0.15 × 0.06 mm
Bruker Proteum-R  
diffractometer
4227 independent reflections
Radiation source: rotating anode 4022 reflections with I > 2s(I)
Montel Rint = 0.064
f and w scans qmax = 67.9°, qmin = 2.3°
Absorption correction: multi-scan  
SADABS2016/2 (Bruker,2016/2) was used for 
absorption correction. wR2(int) was 0.1516 before 
and 0.0637 after correction. The Ratio of minimum to 
maximum transmission is 0.7865. The l/2 correction 
factor is Not present.
h = -22®23
Tmin = 0.592, Tmax = 0.753 k = -10®10
73254 measured reflections l = -16®16
Refinement on F2 0 restraints
Least-squares matrix: full Hydrogen site location: mixed
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Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes)  are estimated 
using the full covariance matrix. The cell esds are taken into account individually in the 
estimation of esds in distances, angles and torsion angles; correlations between esds in cell 
parameters are only  used when they are defined by crystal symmetry.  An approximate (isotropic)  
treatment of cell esds is used for estimating esds involving l.s. planes. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
R[F2 > 2s(F2)] = 0.050 H atoms treated by a mixture of independent and 
constrained refinement
wR(F2) = 0.132 w = 1/[s2(Fo2) + (0.0686P)2 + 2.7486P]   
where P = (Fo2 + 2Fc2)/3
S = 1.03 (D/s)max = 0.001
4227 reflections Dρmax = 0.99 e Å-3
290 parameters Dρmin = -0.44 e Å-3
x y z Uiso*/Ueq
Si01 0.88345 (3) 0.83426 (6) 0.38476 (4) 0.01889 (16)
O002 0.82651 (6) 0.69412 (15) 0.35958 (9) 0.0172 (3)
O003 0.90662 (7) 0.55014 (17) 0.25456 (10) 0.0219 (3)
O004 0.81534 (7) 0.39462 (16) 0.17694 (10) 0.0228 (3)
O005 0.62262 (7) 0.54716 (18) 0.23524 (11) 0.0262 (3)
O006 0.72449 (7) 0.74963 (17) 0.45947 (10) 0.0244 (3)
O1 0.65507 (7) 0.64556 (19) 0.58386 (11) 0.0283 (3)
H1 0.6967 0.6446 0.5850 0.042*
C008 0.84550 (9) 0.4813 (2) 0.26524 (14) 0.0186 (4)
C009 0.74452 (9) 0.4859 (2) 0.31163 (13) 0.0166 (4)
H009 0.7290 0.4090 0.2567 0.020*
C00A 0.68304 (9) 0.7208 (2) 0.35639 (14) 0.0186 (4)
C00B 0.79157 (9) 0.5984 (2) 0.27776 (13) 0.0164 (4)
C00C 0.79692 (10) 0.3995 (2) 0.39596 (14) 0.0199 (4)
H00A 0.7788 0.2974 0.4074 0.024*
H00B 0.8084 0.4597 0.4583 0.024*
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C00D 0.75628 (10) 0.6955 (2) 0.18741 (14) 0.0204 (4)
H00C 0.7919 0.7358 0.1590 0.025*
H00D 0.7251 0.6282 0.1369 0.025*
C00E 0.91183 (10) 0.5104 (3) 0.15890 (14) 0.0228 (4)
H00E 0.9604 0.4924 0.1612 0.027*
H00F 0.8919 0.5921 0.1097 0.027*
C00F 0.67721 (9) 0.5495 (2) 0.32729 (14) 0.0186 (4)
C00G 0.71488 (10) 0.8300 (2) 0.20781 (15) 0.0233 (4)
C00H 0.65187 (10) 0.7754 (2) 0.43314 (15) 0.0234 (4)
H00H 0.6377 0.8863 0.4274 0.028*
C00I 0.68698 (10) 0.8386 (2) 0.28126 (15) 0.0214 (4)
H00I 0.6662 0.9350 0.2870 0.026*
C00J 0.86074 (10) 0.3819 (2) 0.35871 (15) 0.0221 (4)
H00G 0.9029 0.4185 0.4094 0.027*
H00J 0.8673 0.2727 0.3432 0.027*
C00K 0.86980 (10) 0.3631 (2) 0.13512 (15) 0.0217 (4)
H00K 0.8518 0.3458 0.0627 0.026*
H00L 0.8973 0.2723 0.1668 0.026*
C00L 0.85052 (10) 0.9787 (2) 0.45652 (16) 0.0258 (4)
H00M 0.8072 1.0228 0.4143 0.039*
H00N 0.8847 1.0609 0.4792 0.039*
H00O 0.8422 0.9284 0.5140 0.039*
C00M 0.61210 (10) 0.6721 (2) 0.48443 (15) 0.0238 (4)
C00N 0.96692 (10) 0.7554 (3) 0.46413 (16) 0.0258 (4)
H00P 0.9595 0.7025 0.5214 0.039*
H00Q 0.9999 0.8399 0.4872 0.039*
H00R 0.9853 0.6821 0.4257 0.039*
C00O 0.65509 (11) 0.4480 (2) 0.40246 (16) 0.0250 (4)
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Atomic displacement parameters (Å2) 
H00S 0.6950 0.4398 0.4642 0.030*
C00P 0.89904 (12) 0.9321 (3) 0.27625 (17) 0.0316 (5)
H00T 0.9138 0.8558 0.2356 0.047*
H00U 0.9352 1.0102 0.2995 0.047*
H00V 0.8563 0.9818 0.2365 0.047*
C00Q 0.70423 (13) 0.9595 (3) 0.13363 (17) 0.0343 (5)
H00W 0.7492 0.9963 0.1305 0.051*
H00X 0.6796 1.0443 0.1540 0.051*
H00Y 0.6770 0.9220 0.0682 0.051*
C00R 0.59435 (11) 0.5184 (3) 0.42950 (17) 0.0288 (5)
H00Z 0.5786 0.4447 0.4716 0.035*
H 0.5557 0.5347 0.3681 0.035*
C00S 0.49708 (12) 0.7980 (3) 0.39127 (19) 0.0386 (6)
H00 0.5218 0.8495 0.3503 0.058*
HA 0.4623 0.8682 0.4024 0.058*
HB 0.4744 0.7050 0.3573 0.058*
C00T 0.54693 (11) 0.7546 (3) 0.48826 (17) 0.0289 (5)
C00U 0.63525 (12) 0.2849 (2) 0.36182 (18) 0.0318 (5)
H0AA 0.5915 0.2887 0.3083 0.048*
HC 0.6302 0.2180 0.4151 0.048*
HD 0.6715 0.2436 0.3361 0.048*
C00V 0.53630 (12) 0.7888 (3) 0.5740 (2) 0.0377 (6)
H1AA 0.4958 0.8428 0.5749 0.045*
HE 0.5692 0.7592 0.6346 0.045*
H005 0.6326 (16) 0.495 (4) 0.190 (2) 0.057*
U11 U22 U33 U12 U13 U23
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Si01 0.0154 (3) 0.0182 (3) 0.0224 (3) -0.00198 
(19)
0.0046 
(2)
0.00120 
(19)
O002 0.0143 (6) 0.0181 (6) 0.0171 (6) -0.0019 (5) 0.0018 
(5)
-0.0013 
(5)
O003 0.0147 (6) 0.0295 (8) 0.0220 (7) -0.0033 (5) 0.0064 
(5)
-0.0036 
(6)
O004 0.0163 (7) 0.0289 (8) 0.0245 (7) -0.0037 (6) 0.0078 
(5)
-0.0093 
(6)
O005 0.0144 (7) 0.0318 (8) 0.0278 (7) 0.0015 (6) -0.0007 
(6)
-0.0098 
(6)
O006 0.0213 (7) 0.0293 (8) 0.0225 (7) -0.0048 (6) 0.0063 
(6)
-0.0043 
(6)
O1 0.0212 (7) 0.0393 (9) 0.0250 (7) -0.0020 (6) 0.0077 
(6)
0.0008 (6)
C008 0.0134 (9) 0.0218 (10) 0.0201 (9) -0.0024 (7) 0.0044 
(7)
-0.0037 
(7)
C009 0.0150 (9) 0.0163 (9) 0.0179 (9) -0.0002 (7) 0.0040 
(7)
-0.0012 
(7)
C00A 0.0116 (8) 0.0202 (9) 0.0205 (9) -0.0006 (7) -0.0004 
(7)
-0.0024 
(8)
C00B 0.0134 (9) 0.0190 (9) 0.0152 (8) -0.0001 (7) 0.0016 
(7)
-0.0022 
(7)
C00C 0.0180 (9) 0.0186 (9) 0.0223 (9) 0.0018 (7) 0.0047 
(8)
0.0024 (7)
C00D 0.0172 (9) 0.0255 (10) 0.0175 (9) 0.0011 (8) 0.0035 
(7)
0.0026 (8)
C00E 0.0182 (9) 0.0320 (11) 0.0186 (9) -0.0012 (8) 0.0063 
(7)
-0.0008 
(8)
C00F 0.0136 (9) 0.0202 (9) 0.0202 (9) -0.0013 (7) 0.0022 
(7)
-0.0031 
(7)
C00G 0.0183 (10) 0.0227 (10) 0.0251 (10) 0.0029 (8) 0.0010 
(8)
0.0054 (8)
C00H 0.0200 (10) 0.0258 (10) 0.0235 (10) -0.0026 (8) 0.0050 
(8)
-0.0044 
(8)
C00I 0.0169 (9) 0.0194 (10) 0.0267 (10) 0.0026 (7) 0.0045 
(8)
0.0014 (8)
C00J 0.0187 (10) 0.0213 (10) 0.0258 (10) 0.0051 (8) 0.0058 
(8)
0.0033 (8)
C00K 0.0179 (9) 0.0268 (10) 0.0222 (9) 0.0024 (8) 0.0086 
(8)
-0.0017 
(8)
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Geometric parameters (Å, º) 
C00L 0.0209 (10) 0.0188 (10) 0.0366 (11) -0.0037 (8) 0.0067 
(9)
-0.0015 
(8)
C00
M
0.0206 (10) 0.0273 (11) 0.0230 (10) -0.0024 (8) 0.0059 
(8)
-0.0016 
(8)
C00N 0.0161 (10) 0.0301 (11) 0.0301 (11) -0.0017 (8) 0.0053 
(8)
-0.0041 
(9)
C00O 0.0259 (11) 0.0208 (10) 0.0333 (11) -0.0032 (8) 0.0166 
(9)
-0.0030 
(8)
C00P 0.0337 (12) 0.0290 (11) 0.0326 (11) -0.0080 (9) 0.0109 
(10)
0.0025 (9)
C00Q 0.0355 (12) 0.0356 (13) 0.0331 (12) 0.0115 
(10)
0.0122 
(10)
0.0152 
(10)
C00R 0.0255 (11) 0.0263 (11) 0.0397 (12) -0.0068 (9) 0.0172 
(9)
-0.0064 
(9)
C00S 0.0200 (11) 0.0393 (13) 0.0485 (14) 0.0033 
(10)
-0.0017 
(10)
-0.0090 
(11)
C00T 0.0166 (10) 0.0326 (12) 0.0368 (12) -0.0020 (9) 0.0067 
(9)
-0.0100 
(9)
C00U 0.0335 (12) 0.0215 (11) 0.0470 (13) -0.0059 (9) 0.0221 
(10)
-0.0059 
(10)
C00V 0.0275 (12) 0.0439 (14) 0.0491 (14) -0.0047 
(10)
0.0228 
(11)
-0.0130 
(12)
Si01—O002 1.6405 (13) C00H—H00H 1.0000
Si01—C00L 1.857 (2) C00H—C00M 1.527 (3)
Si01—C00N 1.859 (2) C00I—H00I 0.9500
Si01—C00P 1.862 (2) C00J—H00G 0.9900
O002—C00B 1.428 (2) C00J—H00J 0.9900
O003—C008 1.425 (2) C00K—H00K 0.9900
O003—C00E 1.430 (2) C00K—H00L 0.9900
O004—C008 1.428 (2) C00L—H00M 0.9800
O004—C00K 1.428 (2) C00L—H00N 0.9800
O005—C00F 1.435 (2) C00L—H00O 0.9800
O005—H005 0.86 (3) C00M—C00R 1.529 (3)
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O006—C00A 1.470 (2) C00M—C00T 1.519 (3)
O006—C00H 1.425 (2) C00N—H00P 0.9800
O1—H1 0.8400 C00N—H00Q 0.9800
O1—C00M 1.434 (2) C00N—H00R 0.9800
C008—C00B 1.542 (3) C00O—H00S 1.0000
C008—C00J 1.530 (3) C00O—C00R 1.523 (3)
C009—H009 1.0000 C00O—C00U 1.534 (3)
C009—C00B 1.538 (3) C00P—H00T 0.9800
C009—C00C 1.534 (2) C00P—H00U 0.9800
C009—C00F 1.549 (2) C00P—H00V 0.9800
C00A—C00F 1.535 (3) C00Q—H00W 0.9800
C00A—C00H 1.488 (3) C00Q—H00X 0.9800
C00A—C00I 1.493 (3) C00Q—H00Y 0.9800
C00B—C00D 1.518 (3) C00R—H00Z 0.9900
C00C—H00A 0.9900 C00R—H 0.9900
C00C—H00B 0.9900 C00S—H00 0.9800
C00C—C00J 1.545 (3) C00S—HA 0.9800
C00D—H00C 0.9900 C00S—HB 0.9800
C00D—H00D 0.9900 C00S—C00T 1.488 (3)
C00D—C00G 1.515 (3) C00T—C00V 1.328 (3)
C00E—H00E 0.9900 C00U—H0AA 0.9800
C00E—H00F 0.9900 C00U—HC 0.9800
C00E—C00K 1.517 (3) C00U—HD 0.9800
C00F—C00O 1.547 (3) C00V—H1AA 0.9500
C00G—C00I 1.326 (3) C00V—HE 0.9500
C00G—C00Q 1.507 (3)
O002—Si01—C00L 105.78 (8) C008—C00J—C00C 105.43 (15)
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O002—Si01—C00N 108.30 (8) C008—C00J—H00G 110.7
O002—Si01—C00P 116.17 (9) C008—C00J—H00J 110.7
C00L—Si01—C00N 109.26 (10) C00C—C00J—H00G 110.7
C00L—Si01—C00P 108.75 (10) C00C—C00J—H00J 110.7
C00N—Si01—C00P 108.42 (10) H00G—C00J—H00J 108.8
C00B—O002—Si01 138.82 (12) O004—C00K—C00E 101.58 (15)
C008—O003—C00E 108.25 (14) O004—C00K—H00K 111.5
C00K—O004—C008 106.30 (14) O004—C00K—H00L 111.5
C00F—O005—H005 113 (2) C00E—C00K—H00K 111.5
C00H—O006—C00A 61.83 (12) C00E—C00K—H00L 111.5
C00M—O1—H1 109.5 H00K—C00K—H00L 109.3
O003—C008—O004 106.62 (14) Si01—C00L—H00M 109.5
O003—C008—C00B 114.00 (15) Si01—C00L—H00N 109.5
O003—C008—C00J 111.74 (15) Si01—C00L—H00O 109.5
O004—C008—C00B 108.28 (14) H00M—C00L—H00N 109.5
O004—C008—C00J 112.48 (16) H00M—C00L—H00O 109.5
C00J—C008—C00B 103.79 (15) H00N—C00L—H00O 109.5
C00B—C009—H009 105.2 O1—C00M—C00H 107.88 (16)
C00B—C009—C00F 118.39 (15) O1—C00M—C00R 109.89 (17)
C00C—C009—H009 105.2 O1—C00M—C00T 108.71 (17)
C00C—C009—C00B 101.61 (14) C00H—C00M—C00R 110.30 (17)
C00C—C009—C00F 119.86 (15) C00T—C00M—C00H 109.33 (17)
C00F—C009—H009 105.2 C00T—C00M—C00R 110.67 (17)
O006—C00A—C00F 113.93 (15) Si01—C00N—H00P 109.5
O006—C00A—C00H 57.61 (12) Si01—C00N—H00Q 109.5
O006—C00A—C00I 116.91 (16) Si01—C00N—H00R 109.5
C00H—C00A—C00F 119.17 (17) H00P—C00N—H00Q 109.5
C00H—C00A—C00I 115.27 (17) H00P—C00N—H00R 109.5
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C00I—C00A—C00F 119.13 (16) H00Q—C00N—H00R 109.5
O002—C00B—C008 106.17 (14) C00F—C00O—H00S 108.3
O002—C00B—C009 108.64 (14) C00R—C00O—C00F 111.62 (17)
O002—C00B—C00D 110.80 (15) C00R—C00O—H00S 108.3
C009—C00B—C008 98.43 (15) C00R—C00O—C00U 108.78 (17)
C00D—C00B—C008 116.13 (15) C00U—C00O—C00F 111.36 (17)
C00D—C00B—C009 115.65 (15) C00U—C00O—H00S 108.3
C009—C00C—H00A 111.0 Si01—C00P—H00T 109.5
C009—C00C—H00B 111.0 Si01—C00P—H00U 109.5
C009—C00C—C00J 103.87 (15) Si01—C00P—H00V 109.5
H00A—C00C—H00B 109.0 H00T—C00P—H00U 109.5
C00J—C00C—H00A 111.0 H00T—C00P—H00V 109.5
C00J—C00C—H00B 111.0 H00U—C00P—H00V 109.5
C00B—C00D—H00C 108.6 C00G—C00Q—H00W 109.5
C00B—C00D—H00D 108.6 C00G—C00Q—H00X 109.5
H00C—C00D—H00D 107.6 C00G—C00Q—H00Y 109.5
C00G—C00D—C00B 114.50 (16) H00W—C00Q—H00X 109.5
C00G—C00D—H00C 108.6 H00W—C00Q—H00Y 109.5
C00G—C00D—H00D 108.6 H00X—C00Q—H00Y 109.5
O003—C00E—H00E 111.3 C00M—C00R—H00Z 109.0
O003—C00E—H00F 111.3 C00M—C00R—H 109.0
O003—C00E—C00K 102.48 (15) C00O—C00R—C00M 113.01 (17)
H00E—C00E—H00F 109.2 C00O—C00R—H00Z 109.0
C00K—C00E—H00E 111.3 C00O—C00R—H 109.0
C00K—C00E—H00F 111.3 H00Z—C00R—H 107.8
O005—C00F—C009 109.85 (15) H00—C00S—HA 109.5
O005—C00F—C00A 103.50 (15) H00—C00S—HB 109.5
O005—C00F—C00O 108.14 (16) HA—C00S—HB 109.5
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C00A—C00F—C009 112.43 (15) C00T—C00S—H00 109.5
C00A—C00F—C00O 112.36 (16) C00T—C00S—HA 109.5
C00O—C00F—C009 110.26 (15) C00T—C00S—HB 109.5
C00I—C00G—C00D 125.75 (18) C00S—C00T—C00M 116.43 (19)
C00I—C00G—C00Q 119.85 (19) C00V—C00T—C00M 121.3 (2)
C00Q—C00G—C00D 114.37 (18) C00V—C00T—C00S 122.3 (2)
O006—C00H—C00A 60.55 (12) C00O—C00U—H0AA 109.5
O006—C00H—H00H 114.9 C00O—C00U—HC 109.5
O006—C00H—C00M 115.90 (17) C00O—C00U—HD 109.5
C00A—C00H—H00H 114.9 H0AA—C00U—HC 109.5
C00A—C00H—C00M 124.14 (18) H0AA—C00U—HD 109.5
C00M—C00H—H00H 114.9 HC—C00U—HD 109.5
C00A—C00I—H00I 114.9 C00T—C00V—H1AA 120.0
C00G—C00I—C00A 130.21 (18) C00T—C00V—HE 120.0
C00G—C00I—H00I 114.9 H1AA—C00V—HE 120.0
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 (a) Margrey, K. A.; Nicewicz, D. A. Acc. Chem. Res. 2016, 49, 1997-2006. (b) Hu, X.; 64
Zhang, G.; Bu, F.; Lei, A. ACS Catal. 2017, 7, 1432-1437.
 (a) Cardillo, G.; Orena, M.; Porzi, G.; Sandri, S. J. Chem. Soc., Chem. Commun. 1981, 65
465-466. (b) Minakata, S.; Sasaki, I.; Ide, T. Angew. Chem. Int. Ed. 2010, 49, 1309-1311.
 This assumption was difficult to substantiate since the conversion of 3.42 → 3.43 is 66
actually contra-thermodynamic. Radical inversion may be preferable upon homolytic 
cleavage of the epoxide based on noncovalent steric interactions but the excess of 
Cp2TiCl2 required and the existence of two free alcohols in the starting material also 
implicates the large steric bulk of multiple titanocene alkoxides in enforcing the 
stereochemical preference of the tertiary alkyl radical formed.
 For recent examples, see: (a) Carreño, M. C.; Merino, E.; Ribagorda, M.; Somoza, A.; 67
Urbano, A. Chem. Eur. J. 2006, 13, 1064-1077. (b) Wenderski, T. A.; Huang, S.; Pettus, T. 
R. R. J. Org. Chem. 2009, 74, 4104-4109. (c) Hammill, J. T.; Contreras-Garcia, J.; 
Virshup, A. M.; Beratan, D. N.; Yang, W.; Wipf, P. Tetrahedron, 2010, 31, 5852-5862.
 (a) Marigo, M.; Franze´n, J.; Poulsen, T. B.; Zhuang, W.; Jørgensen, K. A. J. Am. 68
Chem. Soc. 2005, 127, 6964-6965. (b) Lee, S.; MacMillan, D. W. C. Tetrahedron 2006, 
62, 11413-11424. (c) Wang, X.; List, B. Angew. Chem. Int. Ed. 2008, 47, 1119-1122. (d) 
Wang, X.; Reisinger, C. R.; List, B. J. Am. Chem. Soc. 2008, 130, 6070-6071.
 This observation intimates the possibility of a hydrogen-bonding assembly required for 69
directed epoxidation. It is also possible iminium ion formation may be promoted by this 
polar, protic solvent.
 Urea·H2O2 was also found to be a competent oxidant.70
 A slight drop in yield (59% + 27% rsm) was obtained when the reaction was executed 71
on 3.75 g scale.
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 Isolated as an inseparable 1.3:1 mixture of 3.71 and an unidentifiable side-product; the 72
relative stereochemistry of 3.71 was deduced from 2D-NMR studies of this mixture, 
which could not be further purified.
 Hughes, D. L. Org. React. 1992, 42, 335-656.73
 (a) Matsubara, S.; Takai, K.; Nozaki, H. Tetrahedron Lett. 1983, 24, 3741-3744. (b) 74
Matsubara, S.; Okazoe, T.; Oshima, K.; Takai, K.; Nozaki, H. Bull. Chem. Soc. Jpn. 
1985, 58, 844-849.
 Crandall, J. K.; Apparu, M. Org. React. 1983, 29, 345-443.75
 Tetrasubtituted alkenes react ~25x faster than trisubstituted alkenes and >150x faster 76
than cyclic trisubstituted alkenes, see: Frimer, A. A. Singlet O2. Volume I: Physical-
Chemical Aspects. United States: CRC Press Inc., Boca Raton, FL, 1985.
 The synthesis of tetrasubtituted alkenes derived from ketones and nonstabilized Wittig 77
reagents is historically challenging, see: Flynn, A. B.; Ogilvie, W. W. Chem. Rev. 2007, 
107, 4698-4745.
 NaH is kinetically slower at generating the ylide from i-PrPPh3Br and performance was 78
inferior to KH, see: Taber, D. F.; Nelson, C. G. J. Org. Chem. 2006, 71, 8973-8974 and 
references therein.
 The synthesis of 3.77 and 3.78 indirectly confirms correct stereoinduction of the 79
hydroxyl-directed α-epoxidation (3.23 → 3.65) since neither C13 diastereomer 
corresponds to 3.42 in which the epoxide was proven to be β by X-ray diffraction.
 Carreño, M. C.; González-Lopez, M.; Urbano, A. Angew. Chem. Int. Ed. 2006, 45, 80
2737-2741.
 Otera, J.; Dan-oh, N.; Nozaki, H. Tetrahedron 1992, 48, 1449-1456.81
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CHAPTER FOUR 
Progress towards a short total synthesis of (±)-resiniferatoxin 
4.1 — The unexpected emergence of native functionality as a bad actor in a critical 
radical epoxide opening 
 The development of a concise pathway to vinyl epoxide 4.2 from epoxy ketal 4.1 
(10 steps, 10% yield) outlined in the previous chapter set the stage for the paramount 
titanocene-mediated radical epoxide opening en route to the complete stereopolyad of 
(±)-RTX and all DDOs, in general (Figure 4.1). 
 Accordingly, treatment of 4.2 with Cp2TiCl (4.0 equiv) and excess 1,4-
cyclohexadiene (40.0 equiv) in THF at room temperature gave full consumption of 
starting material after 1 h (Scheme 4.1). Unexpectedly, under the reaction conditions 
diene 4.4 was the sole isolated product. This result was surprising since epoxide 
deoxygenation had not been observed to any appreciable extent in all prior systems.  1
 It was surmised that the C9 tertiary alcohol had undergone exchange with an 
equivalent of titanocene reagent with concomitant loss of HCl and the resulting pendant 
Ti(III)-alkoxide 4.5 was well situated to undergo rapid intramolecular reduction/
O
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4.1
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O Me
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Figure 4.1. Summary and ultimate goal
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elimination to give exclusively 4.4. Control experiments confirmed no reaction occurred 
when 1.0 equivalent of titanocene was used but the formation of 4.4 was observed upon 
addition of a second equivalent, intimating the free C9 hydroxyl group in 4.2 is a bad 
actor in this particular system. 
 Logically, capping the C9 hydroxyl group of 4.2 should halt its aberrant behavior. 
However, as shown in Scheme 4.2, the exact placement of the proposed protection step in 
an already highly choreographed sequence was not obvious. Persilylation of 4.2 would be 
challenging based on sterics but if persilyl epoxide 4.6 could be prepared titanocene 
epoxide opening could afford 4.7 with good sterecontrol if the resulting tertiary radical 
4.8 underwent HAT from β-face of the molecule following a chair-flip; undesired non-
covalent interactions between the titanium(IV)-alkoxide at C-14 and the bulky -OTMS 
group of C9 provides rationalization for this radical inversion process.  2
 Alternatively, the previously prepared Wittig adduct could be first protected to 
afford 4.9 and then undergo radical epoxide opening (Scheme 4.2). However, the 
hypothetical allylic alcohol 4.10 lacks the concave structure of 4.6 and the bimolecular 
approach of singlet-oxygen to the tetrasubstituted alkene is cannot be readily deduced a 
priori. 
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 A short sequence of experiments were conducted to gauge the reactivity of the C9 
tert-alcohol (Scheme 4.3). Persilylation of 4.2 was initially attempted but the reaction 
stalled after a single silylation with crude NMR indicating the C13 alcohol displayed 
greater reactivity (not shown in Scheme). Thus, Wittig adduct 4.11 was exposed to an 
excess of TMSCl and imidazole in MeCN and following aqueous work-up the resulting 
intermediate C9-silylated tricycle was immediately exposed to singlet oxygen under 
conditions established in the previous chapter. The epoxy alcohol 4.13 was isolated as a 
single diastereomer in 47% yield over two steps. 
 Unfortunately, upon treatment of 4.13 with Cp2TiCl, no reaction was observed 
with TLC showing only starting material. More forceful conditions (excess Cp2TiCl, 
elevated temperatures) led again to only starting material and after prolonged reaction 
times slow decomposition of the reaction to intractable mixtures was observed. It is 
proposed that the steric environment of the α-face of 4.13, upon protection of the C9 
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Scheme 4.2. Persilylation-radical epoxide opening strategy & a questionable late-stage 1O2-ene reaction
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alcohol, completely suppresss the ability of titanocene to bind to the adjacent epoxide 
functionality. 
4.2 — An intramolecular HAT approach 
 Given the circumstances surrounding the undesired reactivity or lack thereof in 
4.2 and 4.13, respectively, some meditation led to the following proposal. It was recalled 
from prior experiments (see Chapter 3) that the axial alcohol 4.15 afforded, presumably, 
4.17 after treatment with titanocene (Scheme 4.4), although the reaction was not 
reproducible and an analytically pure sample could not be procured. 
 Notwithstanding, it was reasoned that, conceptually, two possible hydrogen atom 
transfer pathways may be operative within this context; a bimolecular process between 
axial radical 4.16 with 1,4-cyclohexadiene (not shown) or an intramolecular 1,5-HAT of 
4.16 from the C8 axial radical to the proximal H-atom of the axial C13 hydroxyl group. 
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 Given that the tertiary alcohol of C9 is exposed in this analogous system but 
elimination was not the sole isolated product of the reaction, it is interesting to consider 
H-atom source upon homolytic cleavage of the epoxide 4.15. An intramolecular 
mechanism would be faster and tolerant of the congested β-face of the molecule. It 
should also be noted that alternative to 1,5-HAT, an intramolecular reduction of the 
resulting tertiary alcohol by a C13 Ti(III)-alkoxide is also possible. The resulting titanium 
carbanion can be quenched to afford the same product. Given the anti nature of the 
alkyltitanium species to the vicinal C14 Ti(IV)-alkoxide, syn elimination cannot occur. 
Whereas in the intramolecular reduction as shown in Scheme 4.1, the resulting 
alkyltitanium is poised to undergo syn elimination to afford diene 4.5. 
 With this proposal in hand, it was thought that the C4 TMS-protected tertiary 
alcohol was not only blocking the top-face approach of any external H-atom source but if 
unmasked could itself serve as the desired H-atom source. As shown in Scheme 4.5, 
following cleavage of the C4 tertiary alcohol (TBAF), exposure to Cp2TiCl could lead to 
radical 4.19 which might undergo stereospecific HAT from the C4 alcohol. Alternatively, 
intramolecular reduction from the corresponding C4 Ti(III)-alkoxide followed by 
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Scheme 4.4. Possibility of 1,5-HAT in the radical epoxide opening of 4.15
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quenching of the resulting alkyltitanium, as discussed above, cannot be ruled out as an 
operative pathway, and leads to the same desired product. 
4.3 — A recalcitrant deprotection and a new difficult situation 
 Cleavage of the trimethylsilyl ether at C4 was initially anticipated to be a trivial 
task. Unfortunately, but not surprising by now given the constant difficulties encountered 
at every step of this synthesis, this deprotection proved remarkably defiant. 
 Initial screening was restricted to basic conditions given the propensity of 4.2 to 
undergo rapid decomposition under even mildly acidic conditions. Treatment of 4.2 with 
excess TBAF at room temperature for 24 h led to no detectable consumption of starting 
material by TLC. Heating the reaction to 60°C overnight led to smooth consumption of 
4.2 but 1H-NMR analysis of the isolated major product of the reaction led to the 
discovery that epoxide ring opening via intramolecular addition of the C4 tertiary alcohol 
had occurred concomitantly with cleavage of the TMS group to afford bridged furan 4.21 
(Scheme 4.6).    
 While not completely unexpected—a near identical furan formation was observed 
by Li and co-workers during their studies —it is perplexing that the TMS group was so 3
resistent to removal in the presence of fluoride. Use of TBAF·(t-BuOH)4 as a non-basic 
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source of nucleophilic fluoride  failed to cleave the TMS group at room temperature and 4
at slightly elevated temperatures (45°C, 3 d) only ~50% starting material consumption 
was observed. Increasing the reaction temperature to 70°C led, as expected, to the 
exclusive formation of furan 4.21 in 91% yield. 
 The frustrating complexity of the situation at this juncture was three-fold: (1) 4.2 
is unstable to acidic conditions (including chromatography on silica gel) which precluded 
exploration of reagents such as HF or buffered TBAF with HOAc; (2) TBAF indeed 
cleaves the TMS group but the elevated temperatures required to effect efficient rates 
likewise provides the driving force for intramolecular epoxide opening to furan 4.21; and 
(3) dwindling material supply forced bringing forward 4.2 in small scales which cost 
multiple days to advance required intermediates to survey deprotection conditions. 
 Furthermore, since the C4 tertiary alcohol is well positioned to add to the C8 
position of a variety of intermediates, changing the current choreography would possibly 
lead to the same results, i.e. undesired furan formation, in a variety of contexts (Scheme 
4.7). Given the investment in optimizing the current ten-step preparation of 4.2, the high 
yield of the tandem deprotection-furan formation, and the fact that the syn-triol of the 
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DDO C-ring system was now available, the remainder of my studies focused on probing 
the reactivity of 4.21.  
4.4 — Attempts at a reductive furan ring-opening 
 It was conceived that given the apparent strain in the bridged furan system it 
might be possible to induce cleavage via triggering a reductive event at the vicinal C14 
position. As shown in Scheme 4.8, it was proposed that oxidation of 4.21 to the ketone 
4.28 followed by proton-coupled electron transfer to generate a ketyl-radical at C14 
might induce a radical fragmentation of the furan ring. Assuming success in this 
fragmentation, enol tautomerization should give ketone 4.30 with correct configuration at 
C8. A second reduction event should proceed with axial selectivity to afford the desired 
stereoheptad 4.20. 
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 An alternative pathway would proceed via a mechanism akin to the well-
established α-hydroxy ketone deoxygenation employing reagents capable of SET.  A 5
pitfall of this is that 4.28 is already a α-hydroxy ketone and deoxygenation at C13 would 
be one possible undesired reaction pathway. 
 Oxidation of 4.21 with IBX in EtOAc at 70°C was followed by a screen of known 
reduction manifolds to trigger ring-opening of the bridged furan. Unfortunately, under all 
conditions screened, neither ketone 4.30 nor tetraol 4.20 could not be identified from any 
of the reaction mixtures (Table 4.1). 
 Excluding the abberrant C13-deoxygenation pathway for the sake of discussion, 
poor orbital overlap in intermediate anion 4.31 provides a rationale for its failure to to 
undergo E1cB-type elimination (Scheme 4.9). Following SET to 4.28 a second SET event 
is likely to occur to give the axial anion 4.31 based on minimization of non-covalent 
steric interactions. The anti-relationship of this anion to the LUMO of C8 prevents the 
requisite n → σ* transition needed to open the furan bridge. Since the required equatorial 
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anion 4.32 is unlikely to form, this reductive pathway appears unfeasible in solving the 
problem at hand based on this analysis in addition to empirical experiments. 
4.5 — Final experiments 
 During the penultimate exploratory phase of this thesis project a Meinwald-type 
rearrangement  was explored and a mechanstic rationale is provided in Scheme 4.10. 6
Exposure of 4.2 to an appropriate Brønsted or Lewis acid was thought to induce opening 
of the epoxide moiety to afford the allylic cation 4.34 which could then undergo 
stereospecific 1,2-hydride migration to afford the desired ketone 4.35 from the previous 
reductive furan-opening studies. Unfortunately, treatment of 4.2 with a variety of reagents 
known to effect such a transformation (BF3·OEt2,  LiClO4 in Et2O,  CuBF4,  etc.) failed 7 8 9
to deliver 4.35. Crude 1H-NMR analysis and attempted isolation of major products 
routinely showed intractable mixtures containing aldehydic peaks implying alternative 
fragmentation pathways were dominant. Given the complexity of 4.2 and the potential 
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lability of the two free tertiary alcohols in addition to the sensitive epoxide functionality, 
these results were not surprising. 
 With the remainder of material in possession a series of experiments were 
conducted in order to probe the reactivity of the C-ring triol and the A-ring. As shown in 
Scheme 4.11, treatment of 4.2 with TBAF·(t-BuOH)4 (5 equiv.) in THF at 75°C afforded 
triol 4.21 in 91% yield. Treatment of 4.21 with the activated mixed anhydride derived 
from phenyl acetic acid and Yamaguchi’s reagent, previously employed by both Wender 
and Inoue,  gave poor conversion (≤ 50% as judged by TLC) and following 10
chromatography gave material with unidentifiable impurities. Interestingly, it was 
discovered that simply treating a CH2Cl2 solution of 4.21 with EDC·HCl, phenyl acetic 
acid, and DMAP at room temperature rapidly (< 30 min) afforded phenyl acetate 4.36 in 
good yield. Attempts at forging the phenyl acetyl orthoester functionality of RTX, 
however, failed under all conditions screened, although material was limited at this point 
and an exhaustive screening could not be conducted. 
 It is worth speculating the consequences of the bridged furan on orthoester 
formation. Although its existence does not appear to dramatically effect the relative 
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geometry of the syn-triol system, the conformational lock bridging C4 and C8 possibly 
limits the overall flexibility of the C-ring—in particular at C9—thus making the boat 
conformation required for orthoester formation impossible even if oxonium intermediate 
4.39 is capable of formation (Scheme 4.12). 
 Lastly, removal of the A-ring ketal protecting group was initally met with 
difficulty. A singular condition—heating a solution of 4.21 and 10 equivalents PPTS in 2-
butanone-H2O (1:4 v/v) at 90°C for 24-72 h—led to the isolation of ketone 4.38 in 
varying yields (30-50%) with significant quantities of unreacted 4.21 remaining. 
Employment of stronger acids such as TsOH and aq. HCl or Lewis acids such as CAN,  11
I2,  or In(OTf)3  gave no reaction or decomposition. This result, coupled with the 12 13
recalcitrant TMS group, was not only befuddling but intimates non-obvious future 
difficulties with the current incarnation of the synthetic strategy. Likely the identification 
and implementation of a different set of protecting groups in the future will be required to 
enable a straight-forward deprotection plan to further progress this project. 
4.6 — Concluding remarks 
 This chapter details my final investigative work towards translating epoxide 4.2 to 
a complex daphnane diterpene stereopolyad found in not only resinaferatoxin but all 
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DDOs in general. Despite prior work which confirmed a titanocene-mediated reductive 
epoxide opening is capable of establishing the desired formal trans anti-Markovnikov 
hydration adduct, a confluence of unforseen features of the complex stereochemistry 
present in 4.2 along with aberrant behavior of unprotected native functionality in the 
molecule precluded its usefulness in accessing the complete RTX stereochemical 
configuration and thus its eventual elaboration to the natural product itself. 
 A series of work-arounds with sound mechanistic rationale were proposed and 
evaluated to combat the undesired reactivity observed but to no avail. Although the use of 
an ethylene ketal and trimethylsilyl group as protecting groups for C3 and C4 proved 
impressively useful in function, their final removal was met not only with remarkable 
resistance but an uncontrollable epoxide opening via addition of the C4 tertiary alcohol 
to afford a bridged furan motif which could not be utilized in a productive fashion despite 
considerable experimentation. Likewise, although phenyl acetylation of the C8 alcohol 
was eventually found to be quite facile, the stereochemical consequence of the bridged 
furan prevented the syn-triol system from undergoing condensation with the pendant ester 
to form the coveted orthoester moiety. 
 In conclusion, it appears the complex epoxide 4.2, for the time being, might be the 
furthest point achievable via the choreography outlined in this work based on a p-quinol 
functionalization strategy. In sum, several complex molecules with seven contiguous 
stereocenters were generated in short order, all containing six stereocenters found in all 
daphnane diterpene orthoesters. 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4.7 — Experimental procedures 
General Methods. Unless otherwise noted, all reactions were performed using flame-
dried glassware under an atmosphere of nitrogen. Air- and moisture-sensitive liquids and 
solutions were transferred via syringe or stainless steel cannula. Organic solutions were 
concentrated under reduced pressure by rotary evaporation. Reactions were monitored by 
thin layer chromatography (TLC) using SiliCycle glass plates pre-coated with silica gel 
(0.25-mm thickness; 60-Å pore size) impregnated with a fluorescent indicator (254 nm). 
TLC plates were visualized by exposure to ultraviolet light (UV) and staining with 
ethanolic solutions of phosphomolybdic acid (PMA), acidic solutions of vanillin, or 
aqueous solutions of potassium permanganate followed by heating. Flash column 
chromatography was performed on silica gel 60 (230-400 mesh) purchased from 
SiliCycle. Solid reagents were weighed out in air. Reaction work-ups and 
chromatographic purifications were performed on the bench top in air using reagent grade 
solvents.  
Materials.  Reagent grade solvents were purchased from Fisher Scientific and used 
without further purification. Anhydrous dichloromethane (DCM), tetrahydrofuran (THF), 
acetonitrile (MeCN), diethyl ether (Et2O), and toluene (PhMe) was obtained by passing 
these previously degassed solvents through two columns of activated alumina prior to 
use. Chemicals were purchased from commercial sources and used at received. 
Instrumentation. 1H NMR and 13C NMR spectra were recorded at 117.42 kG (1H 500 
MHz, 13C 125MHz), 93.94 kG (1H 400 MHz, 13C 100 MHz), or 70.50 kG (1H 300 
MHz, 13C 75 MHz) at ambient temperature on Varian Agilent-500 MHz VNMRS, Varian 
Agilent-400 MHz VNMRS, and Varian Agilent Agilent-300 MHz VNMRS 
spectrometers. Hydrogen chemical shifts are expressed in parts per million (ppm) relative 
to the residual protio solvent resonance: CDCl3 δ 7.26, CD3OD δ 3.31, DMSO-d6 δ 2.50, 
acetone-d6 δ 2.05. For 13C spectra, the centerline of the solvent signal was used as internal 
reference: CDCl3 δ 77.16, CD3OD δ 49.00, DMSO-d6 δ 39.52, acetone-d6 δ 29.84, 
206.26. Data are reported as follows: chemical shifts, multiplicity (s =singlet, d =doublet, 
t = triplet, q = quartet, and m = multiplet), coupling constant in hertz (Hz), and 
integration. 
 Infrared (IR) spectra were recorded on a Thermo-Fisher Nicolet FT-IR with ATR 
and are reported in terms of frequency absorption (cm-1). 
 High resolution mass spectrometry (HR-MS) data was obtained on a Waters Qtof 
(hybrid quadrupolar/time-of-flight) API US system by electrospray (ESI) in the positive 
mode by Dr. Norman Lee of the Boston University Department of Chemistry Chemical 
Instrumentation Center (BU-CIC). 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A 2-dram vial equipped with a magnetic stir-bar was charged a solution of 4.11 (0.041 g, 
0.094 mmol, 1.0 eq) and imidazole (0.129 g, 1.89 mmol, 20.0 eq) in 2 mL MeCN. 
TMSCl (0.120 mL, 0.94 mmol, 10.0 eq) was added and the reaction was stirred at room 
temperature for 24 h. The reaction was poured into sat’d aq. NaHCO3 and extracted with 
Et2O. The organic phase was washed with brine, dried over anhydrous sodium sulfate, 
and concentrated under reduced pressure. 
 The resulting crude material was dissolved in 1:1 CH2Cl2-MeOH (4 mL) and 
dioxygen was bubbled through the mixture for 5 min. The solution was treated with 
methylene blue (~0.5 mg), cooled to 0°C, and irradiated with four white LED corn bulbs 
for 2 h. Triphenylphosphine (0.025 g, 0.094 mmol, 1.0 eq) was added and the reaction 
was stirred for 0.5 h and concentrated under reduced pressure. The resulting crude 
material was purified by flash column chromatography on deactivated silica gel (2% Et3N 
in CH2Cl2 → 1% Et3N + 1% Et2O in hexanes) to afford the title compound as a clear film 
(0.023 g, 47% yield over 2 steps). 
 
1H-NMR (500 MHz, CDCl3): 
δ 5.22 (d, J = 1.9 Hz, 1H), 5.06 (s, 1H), 5.05 (s, 1H) 4.05 – 3.93 (m, 2H), 3.91 – 3.83 (m, 
2H), 3.11 (d, J = 1.6 Hz, 1H), 2.75 (dd, J = 12.5, 7.6 Hz, 1H), 2.32 (d, J = 15.2 Hz, 1H), 
2.19 – 2.08 (m, 2H), 2.03 (dqd, J = 13.0, 6.6, 1.9 Hz, 1H), 1.85 (s, 3H), 1.83 – 1.78 (m, 
1H), 1.72 (s, 3H), 1.69 – 1.63 (m, 3H), 1.57 (ddd, J = 13.3, 9.5, 5.8 Hz, 1H), 1.27 – 1.21 
(m, 1H), 0.94 (d, J = 6.6 Hz, 3H), 0.17 (s, 9H), 0.06 (s, 9H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 146.52, 139.13, 127.42, 117.55, 113.14, 83.82, 75.90, 74.46, 69.89, 68.04, 65.41, 64.42, 
53.39, 39.68, 37.47, 35.70, 32.27, 24.59, 22.35, 18.58, 18.54, 2.39, 2.23 
 
IR (ATR):  
3515, 2940, 2867, 1250, 842 cm-1 
 
HRMS (ESI):  
[M + Na]+ calcd for C27H46O6Si2: 545.2731; found 545.2753 
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A solution of 4.2 (0.051 g, 0.113 mmol, 1.0 eq) in 5 mL THF was treated with TBAF·(t-
BuOH)4 (0.630 g, 1.13 mmol, 10.0 eq) and heated to 75°C (oil bath) for 18 h. The 
reaction was cooled to room temperature, concentrated under reduced pressure, and 
directly purified by flash column chromatography on silica gel (CH2Cl2 → 40% EtOAc 
in hexanes) to afford the title compound as a white foam (0.039 g, 91% yield). 
 
1H-NMR (500 MHz, CDCl3): 
δ 5.89 (s, 1H), 5.17 (s, 1H), 4.94 (s, 1H), 4.05 – 3.91 (overlap m, 5H), 2.87 (s, 1H), 2.84 
(br s, 1 H), 2.47 (d, J = 17.6 Hz, 1 H), 2.39 (dd, J = 8.0, 6.2 Hz, 1H), 2.24 (br s, 1H), 2.08 
(dd, J = 15.1, 7.4 Hz, 1H), 1.98 – 1.89 (m, 2H), 1.89 – 1.82 (m, 2H), 1.81 (s, 3H), 1.77 (s, 
3H), 1.75 – 1.69 (m, 1H), 1.53 (dd, J = 15.1, 11.0 Hz, 1H), 1.04 (d, J = 6.3 Hz, 3H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 147.80, 135.09, 124.86, 114.72, 111.56, 88.85, 88.05. 76.95, 73.90, 65.83, 64.93, 59.02, 
40.95, 36.11, 34.09, 31.70, 30.13, 23.07, 22.89, 19.46, 17.70 
 
IR (ATR):  
3401, 2960, 2917, 2848, 1258, 1014, 792 cm-1 
 
HRMS (ESI):  
[M + Na]+ calcd for C21H30O6: 401.1940; found 401.1947 
OH
Me
HO
Me
OH
Me
OH
O
O
4.21
!  314
A solution of ketal 4.21 (0.044 g, 0.116 mmol, 1.0 eq) in 4:1 H2O-butanone (5 mL) was 
treated with PPTS (0.291 g, 1.16 mmol, 10.0 eq), heated to 80-90°C (oil bath) for 48 h, 
and cooled to room temperature. The reaction mixture was extracted thrice with Et2O and 
the combined organic extracts were washed with brine, dried over anhydrous sodium 
sulfate, and concentrated under reduced pressure. The resulting crude residue was 
purified by flash column chromatography on silica gel (CH2Cl2 → 30% EtOAc in 
hexanes) to afford ketone 4.38 as a white foam (0.019 g, 50% yield). 
1H-NMR (500 MHz, CDCl3): 
δ 5.87 (s, 1H), 5.17 (s, 1H), 4.96 (s, 1H), 4.00 (d, J = 3.0 Hz, 1H), 3.05 (s, 1H), 2.76 (d, J 
= 17.5 Hz, 1H), 2.69 (d, J = 8.5 Hz, 1H), 2.66 (s, 1H), 2.55 (dd, J = 17.0, 8.4 Hz, 1H), 
2.42 (ddd, J = 17.4, 12.4, 9.0 Hz, 1H), 2.36 – 2.28 (m, 2H), 2.12 – 1.97 (m, 3H), 1.96 – 
1.87 (m, 2H), 1.81 (s, 3H), 1.79 (s, 3H), 1.55 (dd, J = 15.0, 10.9 Hz, 1H), 1.04 (d, J = 6.2 
Hz, 3H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 212.62, 148.24, 133.98, 124.68, 111.41, 90.29, 89.49, 84.60, 77.45, 73.76, 59.41, 41.51, 
39.41, 37.03, 30.91, 23.64, 22.76, 19.27, 16.68 
 
IR (ATR):  
3429, 2967, 2929, 2246, 1750, 1443, 1029, 911, 733 cm-1 
 
HRMS (ESI):  
[M + Na]+ calcd for C19H26O5: 357.1678; found 357.1688 
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A solution of 4.21 (0.067 g, 0.177 mmol, 1.0 eq), phenylacetic acid (0.120 g, 0.885 
mmol, 5.0 eq), and EDC·HCl (0.170 g, 0.885 mmol, 5.0 eq) in 5 mL CH2Cl2 was treated 
with DMAP (0.022 g, 0.177 mmol, 1.0 eq) at room temperature. After 0.5 h the reaction 
was concentrated to a lower follow and directly purified by flash column chromatography 
on silica gel (CH2Cl2 → 20-30% EtOAc in hexanes) to afford ester 4.36 as a colorless 
film (0.061 g, 70% yield). 
1H-NMR (500 MHz, CDCl3): 
δ 7.35 – 7.22 (overlap m, 5H), 5.57 (s, 1H), 5.31 (s, 1H), 5.03 (s, 1H), 4.83 (s, 1H), 4.02 – 
3.85 (m, 4H), 3.64 (s, 2H), 2.39 (dd, J = 17.6, 1.5 Hz, 1H), 2.29 (dd, J = 8.7, 6.4 Hz, 1H), 
2.14 – 1.97 (m, 2H), 1.94 – 1.86 (m, 1H), 1.83 (ddd, J = 12.5, 8.0, 6.0 Hz, 1H), 1.81 – 
1.73 (m, 3H), 1.69 (s, 3H), 1.65 (s, 3H), 1.53 – 1.47 (m, 1H), 1.00 (d, J = 6.0 Hz, 3H) 
 
13C-NMR (126 MHz, CDCl3): 
δ 176.26, 170.07, 146.32, 134.62, 134.22, 133.62, 129.49, 128.73, 128.55, 127.37, 
127.14, 124.21, 113.99, 112.14, 88.45, 87.78, 75.39, 65.58, 64.84, 59.43, 41.73, 41.08, 
37.05, 35.17, 30.15, 23.71, 22.77, 19.31, 17.28 
 
IR (ATR):  
3439, 2969, 2200, 1735, 1497, 1454, 1255, 1151, 1037, 909, 715, 647 cm-1 
 
HRMS (ESI):  
[M + H]+ calcd for C29H36O7: 497.2539; found 497.2539 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4.8 — NMR Spectra 
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CHAPTER FIVE 
Prospects & Retrospect 
5.1 — Planned completion of (±)-RTX 
 The last chapter of this thesis provides some working ideas for the completion of 
(±)-RTX in addition to other DDOs. The plans disclosed herein are based on the 
assumption that access to the complete RTX stereoheptad has been realized. Since future, 
and therefore unforseeable, work will be on-going to make this assumption a reality, a 
more productive discussion begins where my plans would have ideally ended. 
 A blueprint for the completion of (±)-RTX 5.8 is detailed in Scheme 5.1. 
Beginning with the complex stereoheptad 5.1, ketal deprotection  unveils the carbonyl 1
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functionality of the A-ring. Accordingly, esterification of triol 5.2 with the activated 
mixed anhydride 5.9 is expected to selectively give 5.3. Exposure to mild acid (HClO4, 
MeOH) would induce orthoester formation as previously reported by both Hecker  and 2
Wender.  3
 With orthoester 5.4 in hand, A-ring functionalization is planned to proceed 
employing the tactic developed in the first-generation synthesis (Chapter 2): Danheiser-
Colby methylenation and RhCl3-catalyzed olefin isomerization is anticipiated to provide 
the complex tricycle 5.6 with nearly all the functionality of 5.8. Allylic oxidation (SeO2) 
could selectively oxidize the C20 methyl and following esterification with the activated 
mixed anhydride 5.10 and global deprotection (TBAF) afford (±)-RTX, ideally via a 
longest linear sequence of twenty steps from readily available starting materials. 
 Although the remaining proposed transformations in this sequence possess 
considerable precedent, the final allylic oxidation deserves additional discussion. 
Examples of late-stage modulation of oxidation state at C20 in daphnane, tigliane, and 
ingenane synthesis finds precedent in all work by Wender and co-workers; Baran and co-
workers; and the total synthesis of (+)-ingenol by Wood and co-workers. 
 Wender’s routes typically feature a Riley oxidation of an exocyclic C6,20 olefin 
and though efficient generally affords mixture of regioisomers. Inoue’s group employed 
the same transform in their synthesis of (+)-RTX, with similar results, although 
importantly were able to show that the C13 isopropenyl group is unscathed by the 
reaction conditions. A displacement reaction with an oxygen nucleophile or 
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transpositional halogenation followed by displacement furnishes the desired C20 
hydroxyl in protected form. 
 Wood and Baran both employ as the last step of their syntheses a stoichiometric 
Riley oxidation on a trisubstituted B-ring olefin of 20-deoxy-ingenol to directly afford 
(+)-ingenol. Baran noted the conditions employed by Wood tended to give over-oxidized 
side-products and inclusion of formic acid followed by basic aqueous work-up provided 
better yields of (+)-ingenol. The corresponding aldehyde was the major product in 
Baran’s synthesis of (+)-phorbol and was reduced and acylated in a secondary step. 
 The synthesis of 5.7 in fact completes a formal total synthesis of (±)-RTX 
although Wender’s end-game required three steps (TBAF deprotection, esterification, and 
acetate cleavage with pyrrolidine). By employing the silylated derivative 5.10, 
deprotection of both the aryl silyl ether and the C4 tertiary TMS ether can occur in one 
step, identical to the end-game of Inoue and co-workers in their synthesis of (+)-RTX. 
 The proposed end-game sequence requires ideally nine discrete steps from 
stereoheptad 5.1. As shown in Scheme 5.2, from 5.4 a two-step sequence can also secure 
a formal total synthesis of (±)-RTX. Enolate alkylation of 5.4 followed by allylic 
oxidation would afford 5.12 which was advanced by Wender’s group to (±)-RTX in eight 
additional steps. Notably the original preparation of 5.12 required thirty-six steps whereas 
the proposed progression would only require sixteen steps from known starting materials. 
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 If executed properly, the plans outlined above would yield the most concise 
chemical synthesis of any DDO to date, surpassing all precedent in step count by a 
reduction of greater than fifty percent. 
5.2 — A proposal for the synthesis of resinaferanoid analogs 
 In order to render the overall synthesis both practical and flexible for analog 
preparation, a robust functional handle must be installed reasonably early to provide 
adequate divergence. As shown in Scheme 5.3, an alkynyl orthoester is proposed to allow 
maximal flexibility in at least the divergent preparation of orthoester analogs of the 
resinaferoid oxidation state. 
 From 5.2 exposure to the activated mixed anhydride 5.18 followed by acid-
mediated orthoester formation and TMS-cleavage should afford the alkynyl orthoester 
5.13. The alkyne moiety is forseen as being an appropriate handle in the preparation of a 
myriad of orthoesters. For example, hydrozirconation  is anticipated to proceed with 4
good selectivity for the alkyne and following cross-coupling can afford aliphatic E-olefin 
based orthoesters common to many daphnanes such as the neurotrophic DDO 
synaptolepis factor K7. 
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 A-ring functionalization, allylic oxidation, esterification, and deprotection could 
afford novel RTX analogs of type 5.17 for biological testing. 
5.3 — A general strategy to access higher order daphnanes: ruminations of an 
abiotic ‘oxidase’ phase 
 As first proposed in Chapter 2, it was originally conceived that access first to 
DDOs of the resinaferanoid oxidation state could in principle lead to higher-order DDOs 
such as synaptolepis factor K7 via an abiotic ‘oxidase’ phase in which the innate 
reactivity of the internal prenyl group of the B-ring could be exploited. This concept 
holds some precedent in Wender’s synthesis of 6,7-epi-yuanhuapin and in Baran’s 
synthesis of (+)-ingenol and unnatural ingenanes but requires additional discussion. 
 Perhaps the most troubling oxidation required is the stereoselective hydroxylation 
of the C5-β C-H bond. Although this position is allylic, the unknown steric effect of the 
C4-OTMS group in addition to possible electronic barriers renders this requisite C-H 
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oxidation ambiguous a priori. A substrate-directed strategy is deemed the most likely to 
succeed and forms the basis of the proposed sequence depicted in Scheme 5.4. 
 The TMS silyl ether of the C4 hydroxyl group would need to be replaced with a 
hydrido-silane group of the type shown on 5.20 (with alkyl chain of synaptolepis factor 
K7 for illustrative purposes). Recent developments in C-H oxidation technology lends 
support for the proposed substrate-directed, catalyst-controlled C-H silylation 5.20 → 
5.21.  A subsequent Fleming-Tamao oxidation would afford the required 1,2-diol 5.22 5
with complete regio- and stereoselectivity. Allylic oxidation of 5.22 is anticipated to 
afford 6,7-des-epoxy-synaptoplepis factor K7 5.23. 
 The required α-epoxidation separating 5.23 from the most potent neurotrophic 
small molecule known is unfortunately forseen to be a non-trivial development (Scheme 
5.5). Since the only known directed epoxidation of substrates of this complexity was 
shown by Wender’s group to proceed with complete β-selectivity, a clear and confident 
solution to this problem is lacking. Thus, the α-selective epoxidation of 6,7-des-epoxy 
DDOs for the time being appears to be an unsolved problem. It is possible the C5 
hydroxyl group could be imparting a directing effect to give the observed selectivity and 
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masking of the the the 4,5-diol system, though taxing in terms of step-economy, may 
provide one possible solution to this problem. 
 Since a reagent-controlled manifold holds the most promise, the use of chiral 
ligands to give matched selectivity requires the starting material to be enantiopure. Up 
until now, all compounds prepared and proposed in this thesis have been racemic. Thus, 
discussion of a future asymmetric variant of the chemistry developed is warranted.  
5.4 — Some proposals for asymmetric syntheses of DDOs 
 Though the epoxy ketal 5.26 has previously been prepared in enantiopure form by 
Shi and co-workers,  the catalyst developed for such a transformation required nine steps 6
to prepare and the yield of 5.26 was moderate (46% yield, 0.15 mmol scale), rendering its 
deployment rather impractical for the large scale preparations. Jacobsen’s asymmetric 
epoxidation  was attempted in earlier incarnations of this work but conversions were low 7
even with large catalyst loadings (>10 mol%). Furthermore, hydrolytic kinetic resolution 
is limited to terminal epoxides. 
 Since the epoxy ketal 5.26 is readily prepared in large quantities, a resolution 
strategy following its opening is one possible avenue that can provide access to 
enantiopure starting material of both antipodes. As shown in Scheme 5.6, an ezymatic 
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resolution of 5.26 with a commercially available enzyme such as lipase could provide 
acetate 5.28 and 5.29 with good levels of enantiomeric enrichment. Oxidation of 5.29 or 
hydrolysis/oxidation of 5.28 would allow access to antipodes 5.30 and ent-5.30, 
respectively. 
 It is important to note, however, the danger of possible racemization during the 
oxidation of ketone 5.30. Since 5.30 has to date only been prepared in racemic fashion, 
the acidity of the benzylic, α-proton and its tendency to undergo epimerization is not 
known. Studies along these lines and the identification of an oxidation system that does 
not induce epimerization of 5.30 will be required for this proposed enantioselective route 
to succeed.  8
 If ketone 5.30 is indeed found to rapidly epimerize under a variety of conditions, 
it may be possible to develop an enantioconvergent preparation of the tertiary alcohol 
5.31 by means of a dynamic kinetic resolution of racemic 5.30. Elegant recent studies by 
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Johnson and co-workers have demonstrated the feasibility of enantio- and 
diastereoselective nucleophilic addition reactions to rapidly equilibrating species to afford 
optically pure building blocks from racemic starting materials.  9
 As shown in Scheme 5.7, it is envisioned that the equilibrating intermediates 5.30 
and ent-5.30 can be stereoselectively methallylated by a combination of, perhaps, a latent 
nucleophile such as a methallyl boronic ester in combination with a chiral catalyst which 
can discriminate between the two enantiomers of 5.30. The diastereoselectivity of the 
allylation is expected to be derived from approach of the nucleophile from the least 
hindered face of the ketone, as observed with the Grignard variant.  10
 Since natural DDOs are isolated exclusively as a single enantiomer, the 
development of enantiodivergent methods would allow for unprecedented biological 
studies and undoubtedly provide new insight into structural requirements for eliciting the 
powerful activities of DDOs. 
5.5 — Retrospective & concluding remarks 
 From the inception of this project a single ambitious goal of developing a concise 
synthetic route to daphnane diterpene orthoesters has provided the impetus for the work 
documented in this thesis. The original concept was to quickly synthesize a DDO-like 
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carbon skeleton and explore oxidative pathways to generate unnatural compounds for 
biological testing. However, as my endeavor advanced it soon became apparent that a 
short DDO total synthesis was possible if historic problems in daphnane synthesis could 
be addressed. These issues include, but are not limited to: the rapid generation of a 5-7-6 
tricyclic core; securing the two trans ring fusions of the carbon skeleton; and concise, 
stereoselective elaboration of the complex C-ring which contains two angular alkyl 
appendages, a challenging methanetriyl group, and a syn triol system derived from a 
complex orthoester cage. 
 Key to this work was the identification of a greatly simplifying series of 
disconnections based on a p-quinol functionalization sequence which are readily 
available in a single step from simple p-alkyl phenols. This sequence was shown to be 
capable of generating molecular complexity rapidly and depending on the choreography 
of transformations, regio- and stereodivergency could be achieved. 
 The DDO core was rapidly assembled by an efficient ring-closing metathesis after 
a convergent coupling of a simple arene nucleophile to a simple epoxy cyclopentanone 
derivative. Coupled with a minimization of concession steps and the largely successful 
quinol elaboration, complex stereopolyads closely resembling DDO motifs were prepared 
in ten two twelve steps (sixteen to eighteen total operations) from readily available 
starting materials. 
 Despite the lack of success in elaboration to the final target of interest, based on 
the established bench-mark for synthetic efficiency in this arena of total synthesis, I 
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believe the results shown delineate a short, controlled pathway towards these incredibly 
complex molecules. It is my hope that future work will exploit the blue-prints disclosed 
herein to continue efforts towards the concise preparation of DDOs and to rectify the 
unsolved problems that I have uncovered during my graduate studies in the Beeler 
laboratory. 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